nrc20221231_10k.htm

0001437749-23-005305.txt : 20230303 0001437749-23-005305.hdr.sgml : 20230303 20230303104947 ACCESSION NUMBER: 0001437749-23-005305 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP CENTRAL INDEX KEY: 0000070487 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 470634000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35929 FILM NUMBER: 23702200 BUSINESS ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 BUSINESS PHONE: 4024752525 MAIL ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 10-K 1 nrc20221231_10k.htm FORM 10-K nrc20221231_10k.htm

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from to

Commission File Number 001-35929

National Research Corporation

(Exact name of Registrant as specified in its charter)

Delaware		47-0634000
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

	1245 Q Street, Lincoln, Nebraska 68508
	(Address of principal executive offices) (Zip Code)

	(402) 475-2525
	(Registrant’s telephone number, including area code)

Securities registered pursuant to 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.001 par value	NRC	The NASDAQ stock market

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.) Yes ☐ No ☒

Aggregate market value of the common stock held by non-affiliates of the registrant at June 30, 2022: $444,018,792.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

Common Stock, $.001 par value, outstanding as of February 23, 2023: 24,594,390

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Proxy Statement for the 2023 Annual Meeting of Shareholders are incorporated by reference into Part III.

Table of Contents

TABLE OF CONTENTS

		Page
PART I

Item 1.	Business	1
Item 1A.	Risk Factors	7
Item 1B.	Unresolved Staff Comments	14
Item 2.	Properties	14
Item 3.	Legal Proceedings	14
Item 4.	Mine Safety Disclosures	14

PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	15
Item 6.	[Reserved]	16
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 7A.	Quantitative and Qualitative Disclosure About Market Risk	23
Item 8.	Financial Statements and Supplementary Data	23
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	52
Item 9A.	Controls and Procedures	52
Item 9B.	Other Information	52
Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	52

PART III

Item 10.	Directors, Executive Officers and Corporate Governance	53
Item 11.	Executive Compensation	53
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters	53
Item 13.	Certain Relationships and Related Transactions, and Director Independence	53
Item 14.	Principal Accountant Fees and Services	53

PART IV

Item 15.	Exhibits	54
Item 16.	Form 10-K Summary	55
Signatures		57

Table of Contents

PART I

Item 1.

Business

Special Note Regarding Forward-Looking Statements

Certain matters discussed in this Annual Report on Form 10-K are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can generally be identified as such because the context of the statement includes phrases such as National Research Corporation, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), “believes,” “expects,” “may,” “could,” “anticipates,” “estimates,” “plans,” “intends,” or the use of words such as “would,” “will,” “may,” “could,” “goal,” “focus,” or “should,” or other words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. In this Annual Report on Form 10-K, statements regarding the value and utility of, and market demand for, our service offerings, future opportunities for growth with respect to new and existing clients, our future ability to compete and the types of firms with which we will compete, future consolidation in the healthcare industry, future adequacy of our liquidity sources, future revenue sources, future revenue growth, future revenue estimates used to calculate recurring contract value, the expected impact of economic factors, including inflation, future capital expenditures including, without limitation, our headquarters renovation costs, and the timing, amount, and sources of cash to fund such capital expenditures, future stock repurchases and dividends, the expected impact of pending claims and contingencies, the future outcome of uncertain tax positions, our future use of owned and leased real property, the expected impact of the conflict in Ukraine, and the expected impact of the COVID-19 pandemic, among others, are forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which could cause actual results or outcomes to differ materially from those currently anticipated. Factors that could affect actual results or outcomes include, without limitation, the following factors:

●

The possibility of non-renewal of our client service contracts, reductions in services purchased or prices, and failure to retain key clients;

●

Our ability to compete in our markets, which are highly competitive with new market entrants, and the possibility of increased price pressure and expenses;

●

The likelihood that the COVID-19 or other pandemic will adversely affect our operations, sales, earnings, financial condition and liquidity;

●

The likelihood that the ongoing Russian-Ukraine conflict will adversely affect our operations, sales, earnings, financial condition and liquidity;

●

The effects of an economic downturn;

●

The impact of consolidation in the healthcare industry;

●

The impact of federal healthcare reform legislation or other regulatory changes;

●

Our ability to attract and retain key managers and other personnel;

●

The possibility that our intellectual property and other proprietary information technology could be copied or independently developed by our competitors;

●

The possibility for failures or deficiencies in our information technology platform;

●

The possibility that we or our third-party providers could be subject to cyber-attacks, security breaches or computer viruses; and

●

The factors set forth under the caption “Risk Factors” in Part I, Item 1A of this Annual Report on Form 10-K and various disclosures in our press releases, stockholder reports, and other filings with the Securities and Exchange Commission.

Shareholders, potential investors and other readers are urged to consider these and other factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included are only made as of the date of this Annual Report on Form 10-K and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as required by the federal securities laws.

Table of Contents

General

For more than 40 years, NRC Health has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health’s commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health’s patient-focused approach, unmatched market research, and emphasis on consumer preferences are transforming the healthcare experience, creating strong outcomes for patients and entire healthcare systems.

Our end-to-end solutions enable our clients to understand what matters most to each person they serve – before, during, after, and beyond clinical encounters – to gain a longitudinal understanding of how life and health intersect, with the goal of developing lasting, trusting relationships. Our ability to measure what matters most and systematically capture, analyze, and deliver insights based on self-reported information from patients, families, and consumers is critical in today’s healthcare market. We believe access to and analysis of our extensive consumer-driven information is increasingly valuable as healthcare providers need to better understand and engage the people they serve to create long-term relationships and build loyalty.

Our expertise includes the efficient capture, transmittal, analysis, and interpretation of critical data elements from millions of healthcare consumers. Using our solutions, our partners gain insights into what people think and feel about their organizations in real-time, allowing them to build on their strengths and implement service recovery with greater speed and personalization. We also provide legacy experience-based solutions and shared intelligence from industry thought leaders and the nation’s largest member network focused on healthcare governance and strategy to member boards and executives.

Our portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. We partner with clients across the continuum of healthcare services and believe this cross-continuum positioning is a unique and an increasingly important capability as evolving payment models drive healthcare providers and payers towards a more collaborative and integrated service model.

We have a broad and diversified client base that is distributed primarily across the United States. Our ten largest clients collectively accounted for 15%, 14%, and 14% of our total revenue in 2022, 2021 and 2020, respectively. Approximately 1%, 2% and 2% of our revenue was derived from foreign customers in 2022, 2021, and 2020, respectively.

We have achieved a market leadership position through our more than 40 years of industry innovation and experience, as well as our long-term, recurring revenue relationships (solutions that are used or required by a client each year) with many of the healthcare industry’s largest organizations. Since our founding in 1981, we have focused on meeting the evolving information needs of the healthcare industry through internal product development, as well as select acquisitions. We are a Delaware corporation headquartered in Lincoln, Nebraska.

Human Understanding Solutions

NRC Health recognizes that behind every person is a story. We help our partners get to know each person they serve - their behaviors, preferences, wants, and needs—not as point-in-time insights, but as an ongoing relationship.

With the complexity and demands associated with healthcare delivery today, seeing the whole picture is now more important than ever. The end-to-end Human Understanding solutions are designed to help capture and act on what matters most to patients and their families.

The Human Understanding solutions deliver the capabilities needed to turn strategic aspiration into action in critical focus areas. Each set of capabilities unlocks Human Understanding at the right time and place to improve care, enhance performance, and catalyze growth.

Our digital solutions consist of three primary solution categories which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. The primary solution categories include Marketing, Reputation, and Experience.

Table of Contents

Marketing Solutions – Our Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators; and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. Market Insights is the largest U.S. healthcare consumer database of its kind, measuring the opinions and behaviors of approximately 300,000 healthcare consumers across the contiguous United States annually. Market Insights is a syndicated survey that provides clients with an independent third-party source of information that is used to understand consumer perception and preferences and optimize marketing strategies. Our Marketing solutions provide clients with on-demand tools to measure brand value and build brand equity in their markets, evaluate and optimize advertising efficacy and consumer recall, and tailor research to obtain the real time voice of customer feedback to support branding and loyalty initiatives.

Experience Solutions – Our Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform that collects and measures data and then delivers business intelligence that our clients utilize to improve patient experience, engagement and loyalty. Patient experience data can also be collected on a periodic basis using Consumer Assessment of Healthcare Providers and Systems (“CAHPS”) compliant mail and telephone survey methods for regulatory compliance purposes and to monitor and measure improvement in CAHPS survey scores. CAHPS survey data can be collected and measured as an integrated service within our digital platform or independently as a legacy service offering. Our Experience solutions provide healthcare systems with the ability to receive and act on customer and employee feedback across all care settings in real-time. Experience solutions include patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. These solutions enable clients to comply with regulatory requirements and to improve their reimbursement under value-based purchasing models. More importantly, our Experience solutions provide quantitative and qualitative real-time feedback, improvement plans, and coaching insights. By illuminating the complete care journey in real time, our clients can ensure each individual receives the care, respect, and experience they deserve. Developing a longitudinal profile of what healthcare customers want and need allows for organizational improvement and increased customer loyalty.

Our Experience solutions also include tools to drive effective communication between healthcare providers and patients in the critical 24-72 hours post discharge using an automated discharge call workflow supported by our digital platform. Through preference-based communications and real-time alerts, these solutions enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction and support safe care transitions. Tracking, trending and benchmarking tools isolate the key areas for process improvement allowing organizations to implement changes and reduce future readmissions.

Reputation Solutions – Our Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making. Our star ratings tools enable our partners to publish a five-star rating metric and verified patient feedback derived from actual patient survey data to complement their online physician information. Sharing this feedback not only results in better-informed consumer decision-making but also has the ability to drive new patient acquisition and grow online physician reputation. Our reputation monitoring tool alerts our partners to ratings and reviews on third-party websites and provides workflows for response and service recovery. These solutions raise physician awareness of survey results and provide access to improvement resources and educational development opportunities designed to improve the way care is delivered.

The Governance Institute

Our Governance solutions, branded as The Governance Institute (“TGI”), serves not-for-profit health system boards of directors, executives, and physician leadership. TGI’s subscription-based, value-driven membership services are provided through national conferences, publications, advisory services, and an online portal designed to improve the effectiveness of hospital and healthcare systems by continually strengthening their board governance, strategic planning, medical leadership, management performance and customer loyalty. TGI also conducts research studies and tracks industry trends showcasing emerging healthcare trends and best practice solutions of healthcare system boards across the country. TGI thought leadership helps our client board members and executives inform and guide their organization’s strategic priorities in alignment with the rapidly changing healthcare market.

For additional information on our operating segment and our revenue and assets by geographic area, see Note 13, “Segment Information,” to our consolidated financial statements.

Table of Contents

Markets

Growth Strategy

We believe that the value proposition of our current solutions, combined with the favorable alignment of our solutions with emerging market demand, positions us to benefit from multiple growth opportunities. We believe that we can accelerate our growth through (1) increasing scope of services and sales of our existing solutions to our existing clients (or cross-selling), (2) winning additional new clients through market share growth in existing market segments, (3) developing and introducing new solutions to new and existing clients, and (4) pursuing acquisitions of, or investments in, firms providing products, solutions or technologies which complement ours.

Increasing contract value with existing clients. Our growth team actively identifies and pursues cross-sell opportunities for clients to add additional solutions in order to accelerate our growth. Organic contract value growth is also realized by the increased scope of solution adoption as the size of client organizations increase from market expansion and consolidation.

Adding new clients. We believe that there is an opportunity to add new clients across all solutions. Our sales organization is actively identifying and engaging new client prospects with a focus on demonstrating the economic value derived from adopting the portfolio of solutions in alignment with the prospect’s strategic objectives.

Adding new solutions. The need for effective solutions in the market segments that we serve is evolving to align with emerging healthcare consumerism trends. The evolving market creates an opportunity for us to introduce new solutions that leverage and extend our existing core competencies. We believe that there is an opportunity to drive sales growth with both existing and new clients, across all of the market segments that we serve, through the introduction of new solutions.

Pursue strategic acquisitions and investments. We have historically complemented our organic growth with strategic acquisitions, having completed eight such transactions over the past nineteen years. These transactions have added new capabilities and access to market segments that are adjacent and complementary to our existing solutions and market segments. We believe that additional strategic acquisition and/or investment opportunities will exist from time to time to complement our organic growth by further expanding our service capabilities, technology offerings and end markets.

We generate the majority of our revenue from the renewal of subscription-based client service agreements, supplemented by sales of additional solutions to existing clients and the addition of new clients. Our sales activities are carried out by our growth team staffed with professional, trained sales associates.

We engage in marketing activities that enhance our brand visibility in the marketplace, generate demand for our solutions and engage existing clients. Strategic campaigns and programs focus on (1) ensuring coverage of prospective clients via targeted advertising and account-based campaigns, (2) elevating client value evidence and success stories to an executive level profile, (3) engaging key stakeholders with content, programming and events and (4) amplifying thought leadership through public and media relations programs that include earning placement in national media and trade publications, securing podium presentations at key industry events and winning awards on behalf of us and our executives.

Competition

We believe the primary competitive factors within our market include quality of service, timeliness of delivery, unique service capabilities, credibility of provider, industry experience, and price. We believe that our industry leadership position, exclusive focus on the healthcare industry, cross-continuum presence, comprehensive portfolio of solutions and relationships with leading healthcare providers position us to compete in this market.

Table of Contents

Although only a few of these competitors have offered specific services that compete directly with our solutions, many of these competitors have substantially greater financial, information gathering, and marketing resources than us and could decide to increase their resource commitments to our market. There are relatively few barriers to entry into our market, and we expect increased competition in our market which could adversely affect our operating results through pricing pressure, increased marketing expenditures, and market share losses, among other factors. There can be no assurance that we will continue to compete successfully against existing or new competitors.

We believe that our competitive strengths include the following:

A leading provider of patient experience solutions for healthcare providers and other healthcare organizations. Our history is based on capturing the voice of the consumer in healthcare markets. Our solutions build on the “Eight Dimensions of Patient-Centered Care,” a philosophy developed by noted patient advocate Harvey Picker, who believed patients’ experiences are integral to quality healthcare. This foundation has been enhanced through our digital platform offering that provides the delivery of data and insights on a real time basis to understand what matters most to each individual. Based on our more than 40 years of experience, we are able to deliver unique and relevant healthcare domain expertise to the clients we serve.

Established client base of leading healthcare organizations. Our client portfolio encompasses a majority of the leading healthcare systems across the United States. Over 270 of the top 400 healthcare systems based on net patient revenue are currently using one or more of our solutions. Our client base provides a unique network effect to share best practices among existing clients and to attract new clients. Our existing client base also provides a significant organic growth opportunity to upsell and cross sell additional solutions.

Highly scalable and visible revenue model. Our solutions are offered primarily through fixed price, subscription-based service agreements. The solutions we provide are also recurring in nature, which enables an ongoing relationship with our clients and favorable retention. This combination of subscription-based revenue, a base of ongoing client renewals and automated platforms creates a highly visible and scalable revenue model.

Comprehensive portfolio of solutions. Our portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. Our end-to-end solutions enable our clients to understand what matters most to each person they serve – before, during, after, and beyond clinical encounters – to gain a longitudinal understanding of each individual. We partner with clients across the continuum of healthcare services and believe this cross-continuum positioning is a unique and an increasingly important capability as evolving payment models drive healthcare providers and payers towards a more collaborative and integrated service model.

Exclusive focus on healthcare. We focus exclusively on healthcare and serving the unique needs of healthcare organizations across the continuum, which we believe gives us a distinct competitive advantage compared to other survey and analytics software providers. Our value proposition incorporates the benefits to clients derived from our deep subject matter expertise that has been built from helping healthcare organizations over the past 40 years. Our platform includes features and capabilities built specifically for healthcare providers, including a library of performance improvement content which can be tailored to the provider based on their specific customer feedback profile.

Experienced senior management team led by our founder. Our senior management team has extensive industry and leadership experience. Michael D. Hays, our Chief Executive Officer and President, founded NRC Health in 1981. Prior to launching the Company, Mr. Hays served as Vice President and as a Director of SRI Research Center, Inc. (now known as the Gallup Organization). Our Chief Financial Officer, Kevin Karas, CPA, has extensive financial experience having served as CFO at two previous companies, along with healthcare experience at Rehab Designs of America, Inc. and NovaCare, Inc. Jona Raasch has served as our Chief Operating Officer for most of the last 31 years and as Chief Executive Officer of the Governance Institute for more than 15 years. Helen Hrdy was appointed as our Chief Growth Officer in 2020. Prior to this position Ms. Hrdy served as our Senior Vice President, Customer Success, for eight years.

Table of Contents

Resources

Our success depends in part upon our data collection processes, research methods, data analysis techniques and internal systems, and procedures that we have developed specifically to serve clients in the healthcare industry. We have no patents for most of our intellectual property. Consequently, we rely on a combination of copyright and trade secret laws and associate nondisclosure agreements to protect our systems, survey instruments and procedures. There can be no assurance that the steps we have taken to protect our rights will be adequate to prevent misappropriation of such rights or that third parties will not independently develop functionally equivalent or superior systems or procedures. We believe that our systems and procedures and other proprietary rights do not infringe upon the proprietary rights of third parties. There can be no assurance, however, that third parties will not assert infringement claims against us in the future or that any such claims will not result in protracted and costly litigation, regardless of the merits of such claims or whether we are ultimately successful in defending against such claims.

Government Regulation

According to the Centers for Medicare and Medicaid Services (“CMS”), health expenditures in the United States were approximately $4.3 trillion in 2021, or $12,914 per person. In total, health spending accounted for 18.3% of the nation’s Gross Domestic Product in 2021. Addressing this growing expenditure burden continues to be a major policy priority at both federal and state levels. In addition, increased co-pays and deductibles in healthcare plans have focused even more consumer attention on health spending and affordability. In the public sector, Medicare provides health coverage for individuals aged 65 and older, while Medicaid provides coverage for low-income families and other individuals in need. Both programs are administered by the CMS. With the aging of the U.S. population, Medicare enrollment has increased significantly. In addition, longer life spans and greater prevalence of chronic illnesses among both the Medicare and Medicaid populations have placed tremendous demands on the health care system.

An increasing percentage of Medicare reimbursement and reimbursement from commercial payers has been determined under value payment models, based on factors such as patient readmission rates and provider adherence to certain quality-related protocols. At the same time, many hospitals and other providers are creating new models of care delivery to improve patient experience, reduce cost and provide better clinical outcomes. These new models are based on sharing financial risk and managing the health and behaviors of large populations of patients and consumers. This transformation towards value-based payment models and increased engagement of healthcare consumers is resulting in a greater need for existing healthcare providers to deliver more customer-centric healthcare. At the same time, organizations that have successfully developed effective customer service models and brand loyalty in other industry verticals are entering the healthcare services market.

We believe that our current portfolio of solutions is uniquely aligned to address these healthcare market trends and related business opportunity. We provide tools and solutions to capture, interpret and improve the CAHPS data required by CMS as well as real time feedback that enables clients to better understand what matters most to people at key moments in their relationship with a health organization. Our solutions enable our clients to both satisfy patient survey compliance requirements and design experiences to build loyalty and improve the wellbeing of the people and communities they care for.

Human Capital

As of December 31, 2022, we employed a total of 491 associates. None of our associates are represented by a collective bargaining unit. The majority of our associates work remotely. We attract a passionate team of associates who care deeply about making a difference in advancing “Human Understanding” in healthcare. We consider our relationships with our associates to be good.

We are committed to providing a workplace free of harassment or discrimination based on race, color, religion, sex, sexual orientation, gender identity, national origin, genetic information, ancestry, veteran status, or disability. We are an equal opportunity employer committed to inclusion and diversity.

Available Information

More information regarding NRC Health is available on our website at www.nrchealth.com. We are not including the information contained on or available through our website as part of, or incorporating such information by reference into, this Annual Report on Form 10-K. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports are made available to the public at no charge through a link appearing on our website. We provide access to such materials through our website as soon as reasonably practicable after electronically filing such material with, or furnishing it to, the Securities and Exchange Commission. Reports and amendments posted on our website do not include access to exhibits and supplemental schedules electronically filed with the reports or amendments.

Table of Contents

Item 1A.

Risk Factors

You should carefully consider each of the risks described below, together with all of the other information contained in this Annual Report on Form 10-K, before making an investment decision with respect to our securities. If any of the following risks develop into actual events, our business, financial condition or results of operations could be materially and adversely affected and you may lose all or part of your investment.

Risks Related to our Business

We depend on contract renewals, including retention of key clients, for a large share of our revenue and our operating results could be adversely affected.

We expect that a substantial portion of our revenue for the foreseeable future will continue to be derived from renewable service contracts. Substantially all contracts are renewable annually at the option of our clients, although contracts with clients under unit-based arrangements generally have no minimum purchase commitments. Client contracts are generally cancelable on short notice without penalty, however we are entitled to payment for services through the cancellation date. To the extent that clients fail to renew or defer their renewals, we anticipate our results may be materially adversely affected. We rely on a limited number of key clients for a substantial portion of our revenue. Our ten largest clients collectively accounted for 15%, 14%, and 14% of our total revenue in 2022, 2021 and 2020, respectively. Our ability to secure renewals depends on, among other things, our ability to gather and analyze performance data in a consistent, high-quality, and timely fashion. In addition, the service needs of our clients are affected by accreditation requirements, enrollment in managed care plans, the level of use of satisfaction measures in healthcare organizations’ overall management and compensation programs, the size of operating budgets, clients’ operating performance, industry and economic conditions, and changes in management or ownership. As these factors are beyond our control, we cannot ensure that we will be able to maintain our renewal rates. Any material decline in renewal rates from existing levels would have an adverse effect on our revenue and a corresponding effect on our operating and net income.

We operate in a highly competitive market and could experience increased price pressure and expenses as a result.

The healthcare information and market research services industry is highly competitive. We have traditionally competed with healthcare organizations’ internal marketing, market research and/or quality improvement departments that create their own performance measurement tools, and with relatively small specialty research firms that provide survey-based healthcare market research and/or performance assessment. Our primary competitors among such specialty firms include Press Ganey, which we believe has significantly higher annual revenue than us, and three or four other firms that we believe have lower annual revenue than us. We also compete with market research firms and technology solutions which provide survey-based, general market research or voice of the customer feedback capabilities and firms that provide services or products that complement healthcare performance assessments, such as healthcare software or information systems. Although only a few of these competitors have offered specific services that compete directly with our services, many of these competitors have substantially greater financial, information gathering, and marketing resources than us and could decide to increase their resource commitments to our market. Furthermore, we do not have a publicly traded group of peers, which makes it difficult to compare and benchmark performance to other similar companies. There are relatively few barriers to entry into our market, and we expect increased competition in our market which could adversely affect our operating results through pricing pressure, increased marketing expenditures, and market share losses, among other factors. There can be no assurance that we will continue to compete successfully against existing or new competitors.

Table of Contents

Because our clients are concentrated in the healthcare industry, our revenue and operating results may be adversely affected by changes in regulations, a business downturn or consolidation with respect to the healthcare industry.

Substantially all of our revenue is derived from clients in the healthcare industry. As a result, our business, financial condition and results of operations are influenced by conditions affecting this industry, including changing political, economic, competitive and regulatory influences that may affect the procurement practices and operation of healthcare providers and payers. Future legislative changes, including additional provisions to control healthcare costs, improve healthcare quality and expand access to health insurance, could result in lower reimbursement rates and otherwise change the environment in which providers and payers operate. In addition, large private purchasers of healthcare services are placing increasing cost pressure on providers. Healthcare providers may react to these cost pressures and other uncertainties by curtailing or deferring purchases, including purchases of our services.

Moreover, there has been consolidation of companies in the healthcare industry, a trend which we believe will continue to grow. Consolidation in this industry, including the potential acquisition of certain of our clients, could adversely affect aggregate client budgets for our services, could result in clients performing more marketing, market research and/or quality improvement functions internally or could result in the termination of a client’s relationship with us. The impact of these developments on the healthcare industry is difficult to predict and could have an adverse effect on our revenue and a corresponding effect on our operating and net income.

We could be negatively impacted by the Coronavirus or “COVID-19” pandemic or other outbreaks or pandemics.

The outbreak of COVID-19, and the associated responses, have impacted our business in a variety of ways, including business and travel restrictions, recommended social distancing and other guidelines. During the COVID-19 pandemic or other outbreaks or pandemics, businesses, including our clients, may de-emphasize external business opportunities and restrict in-person meetings while shifting their attention toward addressing COVID-19 or pandemic planning, business disruptions, higher costs, and revenue shortfalls. We rely on third-party service providers and business partners, for services or supplies that are critical to providing our clients’ services. These third parties are also subject to risks and uncertainties related to the COVID-19 pandemic or similar outbreaks, which may interfere with their ability to provide their services in a timely manner and in accordance with the agreed-upon terms or our agreements, which could interfere with our ability to operate our business.

To the extent the COVID-19 pandemic or other similar outbreaks adversely affects the Company’s business, results of operations, financial condition and stock price, it may also have the effect of heightening many of the other risks described in this Part I, Item 1A of this Form 10-K.

We could be negatively impacted by the Russian-Ukraine conflict or similar global events.

The Russian-Ukraine conflict, and any expansion of the Russian-Ukraine conflict, could adversely affect our business and operations. We outsource certain software development services to third parties in the Ukraine. Since the onset of the active Russian-Ukraine conflict, our contractors have been able to continue their work. However, those services could be more negatively impacted in the future.

Civil unrest, political instability or uncertainty, military activities, utility service breakdowns or broad-based sanctions, should they continue for the long term or escalate, could interrupt our contractors’ ability to provide services and require our associates to perform the services or replace the contractors which could have an adverse effect on our operations and financial performance, including higher volatility in foreign currency exchange rates, increased use of less cost-efficient resources and negative impacts to our business resulting from deteriorating general economic conditions. Further, we cannot predict the impact of the military actions and any heightened military conflict or geopolitical instability that may follow, including additional sanctions or countersanctions, heightened inflation, cyber disruptions or attacks, higher energy costs, and supply chain disruptions.

General economic factors could adversely impact our profitability.

Negative changes in general economic conditions, in the geographic areas in which we operate may reduce our profitability. An economic downturn and inflationary pressures can reduce the demand for our services and result in termination as well as slower client payments or client defaults on receivables. Additionally, in 2022, we experienced increased costs including the costs of labor, contracted services, costs associated with our building improvements and equipment purchases and we expect elevated levels of inflation to continue in 2023. Inflation may increase our costs without a corresponding increase in our contract revenue due to fixed contract arrangements, which could result in decreased margins and profitability.

Table of Contents

We face several risks relating to our ability to collect the data on which our business relies.

Our ability to provide timely and accurate performance measurement and improvement services to our clients depends on our ability to collect large quantities of high-quality data through surveys. If survey operations are disrupted and we are unable to process surveys in a timely manner, then our revenue and net income could be negatively impacted. We outsource certain operations and engage third parties to perform work needed to fulfill our client services. For example, we use vendors to perform certain outreach and data collection services related to our survey operations. If any of these vendors cease to operate or fail to adequately perform the contracted services and alternative resources and processes are not utilized in a timely manner, our business could be adversely affected. The loss of any of our key vendors could impair our ability to perform our client services and result in lower revenues and income. It would also be time-consuming and expensive to replace, either directly or through other vendors, the services performed by these vendors, which could adversely impact revenues, expenses and net income. Furthermore, our ability to monitor and direct our vendors’ activities is limited. If their actions and business practices violate policies, regulations or procedures otherwise considered illegal, we could be subject to reputational damage or litigation which would adversely affect our business.

If receptivity to our survey methods by respondents declines, or, for some other reason, their willingness to complete and return surveys declines, or if we, for any reason, cannot rely on the integrity of the data we receive, then our revenue could be adversely affected with a corresponding effect on our operating and net income.

If intellectual property and other proprietary information technology were copied or independently developed by our competitors, our operating results could be negatively affected.

Our success depends in part upon our data collection process, research methods, data analysis techniques, and internal systems and procedures that we have developed specifically to serve clients in the healthcare industry. We do not hold patents for our intellectual property. Consequently, we rely on a combination of copyright, trade secret laws and associate nondisclosure agreements to protect our systems, survey instruments and procedures. We cannot assure you that the steps we have taken to protect our rights will be adequate to prevent misappropriation of such rights, or that third parties will not independently develop functionally equivalent or superior systems or procedures. We believe that our systems and procedures and other proprietary rights do not infringe upon the proprietary rights of third parties. We cannot assure you, however, that third parties will not assert infringement claims against us in the future, or that any such claims will not result in protracted and costly litigation, regardless of the merits of such claims, or whether we are ultimately successful in defending against such claims.

Failures, interruptions or deficiencies in our information technology and communications systems could negatively impact our business and operating results.

Our ability to provide timely and accurate performance measurement and improvement service to our clients is dependent, to a significant extent, upon the technology that we develop internally as well as the efficient and uninterrupted operation of our information technology and communication systems, and those of our external service providers. Investment in the enhancement of existing and development of new information technology processes is costly and affects our ability to successfully serve our clients. The failure or deficiency of the technology we develop could negatively impact the willingness or ability for our clients to use our services and our ability to perform our services. Our failure to anticipate clients’ expectation and needs, adapt to emerging technological trends, or design efficient and effective information technology platforms, could result in lower utilization, loss of customers, damage to customer relationships, reduced revenue and profits, refunds to customers and damage to our reputation. Although we have procedures to monitor the efficacy of our information technology platforms, the procedures may not prevent failures or deficiencies in the information technology platforms we develop, we may not adapt quickly enough and may incur significant costs and delays that could harm our business. Additional costs could be incurred to further develop and improve our information technology platforms.

Our systems and those of our external service providers could be exposed to damage or interruption from fire, natural disasters, energy loss, telecommunication failure, security breach and computer viruses. An operational failure or outage in our information technology and communication systems or those of our external service providers, could result in loss of customers, damage to customer relationships, reduced revenue and profits, refunds of customer charges and damage to our reputation and may result in additional expense to repair or replace damaged equipment and recover data loss resulting from the interruption. Although we have taken steps to prevent system failures and have back-up systems and procedures to prevent or reduce disruptions, such steps may not prevent an interruption of services and our disaster recovery planning may not account for all contingencies. Additionally, our insurance may not adequately compensate us for all losses or failures that may occur. Any one of the above situations could have a material adverse effect on our business, financial condition, results of operations and reputation.

Table of Contents

If we or our third-party service providers sustain cyber-attacks or other privacy or data security incidents that result in security breaches that disrupt our operations or result in the unintended dissemination of protected personal information or proprietary or confidential information, we could suffer a loss of revenue and increased costs, exposure to significant liability, reputational harm and other serious negative consequences.

In connection with our client services, we and our third-party service providers receive, process, store and transmit sensitive business information and, in certain circumstances, personal medical information of our clients’ patients, electronically over the internet. We or our third-party service providers may become the target of attempted cyber-attacks and other security threats and may be subject to breaches of the information technology systems we use. Experienced computer programmers and hackers may be able to penetrate our security controls and access, misappropriate or otherwise compromise protected personal information or proprietary or confidential information or that of third-parties, create system disruptions or cause system shutdowns that could negatively affect our operations. They also may be able to develop and deploy viruses, worms, ransomware, and other malicious software programs that attack our systems or otherwise exploit any security vulnerabilities.

In addition, the risk of cyber-attacks has increased in connection with the military conflict between Russia and Ukraine and the resulting geopolitical conflict. In light of those and other geopolitical events, nation-state actors or their supporters may launch retaliatory cyber-attacks, and may attempt to cause supply chain and other third-party service provider disruptions, or take other geopolitically motivated retaliatory actions that may disrupt our business operations, result in data compromise, or both. Nation-state actors have in the past carried out, and may in the future carry out, cyber-attacks to achieve their aims and goals, which may include espionage, information operations, monetary gain, ransomware, disruption, and destruction. In February 2022, the U.S. Cybersecurity and Infrastructure Security Agency issued a “Shields Up” alert for American organizations noting the potential for Russia’s cyber-attacks on Ukrainian government and critical infrastructure organizations to impact organizations both within and beyond the United States, particularly in the wake of sanctions imposed by the United States and its allies. These circumstances increase the likelihood of cyber-attacks and/or security breaches.

We were the target of an external cyber-attack in February 2020 (the “February incident”) which resulted in a temporary suspension of our services to clients. One of our third-party service providers was the target of an external cyber-attack in December 2022 which resulted in a temporary suspension of certain services to our clients. In both instances no protected data was compromised or exfiltrated. We, and our service providers, will likely continue to be the target of other attempted cyber-attacks and security threats. Such cyber-attacks may subject us to litigation and regulatory risk, civil and criminal penalties, additional costs and diversion of management attention due to investigation, remediation efforts and engagement of third-party consultants and legal counsel in connection with such incidents, payment of “ransoms” to regain access to our systems and information, loss of clients, damage to client relationships, reduced revenue and profits, refunds of client charges and damage to our reputation, any of which could have a material adverse effect on our business, cash flows, financial condition and results of operations. While we have contingency plans and insurance coverage for potential liabilities of this nature, they may not be sufficient to cover all claims and liabilities and in some cases are subject to deductibles and layers of self-insured retention.

We cannot ensure that we or our third-party service providers will be able to identify, prevent or contain the effects of cyber-attacks or other cybersecurity risks that bypass our security measures or disrupt our information technology systems or business. We have security technologies, processes and procedures in place to protect against cybersecurity risks and security breaches. However, hardware, software or applications we develop or procure from third parties may contain defects in design, manufacturer defects or other problems that could unexpectedly compromise information security. In addition, because the techniques used to obtain unauthorized access, disable or degrade service or sabotage systems change frequently, are becoming increasingly sophisticated, and may not immediately produce signs of intrusion, we may be unable to anticipate these techniques, timely discover or counter them or implement adequate preventative measures.

In addition, we use third-party technology, systems and services for a variety of reasons, including, without limitation, encryption and authentication technology, employee email, content delivery to clients, back-office support, and other functions that in some cases involve processing, storing and transmitting large amounts of data for our business. These third-party providers may also experience security breaches or interruptions to their information technology hardware and software infrastructure and communications systems that could adversely impact us.

Under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, implementing regulations promulgated by the U.S. Department of Health and Human Services, or “HHS,” including what are referred to as the “Privacy Rule” and the “Security Rule” (collectively, “HIPAA”), we face potential liability related to the privacy of health information we obtain. We are required through our contracts with our clients and by HIPAA to protect the privacy and security of certain health information and to make certain disclosures to our clients or to the public if this information is unlawfully accessed.

Table of Contents

Changes in privacy and information security laws and standards may require that we incur significant expense to ensure compliance due to increased technology investment and operational procedures. Noncompliance with any privacy or security laws and regulations, including, without limitation, HIPPA, or any security breach, cyber-attack or cybersecurity breach, and any incident involving the misappropriation, loss or other unauthorized disclosure or use of, or access to, sensitive or confidential information, whether by us or by one of our third-party service providers, could require us to expend significant resources to continue to modify or enhance our protective measures and to remediate any damage. In addition, this could negatively affect our operations, cause system disruptions, damage our reputation, cause client losses and contract breaches, and could also result in regulatory enforcement actions, material fines and penalties, litigation or other actions that could have a material adverse effect on our business, cash flows, financial condition and results of operations. Even if cyber-attacks or other cybersecurity breaches do not result in noncompliance with privacy or security laws, the perception that such noncompliance may have occurred by our clients or in the news media may have an adverse impact on our stock price and could result in damage to our reputation or loss of clients, which could have a material adverse effect on our business, cash flows, financial condition and results of operations.

Reputational harm could have a material adverse effect on our business, financial condition and results of operations.

Our ability to maintain a positive reputation is critical to selling our services. Our reputation could be adversely impacted by any of the following (whether or not valid): the failure to maintain high ethical and social standards; the failure to perform our client services in a timely manner; violations of laws and regulations; failure to adequately preserve information security; and the failure to maintain an effective system of internal controls or to provide accurate and timely financial information. Damage to our reputation or loss of our clients’ confidence in our services for any of these, or any other reasons, could adversely impact our business, revenues, financial condition, and results of operations, as well as require additional resources to rebuild our reputation.

Our operations are subject to laws and regulations that impose significant compliance costs and create reputational and legal risk.

Due to the nature of the services we offer, we are subject to significant commercial, trade and privacy regulations. We cannot predict the nature, scope or effect of future regulatory requirements to which our operations might be subject or the manner in which existing laws might be administered or interpreted, which could have a material and negative impact on our business and our results of operation. For example, recent years have seen an increase in the development or enforcement of legislation related to healthcare reform, privacy, trade compliance and anti-corruption. Additionally, some of the services we provide include information our clients need to fulfill regulatory reporting requirements. If our services result in errors or omissions in our clients’ regulatory reporting, we may be subject to loss of clients, reputational harm or litigation, each potentially adversely impacting our business. Furthermore, although we maintain a variety of internal policies and controls designed to educate, discourage, prevent and detect violations of such laws, we cannot guarantee that such actions will be effective or sufficient or that individual employees will not engage in inappropriate behavior in breach of our policies. Such conduct, or even an allegation of misbehavior, could result in material adverse reputational harm, costly investigations, severe criminal or civil sanctions, or could disrupt our business, and could negatively affect our results of operations or financial condition.

Our growth strategy includes future acquisitions and/or investments which involve inherent risk.

In order to expand services or technologies to existing clients and increase our client base, we have historically, and may in the future, make strategic business acquisitions and/or investments that we believe complement our business. Acquisitions have inherent risks which may have material adverse effects on our business, financial condition, or results of operations, including, among other things: (1) failure to successfully integrate the purchased operations, technologies, products or services and maintain uniform standard controls, policies and procedures; (2) substantial unanticipated integration costs; (3) loss of key associates including those of the acquired business; (4) diversion of management’s attention from other operations; (5) failure to retain the customers of the acquired business; (6) failure to achieve any projected synergies and performance targets; (7) additional debt and/or assumption of known or unknown liabilities; (8) dilutive issuances of equity securities; and (9) a write-off of goodwill, software development costs, client lists, other intangibles and amortization of expenses. If we fail to successfully complete acquisitions or integrate acquired businesses, we may not achieve projected results and there may be a material adverse effect on our business, financial condition and results of operations.

Table of Contents

Risks Related to our Common Stock

Our principal shareholders effectively control the Company.

A majority of our common stock and voting power was historically owned and/or held by Michael D. Hays, our Chief Executive Officer and President. However, over the years Mr. Hays, for estate planning purposes, gifted and/or transferred almost all of his directly owned shares to trusts for the benefit of his family. Currently, the principal holders of shares previously owned by Mr. Hays are the Common Property Trust and the Amandla MK Trust (collectively the “Trusts”).

As of February 23, 2022, approximately 41.1% of our outstanding common stock was owned by the Trusts and approximately 50.8% of our outstanding common stock was held by the Trusts and other entities owned or controlled by members of Mr. Hays’ family. As a result, the Trusts and these other entities have the power to indirectly control decisions such as whether to issue additional shares or declare and pay dividends and can control matters requiring shareholder approval, including the election of directors and the approval of significant corporate matters such as change of control transactions. The effects of such influence could be to delay or prevent a change of control of the Company unless the terms are approved by the Trusts and these other entities.

The market price of our common stock may be volatile and shareholders may be unable to resell shares at or above the price at which the shares were acquired.

The market price and trading volume of our common stock has historically been and may continue to be highly volatile, and investors in our common stock may experience a decrease in the value of their shares, including decreases that are in response to factors beyond our control, including, but not limited to:

	●	Variations in our financial performance and that of similar companies;
	●	Regulatory and other developments that may impact the demand for our services;
	●	Reaction to our press releases, public announcements and filings with the Securities and Exchange Commission;
	●	Client, market and industry perception of our services and performance;
	●	Actions of our competitors;
	●	Changes in earnings estimates or recommendations by analysts who follow our stock;
	●	Loss of key personnel;
	●	Investor, management team or large stockholder sales of our stock;
	●	Changes in accounting principles; and
	●	Variations in general market, economic and political conditions or financial markets.

Any of these factors, among others, may result in changes in the trading volume and/or market price of our common stock. Following periods of volatility in the market price of securities, shareholders have often filed securities class-action lawsuits. Our involvement in a class-action lawsuit would result in substantial legal fees and divert our senior management’s attention from operating our business, which could harm our business and net income.

General Risk Factors

Our operating results may fluctuate and this may cause our stock price to decline.

Our overall operating results may fluctuate as a result of a variety of factors, including the size and timing of orders from clients, client demand for our services (which, in turn, is affected by factors such as accreditation requirements, enrollment in managed care plans, operating budgets and clients’ operating performance), the hiring and training of additional staff, expense increases, and industry and general economic conditions. Because a significant portion of our overhead is fixed in the short-term, particularly some costs associated with owning and occupying our building and full-time personnel expenses, our results of operations may be materially adversely affected in any particular period if revenue falls below our expectations. These factors, among others, make it possible that in some future period our operating results may be below the expectations of securities analysts and investors which would have a material adverse effect on the market price of our common stock.

Table of Contents

Our business and operating results could be adversely affected if we are unable to attract or retain key managers and other personnel.

Our future performance may depend, to a significant extent, upon the efforts and ability of our key personnel who have expertise in gathering, interpreting and marketing survey-based performance information for healthcare markets. Although client relationships are managed at many levels within our company, the loss of the services of Michael D. Hays, our Chief Executive Officer and President, or one or more of our other senior managers, could have a material adverse effect, at least in the short to medium term, on most significant aspects of our business, including strategic planning, product development, and sales and customer relations. Our success will also depend on our ability to hire, train and retain skilled personnel in all areas of our business. Competition for qualified personnel in our industry is intense, and many of the companies that compete with us for qualified personnel have substantially greater financial and other resources than us. Furthermore, we expect competition for qualified personnel to become more intense as competition in our industry increases. We cannot assure you that we will be able to recruit, retain and motivate a sufficient number of qualified personnel to compete successfully.

Like many other companies, we experienced higher attrition rates the last two years. We may incur higher costs to attract, train and retain these associates. Attrition in our sales and service areas can also impact our ability to retain and attract new business. We may need to develop or adapt to new ways of doing business that challenge our leadership, our associate training, our human resources, and our business practices, and we cannot assure you that we will be successful in doing so. The short and long-term costs associated with these potential changes are difficult to quantify.

Failure to comply with public company regulations could adversely impact our profitability.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, the Sarbanes-Oxley Act of 2002, the Dodd-Frank Act Wall Street Reform and Consumer Protection Act, the listing requirements of NASDAQ and other applicable securities rules and regulations. Additionally, laws, regulations and standards relating to corporate governance and public disclosure are subject to varying interpretations and continue to develop and change. If we misinterpret or fail to comply with these rules and regulations, our legal and financial compliance costs and net income may be adversely affected.

Table of Contents

Item 1B.

Unresolved Staff Comments

We have no unresolved staff comments to report pursuant to this item.

Item 2.

Properties

Our headquarters is located in an owned office building in Lincoln, Nebraska, of which 62,000 square feet have been used for operations. Our credit facilities are secured by this property and our other assets. We are currently renovating the building and expect renovations to complete in 2024. In February 2021, we began leasing 19,300 square feet of space in Lincoln, Nebraska for our mail survey processing operations that were previously housed at our headquarters.

We are leasing 4,000 square feet of office space in Markham, Ontario through February 2024, which we vacated as of October 2022. In addition, we lease 1,000 square feet of office space in Bethel, Connecticut. We are subleasing as a sublessor 4,300 square feet of office space in Seattle, Washington. We were leasing 300 square feet of office space in Atlanta, Georgia on a month-to-month lease which we ended in February 2023.

Item 3.

Legal Proceedings

From time to time, we are involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable. For additional information, see Note 1, under the heading “Commitments and Contingencies,” to our consolidated financial statements. Regardless of the final outcome, any legal proceedings, claims, inquiries and investigations, however, can impose a significant burden on management and employees, may include costly defense and settlement costs, and could cause harm to our reputation and brand, and other factors.

Item 4.

Mine Safety Disclosures

Not applicable.

Table of Contents

PART II

Item 5.

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

We have one class of outstanding capital stock, which is our Common Stock, par value $.001 per share (“Common Stock”). Our Common Stock trades on the NASDAQ Global Select Market under the symbol “NRC”.

Cash dividends in the aggregate amount of $20.9 million, $12.2 million and $5.3 million were declared in 2022, 2021 and 2020 respectively. The payment and amount of future dividends, if any, is at the discretion of our Board of Directors and will depend on our future earnings, financial condition, general business conditions, alternative uses of our earnings and cash and other factors.

On February 14, 2023, there were approximately 10 shareholders of record and approximately 13,661 beneficial owners of our Common Stock.

The table below summarizes repurchases of Common Stock during the three-month period ended December 31, 2022.

Period	Total Number of Shares Purchased		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)		Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs(1)

Oct 1 – Oct 31, 2022		—		—		—		1,987,517
Nov 1 – Nov 30, 2022		51,083		36.69		51,083		1,936,434
Dec 1 – Dec 31, 2022		11,990		36.96		11,990		1,924,444
Total		63,073				63,073

(1)

Shares were repurchased pursuant to the 2022 program.

See Item 12 in Part III of this Annual Report on Form 10-K for certain information concerning shares of our Common Stock authorized for issuance under our equity compensation plans.

Table of Contents

The following graph compares the cumulative 5-year total return provided shareholders on our Common Stock relative to the cumulative total returns of the NASDAQ Composite Index and the Russell 2000 Index. Because of the uniqueness of our markets and products and lack of publicly traded peers, we do not believe that a combination of peer issuers can be selected on an industry or line-of-business basis to provide a meaningful basis for comparing shareholder return. Accordingly, the Russell 2000 Index, which is comprised of issuers with generally similar market capitalizations to that of the Company, is included in the graph as permitted by applicable regulations. An investment of $100 (with reinvestment of all dividends) is assumed to have been made in our Common Stock and in each of the indexes on December 31, 2017, and our relative performance is tracked through December 31, 2022.

The stock price performance included in this graph is not necessarily indicative of future stock price performance.

12/17

12/18

12/19

12/20

12/21

12/22

National Research Corporation Common Stock (1)

100.00

105.36

184.87

120.42

118.22

108.51

NASDAQ Composite

100.00

97.16

132.81

192.47

235.15

158.65

Russell 2000

100.00

88.99

111.70

134.00

153.85

122.41

(1)Prior to a recapitalization that took place in 2018, our Common Stock was referred to as Class A Common Stock.

Item 6.

[Reserved]

Table of Contents

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis provides a summary of significant factors relevant to our financial performance and condition. It should be read in conjunction with the consolidated financial statements and accompanying notes included in Part II, Item 8 of this Form 10-K. This section of this Form 10-K generally discusses 2022 and 2021 items and year-to-year comparisons between 2022 and 2021. Discussions of 2020 items and year-to-year comparisons between 2021 and 2020 are not included in this Form 10-K, and can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

Overview

Our purpose is to humanize healthcare and support organizations in their understanding of each unique individual. Our commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Our end-to-end solutions enable our clients to understand what matters most to each person they serve – before, during, after, and beyond clinical encounters – to gain a longitudinal understanding of how life and health intersect, with the goal of developing lasting, trusting relationships. Our ability to measure what matters most and systematically capture, analyze, and deliver insights based on self-reported information from patients, families, and consumers is critical in today’s healthcare market. We believe access to and analysis of our extensive consumer-driven information is increasingly valuable as healthcare providers need to better understand and engage the people they serve to create long-term relationships and build loyalty.

The outbreak of COVID-19, and the associated responses, have impacted our business in a variety of ways. Many businesses, including many of our clients, have de-emphasized external business opportunities and restricted in-person meetings while shifting their attention toward addressing COVID-19 planning, business disruptions, higher costs, and revenue shortfalls. The on-going impacts of the COVID-19 pandemic and associated impacts on our business, including the impact on our revenue, expenses, and cash flows, cannot be predicted at this time.

Critical Accounting Policies and Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect amounts reported therein. The following areas are considered critical accounting estimates because they involve significant judgments or assumptions, involve complex or uncertain matters or they are susceptible to change and the impact could be material to our financial condition or operating results:

	●	Revenue recognition; and
	●	Valuation of goodwill and identifiable intangible assets.

Revenue Recognition

We derive a majority of our revenue from annually renewable subscription-based service agreements with our customers. Such agreements are generally cancelable on short or no notice without penalty. We also derive revenue from fixed, non-subscription arrangements. Our revenue recognition policy requires management to estimate, among other factors, the future contract consideration we expect to receive under variable consideration subscription arrangements as well as future total estimated contract costs over the contract term with respect to fixed, non-subscription arrangements. If management made different judgments and estimates, then the amount and timing of revenue for any period could differ from the reported revenue. See Notes 1 and 3 to our consolidated financial statements for a description of our revenue recognition policies.

Table of Contents

Valuation of Goodwill and Identifiable Intangible Assets

Intangible assets include customer relationships, trade names, technology, and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment with other long-lived assets in the related asset group whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. We review intangible assets with indefinite lives for impairment annually as of October 1 and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. This review requires management to assess qualitative factors to determine whether an impairment may have occurred, which inherently involves management’s judgment. This assessment also requires a determination of the fair value of the asset, which often includes several significant estimates and assumptions, including future cash flow estimates, determination of appropriate discount rates, and other assumptions that management believed reasonable under the circumstances. Changes in these estimates and assumptions could materially affect the determination of fair value and/or impairment of goodwill or other intangible assets. See Notes 1 and 6 to our consolidated financial statements for a description of our goodwill and intangible asset valuation and impairment policies and associated impacts for the reported periods.

In March 2021, we changed our operating segments from six to one to reflect a change in the way we operated and managed our business, including changes to our corporate reporting structure to the Company’s Chief Executive Officer and chief operating decision maker. In connection with the revision to our operating segments, we performed an interim qualitative analysis immediately before and after the reorganization and concluded that the fair value of our reporting units likely exceeded the carrying values and no impairments were recorded. Following the reorganization, we considered the current and expected future economic and market conditions, including the impact of the COVID-19 pandemic, on our reporting unit. We also assessed our current market capitalization compared to book value, forecasts and margins in our last quantitative impairment testing. We concluded that a triggering event had not occurred which would require an additional interim impairment test to be performed as it is not more likely than not that an impairment loss had been incurred at December 31, 2022.

Table of Contents

Key Financial Metrics and Results of Operations

The following table sets forth, for the periods indicated, selected financial information derived from our consolidated financial statements and the percentage change in such items versus the prior comparable period, as well as other key financial metrics. The discussion that follows the information should be read in conjunction with our consolidated financial statements.

Due to changes in our corporate reporting structure in 2021, certain associates moved between departments. As a result, the related salaries and benefits and company incentive expenses are included in Selling, general and administrative expenses in the 2022 and 2021 periods instead of Direct as in the 2020 periods. The total amount of the reclassified expenses approximates $1.9 million in 2021.

	(In thousands, except percentages) Year Ended December 31,									Percentage Increase (Decrease)
	2022			2021			2020			2022 over 2021			2021 over 2020
Revenue	$	151,568		$	147,954		$	133,277			2.4			11.0
Direct expenses		57,049			52,350			49,187			9.0			6.4
Selling, general, and administrative		42,699			38,960			34,441			9.6			13.1
Depreciation, amortization and impairment		5,277			6,374			7,505			(17.2	)		(15.1	)
Operating income		46,543			50,270			42,677			(7.4	)		17.8
Total other income (expense)		(3,728	)		(1,649	)		(1,210	)		126.1			36.3
Provision for income taxes		11,015			11,155			4,207			(1.3	)		165.2
Effective Tax Rate		25.7	%		22.9	%		10.1	%		2.8			12.8

Operating Margin		30.7	%		34.0	%		32.0	%		(3.3	)		2.0
Recurring Contract Value		146,839			150,937			145,079			(2.7	)		4.0
Cash provided by operating activities		36,265			46,344			40,636			(21.7	)		14.0

Revenue. Revenue in 2022 increased compared to 2021 due to an increase in US revenue of $5.8 million partially offset by decreased Canadian revenue of $2.2 million due to the closure of the Canadian office in 2022. US revenue increased due to growth in recurring revenue in our existing client base of $13.1 million partially offset by decreases in US recurring revenue from new customer sales of $6.8 million and non-recurring revenues of $557,000. We do not expect Canadian revenues in the future due to the closure of the Canadian office.

Direct expenses. Variable expenses increased $584,000 in 2022 compared to 2021 primarily due to growth in conference expenses of $1.3 million due to additional conferences being held in 2022 compared to 2021 and the shift to allow live or virtual attendance at conferences partially offset by lower survey and other subscription services of $801,000. Variable expenses as a percentage of revenue were 14.4% in 2022 and 2021. Fixed expenses increased $4.1 million primarily as a result of increased salary and benefit costs to attract and retain associates of $3.3 million, contracted services to support our Human Understanding Solutions of $547,000 and increased travel costs of $376,000 due to COVID travel restrictions being lifted.

Selling, general and administrative expenses. Selling, general and administrative expenses increased in 2022 compared to 2021 primarily due to innovation investments to support further development of our Human Understanding Solutions of $1.5 million, new marketing initiatives of $2.3 million, increased travel costs of $645,000 due to COVID travel restrictions being lifted, and new associate coaching benefit expense of $561,000, as well as increased business insurance costs of $405,000, partially offset by decreases in public company and other legal and accounting costs of $861,000.

Table of Contents

Depreciation, amortization and impairment. Depreciation, amortization and impairment expenses decreased in 2022 compared to 2021 primarily due to a decrease in building depreciation expense of $352,000 resulting from shortening the estimated useful lives of certain building assets, incurring a right-of-use asset impairment of $324,000 from subleasing a remote office location in 2021 and a decrease of $460,000 due to certain software development and intangible assets being fully amortized after 2021.

Operating income and margin. Operating income and margin decreased in 2022 compared to 2021 primarily due to growth in salary and benefit costs to attract and retain associates including a new associate benefit, as well as additional investments in our Human Understanding Solutions and marketing initiatives outpacing our revenue growth.

Total other income (expense). Total other expense increased in 2022 compared to 2021 primarily due the reclassification of the cumulative foreign currency translation adjustment of $2.6 million to other expense as a result of the substantial liquidation of our investment in our Canadian subsidiary in December 2022. Any future currency changes related to our Canadian subsidiary will be recognized in Other income (expense), net in our Consolidated Statements of Income. This expense was partially offset by a $458,000 decrease in interest expense due to the declining balance on our term loan.

Provision for income taxes and effective tax rate. Provision for income taxes decreased in 2022 compared to 2021 primarily due to decreased taxable income. The effective tax rate increased in 2022 compared to 2021 mainly due to decreased tax benefits from share-based compensation awards of $540,000, the non-deductible reclassification of cumulative foreign currency translation adjustment into earnings of $539,000 and $383,000 in higher state income taxes. See Note 7, “Income Taxes,” to our Consolidated Financial Statements contained in this report for additional information on the change in the effective tax rates.

Recurring Contact Value. Recurring contract value declined in 2022 compared to 2021 primarily from a decrease in new client sales as well as a 2.0% decrease in our client retention rate partially due to our strategy to focus on our core digital solutions. The recurring contract value of our core digital solutions declined 1.1% at December 31, 2022 compared to December 31, 2021. Our recurring contract value metric represents the total revenue projected under all renewable contracts for their respective next annual renewal periods, assuming no upsells, downsells, price increases, or cancellations, measured as of the most recent quarter end.

Liquidity and Capital Resources

Our Board of Directors has established priorities for capital allocation, which prioritize funding of innovation and growth investments, including merger and acquisition activity as well as internal projects. The secondary priority is capital allocation for quarterly dividends and share repurchases. We believe that our existing sources of liquidity, including cash and cash equivalents, borrowing availability, and operating cash flows will be sufficient to meet our projected capital and debt maturity needs for the foreseeable future.

As of December 31, 2022, our principal sources of liquidity included $25.0 million of cash and cash equivalents, up to $30 million of unused borrowings under our line of credit and up to $75 million on our delayed draw term note. Of this cash, $78,000 was held in Canada. The delayed draw term note can only be used to fund permitted future business acquisitions or repurchasing our Common Stock.

Our cash flows from operating activities consist of net income adjusted for non-cash items including depreciation, amortization, and impairments, reclassification of cumulative foreign currency translation adjustment into earnings, deferred income taxes, share-based compensation and related taxes, reserve for uncertain tax positions, loss on disposal of property and equipment and the effect of working capital changes. Cash provided by operating activities decreased mainly due to decreased net income net of non-cash items. Cash provided by operating activities also decreased due to working capital changes, mainly consisting of changes in deferred revenue primarily due to timing of initial billings on new and renewal contracts and decreased overall recurring contract value and changes in accrued expenses, wages and bonuses mainly due to decreased bonuses, partially offset by changes in prepaid expenses and other current assets primarily due to the timing of our annual business insurance payment.

See the Consolidated Statements of Cash Flows included in this report for the detail of our operating cash flows.

Table of Contents

We had a working capital surplus of $10.3 million and $33.3 million on December 31, 2022 and 2021, respectively. The change was primarily due to decreases in cash and cash equivalents and prepaid expenses partially offset by decreases in accrued wages and bonuses, accrued expenses and deferred revenue. Cash and cash equivalents decreased mainly due to repurchase of shares of our Common Stock for treasury. Prepaid expenses decreased primarily due to the timing of our annual business insurance payment. Accrued expenses decreased due to timing of payment for services and supplies. Accrued wages and bonuses decreased due to less bonuses being earned in 2022 and the final payment of employer social security taxes that were deferred due to the Coronavirus Aid, Relief, and Economic Security Act. Our working capital is significantly impacted by our large deferred revenue balances which will vary based on the timing and frequency of billings on annual agreements.

Cash used in investing activities consisted of purchases of property and equipment including computer software and hardware, building improvements and furniture and equipment.

Cash used in financing activities consisted of payments for borrowings under the term note, finance lease obligations and debt issuance costs. We also used cash to pay deferred acquisition consideration related to our 2021 acquisition of PatientWisdom, repurchase shares of our Common Stock for treasury, to pay dividends on Common Stock and to pay employee payroll tax withholdings on share-based awards exercised.

Our material cash requirements include the following contractual and other obligations:

Dividends

Cash dividends in the aggregate amount of $20.9 million, $12.2 million and $5.3 million were declared in 2022, 2021 and 2020 respectively. All dividends were paid from cash on hand. The payment and amount of future dividends, if any, is at the discretion of our Board of Directors and will depend on our future earnings, financial condition, general business conditions, alternative uses of our earnings and cash and other factors.

Acquisition Consideration

On January 4, 2021, we acquired substantially all assets and assumed certain liabilities of PatientWisdom, Inc., a company with a health engagement solution that will further our purpose of operationalizing human understanding through tangible and actionable insights. $3.0 million of the total $5.0 million all-cash consideration was paid at closing. We paid the remaining $2.0 million in January 2022. All payments were made with cash on hand.

Capital Expenditures

We paid cash of $9.8 million for capital expenditures in the year ended December 31, 2022. These expenditures consisted mainly of computer software development for our Human Understanding solutions and building renovations to our headquarters of $3.6 million and $5.1 million, respectively We estimate future costs related to our headquarters building renovations to be $16.1 million and $2.9 million in 2023 and 2024, respectively, which we expect to fund through operating cash flows.

Debt

Our amended and restated credit agreement (the “Credit Agreement”) with First National Bank of Omaha (“FNB”) was amended and restated on September 30, 2022 and includes (i) a $30,000,000 revolving credit facility (the “Line of Credit”), (ii) a $23,412,383 term loan (the “Term Loan”) and (iii) a $75,000,000 delayed draw-down term facility (the “Delayed Draw Term Loan” and, together with the Line of Credit and the Term Loan, the “Credit Facilities”). We may use the Delayed Draw Term Loan to fund any permitted future business acquisitions or repurchases of our Common Stock and the Line of Credit to fund ongoing working capital needs and for other general corporate purposes.

The Term Loan has an outstanding balance of $22.3 million and is payable in monthly installments of $462,988 through May 2027. The Term Loan bears interest at a fixed rate per annum of 5%.

Borrowings under the Line of Credit and the Delayed Draw Term Loan, if any, bear interest at a floating rate equal to the 30-day Secured Overnight Financing Rate (“SOFR”) plus 235 basis points (6.10% at December 31, 2022). Interest on the Line of Credit accrues and is payable monthly. Principal amounts outstanding under the Line of Credit are due and payable in full at maturity, in May 2025. As of December 31, 2022, the Line of Credit did not have a balance. There were no borrowings on the Line of Credit during the years ended December 31, 2022 or 2021. There have been no borrowings on the Delayed Draw Term Loan since origination.

Table of Contents

We are obligated to pay ongoing unused commitment fees quarterly in arrears pursuant to the Line of Credit and the Delayed Draw Term Loan facility at a rate of 0.20% per annum based on the actual daily unused portions of the Line of Credit and the Delayed Draw Term Loan facility, respectively.

The Credit Agreement contains customary representations, warranties, affirmative and negative covenants (including financial covenants) and events of default. The negative covenants include, among other things, restrictions regarding the incurrence of indebtedness and liens, repurchases of our Common Stock and acquisitions, subject in each case to certain exceptions. Pursuant to the Credit Agreement, we are required to maintain a minimum fixed charge coverage ratio of 1.10x for all testing periods throughout the term(s) of the Credit Facilities, which calculation excludes, unless our liquidity falls below a specified threshold, (i) any cash dividend in a fiscal quarter that, together with all other cash dividends paid or declared during such fiscal quarter, exceeds $5,500,000 in total cash dividends paid or declared, (ii) the portion of the purchase price for any permitted share repurchase of our shares paid with cash on hand, and (iii) the portion of any acquisition consideration for a permitted acquisition paid with cash on hand. We are also required to maintain a cash flow leverage ratio of 3.00x or less for all testing periods throughout the term(s) of the Credit Facilities. All obligations under the Credit Facilities are to be guaranteed by each of our wholly owned domestic subsidiaries, if any, and, to the extent required by the Credit Agreement, direct and indirect wholly owned foreign subsidiaries. As of December 31, 2022, we were in compliance with our financial covenants.

The Credit Facilities are secured, subject to permitted liens and other agreed upon exceptions, by a first-priority lien on and perfected security interest in substantially all of our and our guarantors’ present and future assets (including, without limitation, fee-owned real property, and limited, in the case of the equity interests of foreign subsidiaries, to 65% of the outstanding equity interests of such subsidiaries).

Leases

We have lease arrangements for certain computer, office, printing and inserting equipment as well as office and data center space. As of December 31, 2022, we had fixed lease payments of $547,000 and $315,000 for operating and finance leases, respectively payable within 12 months. A summary of our operating and finance lease obligations as of December 31, 2022 can be found in Note 10, "Leases", to the Consolidated Financial Statements contained in this report.

Taxes

The liability for gross unrecognized tax benefits related to uncertain tax positions was $1.6 million as of December 31, 2022. See Note 7, "Income Taxes", to the Consolidated Financial Statements contained in this report for income tax related information.

As of December 31, 2022, the balance of the deemed repatriation tax payable imposed by the U.S. Tax Cuts and Jobs Act of 2017 was $82,000, which we expect to pay in the next year.

We generally do not make unconditional, non-cancelable purchase commitments. We enter into purchase orders in the normal course of business, but these purchase obligations do not exceed one year.

Stock Repurchase Program

In February 2006 and subsequently amended in May 2013, our Board of Directors authorized the repurchase of up to 2,250,000 shares of Common Stock in the open market or in privately negotiated transactions under a stock repurchase program under the 2006 Program. In 2022, we repurchased all the remaining shares authorized for repurchase under the 2006 Program. In May 2022, our Board of Directors approved the 2022 Program with a repurchase authorization of 2,500,000 shares of Common Stock. Under the 2022 Program we are authorized to repurchase from time-to-time shares of our outstanding Common Stock on the open market or in privately negotiated transactions. The timing and amount of stock repurchases will depend on a variety of factors, including market conditions as well as corporate and regulatory considerations. The 2022 Program may be suspended, modified, or discontinued at any time and we have no obligation to repurchase any amount of Common Stock in connection with the 2022 Program. The 2022 Program has no set expiration date.

During 2022, we repurchased 744,499 shares of our Common Stock for an aggregate of $27.6 million, of which 168,943 shares were repurchased under the 2006 Program and 575,556 shares were repurchased under the 2022 Program. As of December 31, 2022, the remaining number of shares of Common Stock that could be purchased under the 2022 Program was 1,924,444 shares.

Recent Accounting Pronouncements

There are no recently issued accounting pronouncements we believe will have a material impact on our financial position, results of operations or cash flows.

Table of Contents

Item 7A.

Quantitative and Qualitative Disclosure About Market Risk

Our primary market risk exposures are changes in foreign currency exchange rates and interest rates.

Our Canadian subsidiary uses Canadian dollars as its functional currency. It translates its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. We translate its revenue and expenses at the average exchange rate during the period. We included foreign currency translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. During December 2022, we substantially liquidated our investment in Canada. As a result, we reclassified the cumulative foreign currency translation adjustment balance into earnings and recognized a net cumulative foreign currency translation loss of $2.6 million, which is included in Other income (expense), net in our Consolidated Statements of Income. Foreign currency translation gains (losses) were ($194,000), $24,000, and ($190,000) in 2022, 2021, and 2020, respectively. Gains and losses related to transactions denominated in a currency other than the functional currency of the countries in which we operate and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income and amounted to ($65,000), $10,000, and ($333,000) in 2022, 2021, and 2020, respectively. The change is primarily the result of exchange rate fluctuation applied to an intercompany loan from our Canadian subsidiary which was paid off in September 2020. A portion of our cash in our Canadian subsidiary is denominated in foreign currencies, where fluctuations in exchange rates will impact our cash balances in U.S. dollar terms. A sensitivity analysis assuming a hypothetical 10% change in the value of the U.S. dollar versus the Canadian dollar would impact our reported cash balance by approximately $8,000. Any future currency changes, related to our Canadian subsidiary will be recognized in Other income (expense), net in our Consolidated Statements of Income. However, due to the substantial liquidation of the subsidiary, we do not expect the amounts to be significant after 2022. We have not entered into any foreign currency hedging transactions. We do not purchase or hold any currency exchange related derivative financial instruments.

We are exposed to interest rate risk with both our fixed-rate Term Loan and variable rate Line of Credit. Interest rate changes for borrowings under our fixed-rate Term Loan would impact the fair value of such debt, but do not impact earnings or cash flow. At December 31, 2022, our fixed-rate Term Loan totaled $22.3 million. Based on a sensitivity analysis, a one percent per annum change in market interest rates as of December 31, 2022, would impact the estimated fair value of our fixed-rate Term Loan outstanding at December 31, 2022 by approximately $470,000.

Borrowings under our Line of Credit and Delayed Draw Term Loan, if any, bear interest at a floating rate equal to the 30-day SOFR plus 235 basis points. Borrowings under the Line of Credit and Delayed Draw Term Note may not exceed $30.0 million and $75.0 million, respectively. There were no borrowings outstanding under the Line of Credit at December 31, 2022, or at any time during 2022. There were no borrowings outstanding under the Delayed Draw Term Note at December 31, 2022, or at any time during 2022. A sensitivity analysis assuming a hypothetical 10% movement in interest rates applied to the average daily borrowings and the maximum borrowings available under the Line of Credit for 2022 indicated that such a movement would not have a material impact on our consolidated financial position, results of operations or cash flows. We have not entered into any interest rate swaps or hedging transactions.

Item 8.

Financial Statements and Supplementary Data

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Shareholders and the Board of Directors
National Research Corporation:

Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting

We have audited the accompanying consolidated balance sheets of National Research Corporation and subsidiary (the Company) as of December 31, 2022 and 2021, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Basis for Opinions

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Table of Contents

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Sufficiency of audit evidence over new and modified subscription-based service agreement terms

As discussed in Notes 1 and 3 to the consolidated financial statements, revenue consists of service arrangement contracts with customers that can include more than one separately identifiable performance obligation. The Company’s revenue for the year ended December 31, 2022 included $142.0 million for subscription-based service agreements, a portion of which was revenue from new and modified subscription-based service agreements, that was recognized ratably over the subscription period and which agreements are renewable at the option of the customer. Subscription-based service agreements represent a single promise to stand ready to provide reporting, tools and services throughout the subscription period.

We identified the evaluation of the sufficiency of audit evidence over the key terms within new and modified subscription-based service agreements as a critical audit matter. Specifically, the nature and extent of procedures performed over the key terms within the new and modified subscription-based service agreements required subjective auditor judgment as recognition of revenue by the Company is dependent on the accuracy of the key terms within the related information technology (IT) application used to calculate revenue. The key terms within the new subscription-based service agreements included the description of service, transaction price, renewal price and contract term, and the key terms within the modified subscription-based service agreements were the transaction price and contract term.

The following are the primary procedures we performed to address this critical audit matter. We applied auditor judgment to determine the nature and extent of procedures to be performed over the accuracy of key terms within the IT application, including the identification of key terms. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s subscription-based service revenue process, including controls related to the key terms within the new and modified subscription-based service agreements. We also tested certain internal controls over the accurate input of the underlying key terms of the subscription-based service agreement into the related IT application. For a sample of revenue transactions, we compared the key terms used in the revenue calculation to the underlying contract with the customer. We evaluated the sufficiency of audit evidence obtained over the key terms within new and modified subscription-based service agreements by assessing the results of procedures performed, including the appropriateness of the nature and extent of audit effort.

/s/ KPMG LLP

We have served as the Company’s auditor since 1997.

Lincoln, Nebraska
March 3, 2023

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts)

	2022			2021
Assets
Current assets:
Cash and cash equivalents	$	25,026		$	54,361
Trade accounts receivable, less allowance for doubtful accounts of $65 and $94, respectively		14,461			13,728
Prepaid expenses		2,386			3,884
Income taxes receivable		733			752
Other current assets		1,110			982
Total current assets		43,716			73,707

Net property and equipment		17,248			12,391
Intangible assets, net		1,611			1,790
Goodwill		61,614			61,614
Operating lease right-of-use assets		556			975
Deferred contract costs, net		2,441			3,772
Deferred income taxes		14			14
Other		3,261			3,277

Total assets	$	130,461		$	157,540

Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of notes payable, net of unamortized debt issuance costs	$	4,491		$	4,278
Accounts payable		1,153			1,943
Accrued wages and bonuses		4,551			7,139
Accrued expenses		3,983			5,450
Dividends payable		2,956			3,044
Deferred revenue		15,198			17,213
Other current liabilities		1,085			1,321
Total current liabilities		33,417			40,388

Notes payable, net of current portion and unamortized debt issuance costs		17,690			22,269
Deferred income taxes		5,274			7,002
Other long-term liabilities		2,047			2,544
Total liabilities		58,428			72,203

Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued		—			—
Common stock, $0.001 par value; authorized 110,000,000 shares, issued 30,922,181 in 2022 and 30,898,600 in 2021, outstanding 24,628,173 in 2022 and 25,361,409 in 2021		31			31
Additional paid-in capital		175,453			173,942
Retained earnings (accumulated deficit)		(25,184	)		(36,112	)
Accumulated other comprehensive loss, foreign currency translation adjustment		—			(2,375	)
Treasury stock, at cost; 6,294,008 Common shares in 2022 and 5,537,191 Common shares in 2021		(78,267	)		(50,149	)
Total shareholders’ equity		72,033			85,337

Total liabilities and shareholders’ equity	$	130,461		$	157,540

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except share amounts)

	2022			2021			2020

Revenue	$	151,568		$	147,954		$	133,277

Insurance recoveries		—			—			533

Operating expenses:
Direct		57,049			52,350			49,187
Selling, general and administrative		42,699			38,960			34,441
Depreciation, amortization and impairment		5,277			6,374			7,505
Total operating expenses		105,025			97,684			91,133

Operating income		46,543			50,270			42,677

Other income (expense):
Interest income		168			14			18
Interest expense		(1,209	)		(1,667	)		(1,813	)
Reclassification of cumulative foreign currency translation adjustment into earnings		(2,569	)		—			—
Other, net		(118	)		4			585

Total other income (expense)		(3,728	)		(1,649	)		(1,210	)

Income before income taxes		42,815			48,621			41,467

Provision for income taxes		11,015			11,155			4,207

Net income	$	31,800		$	37,466		$	37,260

Earnings per share of common stock:
Basic earnings per share	$	1.28		$	1.47		$	1.48
Diluted earnings per share	$	1.27		$	1.46		$	1.45

Weighted average shares and share equivalents outstanding
Basic		24,922			25,422			25,170
Diluted		25,052			25,640			25,696

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

	2022			2021		2020

Net income	$	31,800		$	37,466	$	37,260

Other comprehensive income (loss):
Cumulative foreign currency translation adjustment	$	(194	)	$	24	$	(190	)
Reclassification of cumulative foreign currency translation into earnings		2,569			—		—
Other comprehensive income (loss)	$	2,375		$	24	$	(190	)

Comprehensive income	$	34,175		$	37,490	$	37,070

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In thousands except share and per share amounts)

	Common Stock		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)			Accumulated Other Comprehensive Income (Loss)			Treasury Stock			Total
Balances at December 31, 2019	$	30	$	162,154	$	(93,357	)	$	(2,209	)	$	(33,726	)	$	32,892
Purchase of 180,112 shares of treasury stock		—		—		—			—			(10,001	)		(10,001	)
Issuance of 630,373 common shares for the exercise of stock options		1		8,951		—			—			—			8,952
Forfeiture of 6,793 restricted common shares		—		—		—			—			—			—
Non-cash stock compensation expense		—		680		—			—			—			680
Dividends declared of $0.21 per common share		—		—		(5,278	)		—			—			(5,278	)
Other comprehensive loss, foreign currency translation adjustment		—		—		—			(190	)		—			(190	)
Net income		—		—		37,260			—			—			37,260
Balances at December 31, 2020	$	31	$	171,785	$	(61,375	)	$	(2,399	)	$	(43,727	)	$	64,315
Purchase of 153,005 shares treasury stock		—		—		—			—			(6,422	)		(6,422	)
Issuance of 116,753 common shares for the exercise of stock options		—		1,534		—			—			—			1,534
Non-cash stock compensation expense		—		623		—			—			—			623
Dividends declared of $0.48 per common share		—		—		(12,203	)		—			—			(12,203	)
Other comprehensive income, foreign currency translation adjustment		—		—		—			24			—			24
Net income		—		—		37,466			—			—			37,466
Balances at December 31, 2021	$	31	$	173,942	$	(36,112	)	$	(2,375	)	$	(50,149	)	$	85,337
Purchase of 756,817 shares treasury stock		—		—		—			—			(28,118	)		(28,118	)
Issuance of 23,581 common shares for the exercise of stock options		—		311		—			—			—			311
Non-cash stock compensation expense		—		1,200		—			—			—			1,200
Dividends declared of $0.84 per common share		—		—		(20,872	)		—			—			(20,872	)
Other comprehensive income, foreign currency translation adjustment		—		—		—			(194	)		—			(194	)
Reclassification of cumulative foreign currency translation adjustment into earnings		—		—		—			2,569			—			2,569
Net income		—		—		31,800			—			—			31,800
Balances at December 31, 2022	$	31	$	175,453	$	(25,184	)	$	—		$	(78,267	)	$	72,033

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

	2022			2021			2020
Cash flows from operating activities:
Net income	$	31,800		$	37,466		$	37,260
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and impairment		5,277			6,374			7,505
Reclassification of cumulative translation adjustment into earnings		2,569
Deferred income taxes		(1,729	)		(277	)		(134	)
Reserve for uncertain tax positions		488			310			185
Gain on insurance recoveries for damaged property		—			—			(260	)
Loss on disposal of property and equipment		11			7			12
Non-cash share-based compensation expense		1,200			623			680
Change in assets and liabilities:
Trade accounts receivable		(733	)		343			(2,271	)
Prepaid expenses and other current and long-term assets		1,634			(842	)		(827	)
Operating lease assets and liability, net		(39	)		(34	)		16
Deferred contract costs, net		1,331			783			(351	)
Accounts payable		(589	)		4			(247	)
Accrued expenses, wages and bonuses		(2,947	)		(285	)		1,370
Income taxes receivable and payable		6			484			(1,529	)
Deferred revenue		(2,014	)		1,388			(773	)
Net cash provided by operating activities		36,265			46,344			40,636

Cash flows from investing activities:
Purchases of property and equipment		(9,835	)		(5,514	)		(3,984	)
Acquisition consideration		—			(3,000	)		—
Insurance proceeds for damaged property		—			—			260
Net cash used in investing activities		(9,835	)		(8,514	)		(3,724	)

Cash flows from financing activities:
Payments on notes payable		(4,305	)		(4,093	)		(3,568	)
Payment of debt issuance costs		(92	)		—			(36	)
Payments on finance lease obligations		(469	)		(493	)		(332	)
Proceeds from the exercise of stock options		—			446			1,734
Payment of payroll tax withholdings on share-based awards exercised		(190	)		(721	)		(2,784	)
Payment of deferred acquisition consideration		(1,950	)		—			—
Repurchase of shares for treasury		(27,616	)		(4,142	)		—
Payment of dividends on common stock		(20,961	)		(9,159	)		(10,517	)
Net cash used in financing activities		(55,583	)		(18,162	)		(15,503	)

Effect of exchange rate changes on cash		(182	)		3			(236	)
Net increase (decrease) in cash and cash equivalents		(29,335	)		19,671			21,173
Cash and cash equivalents at beginning of period		54,361			34,690			13,517
Cash and cash equivalents at end of period	$	25,026		$	54,361		$	34,690

Supplemental disclosure of cash paid for:
Interest expense, net of capitalized amounts	$	1,342		$	1,554		$	1,735
Income taxes	$	12,233		$	10,644		$	5,217
Supplemental disclosure of non-cash investing and financing activities:
Finance lease obligations originated for property and equipment	$	—		$	40		$	817
Purchase of property and equipment in accounts payable and accrued expenses	$	1,109		$	979		$	127
Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans	$	311		$	1,088		$	7,217
Deferred acquisition consideration	$	—		$	1,950		$	—

See accompanying notes to consolidated financial statements.

Table of Contents

NATIONAL RESEARCH CORPORATION AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(1)

Summary of Significant Accounting Policies

Description of Business and Basis of Presentation

National Research Corporation, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Our purpose is to humanize healthcare and support organizations in their understanding of each person they serve not as point-in-time insights, but as an ongoing relationship We believe that understanding the story is the key to unlocking the highest-quality and truly personalized care. Our end-to-end solutions enable health care organizations to understand what matters most to each person they serve – before, during, after, and outside of clinical encounters – to gain a longitudinal understanding of how life and health intersect, with the goal of developing lasting, trusting relationships. Our portfolio of solutions represents a unique set of capabilities that individually and collectively provide value to our clients.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and our wholly-owned subsidiary, National Research Corporation Canada. All significant intercompany transactions and balances have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Translation of Foreign Currencies

Gains and losses related to transactions denominated in a currency other than the functional currency of the country in which we operate and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income. Our Canadian subsidiary uses Canadian dollars as its functional currency. We translate its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. We translate its revenue and expenses at the average exchange rate during the period. We included foreign currency translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. During December 2022, we substantially liquidated our investment in Canada. As a result, we reclassified the cumulative foreign currency translation adjustment balance into earnings and recognized a net cumulative foreign currency translation loss of $2.6 million, which is included in Other income (expense), net in our Consolidated Statements of Income. Any future currency changes, will be recognized in Other income (expense), net in our Consolidated Statements of Income.

Revenue Recognition

We derive a majority of our revenues from our annually renewable subscription-based service agreements with our customers, which include performance measurement and improvement services, healthcare analytics and governance education services. Such agreements are generally cancelable on short or no notice without penalty. See Note 3 for further information about our contracts with customers. We account for revenue using the following steps:

	●	Identify the contract, or contracts, with a customer;
	●	Identify the performance obligations in the contract;
	●	Determine the transaction price;
	●	Allocate the transaction price to the identified performance obligations; and
	●	Recognize revenue when, or as, we satisfy the performance obligations.

Table of Contents

Our revenue arrangements with a client may include combinations of more than one service offering which may be executed at the same time, or within close proximity of one another. We combine contracts with the same customer into a single contract for accounting purposes when the contract is entered into at or near the same time and the contracts are negotiated together. For contracts that contain more than one separately identifiable performance obligation, the total transaction price is allocated to the identified performance obligations based upon the relative stand-alone selling prices of the performance obligations. The stand-alone selling prices are based on an observable price for services sold to other comparable customers, when available, or an estimated selling price using a cost-plus margin or residual approach. We estimate the amount of total contract consideration we expect to receive for variable arrangements based on the most likely amount we expect to earn from the arrangement based on the expected quantities of services we expect to provide and the contractual pricing based on those quantities. We only include some or a portion of variable consideration in the transaction price when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. We consider the sensitivity of the estimate, our relationship and experience with the client and variable services being performed, the range of possible revenue amounts and the magnitude of the variable consideration to the overall arrangement. Our revenue arrangements do not contain any significant financing element due to the contract terms and the timing between when consideration is received and when the service is provided.

Our arrangements with customers consist principally of four different types of arrangements: 1) subscription-based service agreements; 2) one-time specified services performed at a single point in time; 3) fixed, non-subscription service agreements; and 4) unit-priced service agreements.

Subscription-based services - Services that are provided under subscription-based service agreements are usually for a twelve- month period and represent a single promise to stand ready to provide reporting, tools and services throughout the subscription period as requested by the customer. These agreements are renewable at the option of the customer at the completion of the initial contract term for an agreed upon price increase each year. These agreements represent a series of distinct monthly services that are substantially the same, with the same pattern of transfer to the customer as the customer receives and consumes the benefits throughout the contract period. Accordingly, subscription services are recognized ratably over the subscription period. Subscription services are typically billed either annually or quarterly in advance but may also be billed on a monthly basis.

One-time services – These agreements typically require us to perform a specific one-time service in a particular month. We are entitled to a fixed payment upon completion of the service. Under these arrangements, we recognize revenue at the point in time we complete the service and it is accepted by the customer.

Fixed, non-subscription services – These arrangements typically require us to perform an unspecified amount of services for a fixed price during a fixed period of time. Revenues are recognized over time based upon the costs incurred to date in relation to the total estimated contract costs. In determining cost estimates, management uses historical and forecasted cost information which is based on estimated volumes, external and internal costs and other factors necessary in estimating the total costs over the term of the contract. Changes in estimates are accounted for using a cumulative catch-up adjustment which could impact the amount and timing of revenue for any period.

Unit-price services – These arrangements typically require us to perform certain services on a periodic basis as requested by the customer for a per-unit amount which is typically billed in the month following the performance of the service. Revenue under these arrangements is recognized over the time the services are performed at the per-unit amount.

Revenue is presented net of any sales tax charged to our clients that we are required to remit to taxing authorities. We recognize contract assets or unbilled receivables related to revenue recognized for services completed but not invoiced to the clients. Unbilled receivables are classified as receivables when we have an unconditional right to contract consideration. A contract liability is recognized as deferred revenue when we invoice clients in advance of performing the related services under the terms of a contract. Deferred revenue is recognized as revenue when we have satisfied the related performance obligation.

Table of Contents

Deferred Contract Costs

Deferred contract costs, net is stated at gross deferred costs less accumulated amortization. We defer commissions and incentives, including payroll taxes, if they are incremental and recoverable costs of obtaining a renewable customer contract. Deferred contract costs are amortized over the estimated term of the contract, including renewals, which generally ranges from three to five years. The contract term was estimated by considering factors such as historical customer attrition rates and product life. The amortization period is adjusted for significant changes in the estimated remaining term of a contract. An impairment of deferred contract costs is recognized when the unamortized balance of deferred contract costs exceeds the remaining amount of consideration we expect to receive net of the expected future costs directly related to providing those services. We have elected the practical expedient to expense contract costs when incurred for any nonrenewable contracts with a term of one year or less. We deferred incremental costs of obtaining a contract of $454,000, $1.9 million and $3.7 million in the years ended December 31, 2022, 2021 and 2020, respectively. Deferred contract costs, net of accumulated amortization was $2.4 million and $3.8 million at December 31, 2022 and 2021, respectively. In 2021 we changed our sales compensation structure, reducing the incremental costs associated with obtaining a contract, decreasing the amount of incremental costs to defer and the balance of deferred contract costs. Total amortization by expense classification for the years ended December 31, 2022, 2021 and 2020 was as follows:

	2022		2021		2020
	(In thousands)
Direct expenses	$	146	$	157	$	272
Selling, general and administrative expenses	$	1,625	$	2,494	$	2,970
Total amortization	$	1,771	$	2,651	$	3,242

Additional expense included in selling, general and administrative expenses for impairment of costs capitalized due to lost clients was $14,000, $31,000 and $63,000 for the years December 31, 2022, 2021 and 2020, respectively.

Trade Accounts Receivable

The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable, determined based on our historical write-off experience, current economic conditions and reasonable and supportable forecasts about the future. We review the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

The following table provides the activity in the allowance for doubtful accounts for the years ended December 31, 2022, 2021 and 2020 (in thousands):

	Balance at Beginning of Year		Bad Debt Expense		Write-offs, net of Recoveries		Balance at End of Year

Year Ended December 31, 2020	$	144	$	46	$	70	$	120
Year Ended December 31, 2021	$	120	$	38	$	64	$	94
Year Ended December 31, 2022	$	94	$	19	$	48	$	65

Table of Contents

Property and Equipment

Property and equipment is stated at cost. Major expenditures to purchase property or to substantially increase useful lives of property are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income.

We capitalize certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software projects and external direct costs of materials and services. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs are expensed as incurred. We capitalized approximately $3.6 million, $2.8 million and $2.7 million of costs incurred for the development of internal-use software for the years ended December 31, 2022, 2021 and 2020, respectively.

When a software license is included in a cloud computing arrangement and we have the legal right, ability and feasibility to download the software, it is accounted for as software, included in property and equipment, and amortized. If a software license is not included or we do not have the ability or feasibility to download software included in a cloud computing arrangement, it is accounted for as a service contract, which is expensed to direct expenses or selling, general and administrative expenses during the service period.

We provide for depreciation and amortization of property and equipment using annual rates which are sufficient to amortize the cost of depreciable assets over their estimated useful lives. We use the straight-line method of depreciation and amortization over estimated useful lives of two to ten years for furniture and equipment, three to five years for computer equipment, one to five years for capitalized software, and seven to forty years for our office building and related improvements. Software licenses are amortized over the term of the license.

Impairment of Long-Lived Assets and Amortizing Intangible Assets

Long-lived assets, such as property and equipment and purchased intangible assets subject to depreciation or amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, we first compare undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. No significant impairments were recorded during the years ended December 31, 2022, 2021, or 2020.

Among others, management believes the following circumstances are important indicators of potential impairment of such assets and as a result may trigger an impairment review:

	●	Significant underperformance in comparison to historical or projected operating results;
	●	Significant changes in the manner or use of acquired assets or our overall strategy;
	●	Significant negative trends in our industry or the overall economy;
	●	A significant decline in the market price for our common stock for a sustained period; and
	●	Our market capitalization falling below the book value of our net assets.

Goodwill and Intangible Assets

Table of Contents

When performing the impairment assessment, we will first assess qualitative factors to determine whether it is necessary to determine the fair value of the intangible assets with indefinite lives. If we believe, as a result of the qualitative assessment, that it is more likely than not that the fair value of an indefinite-lived intangible is less than its carrying amount, we calculate the fair value using a market or income approach. If the carrying value of the indefinite-lived intangible asset exceeds its fair value, then the intangible asset is written-down to its fair value. We did not recognize any impairments related to indefinite-lived intangibles during 2022, 2021 or 2020.

Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. All of our goodwill is allocated to our reporting unit, which is the same as our operating segment. Goodwill is reviewed for impairment at least annually, as of October 1, and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable.

We review goodwill for impairment by first assessing qualitative factors to determine whether any impairment may exist. If we believe, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the carrying value of the reporting unit exceeds the fair value, then goodwill is written down by this difference. We performed a qualitative analysis as of October 1, 2022 and determined the fair value of our reporting unit likely exceeded the carrying value. No impairments were recorded during the years ended December 31, 2022 or 2021. A substantial portion of the revenue earned by our Canadian subsidiary was concentrated with one customer. While the customer exercised its option to extend its existing contract to September 2022, during December 2020 we chose not to enter into a new contract with this customer or otherwise extend the term of the contract beyond September 2022. We closed the Canada office at the end of the contract in September 2022. As a result, we tested for impairment of the then Canada reporting unit’s goodwill at December 31, 2020. We recognized an impairment of $714,000 for the excess of the then Canada reporting unit’s carrying value over the fair value, using discounted cash flows.

In March 2021, we changed our operating segments from six to one to reflect a change in the way we operated and managed our business, including changes to our corporate reporting structure to the Company’s Chief Executive Officer and chief operating decision maker. In connection with this change, our previous reporting units were combined into one reporting unit. We performed an interim qualitative analysis immediately before and after the reorganization and concluded that the fair value of our reporting units likely exceeded the carrying values and no impairments were recorded. Following the reorganization, we considered the current and expected future economic and market conditions, including the impact of the COVID-19 pandemic, on our reporting unit. We also assessed our current market capitalization compared to book value, forecasts and margins in our last quantitative impairment testing. We concluded that a triggering event has not occurred which would require an additional interim impairment test to be performed as it is not more likely than not that an impairment loss had been incurred at December 31, 2022.

Insurance Recoveries

We record insurance recoveries when the realization of the claim is probable. In 2020 we received $3.3 million in insurance recoveries, and $447,000 was paid directly to certain vendors from the insurer related to a cyber-attack in February 2020 (the “February incident”). We recorded $533,000, representing reimbursement for lost revenues, as insurance recoveries, and the remainder as a reduction to operating expenses. Due to insurance recoveries, the February incident did not have a significant impact on our consolidated financial statements. In 2020, we also recorded a gain in other income of $260,000 from insurance recoveries for property damage due to a flooding.

Income Taxes

We use the asset and liability method of accounting for income taxes. Under that method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances, if any, are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. We use the deferral method of accounting for our investment tax credits related to state tax incentives. During the years ended December 31, 2022, 2021, and 2020, we recorded income tax benefits relating to these tax credits of $36,000, $10,000, and $45,000, respectively. Interest and penalties related to income taxes are included in income taxes in the Consolidated Statements of Income.

Table of Contents

We recognize the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

In 2021, we adopted ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). Among other clarifications and simplifications related to income tax accounting, this ASU simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, hybrid taxes and the recognition of deferred tax liabilities for outside basis differences. The adoption of this standard had no material impact to our consolidated financial statements.

Share-Based Compensation

All of our existing stock option awards and non-vested stock awards have been determined to be equity-classified awards. The compensation expense on share-based payments is recognized based on the grant-date fair value of those awards. We recognize the excess tax benefits and tax deficiencies in the income statement when options are exercised. Amounts recognized in the financial statements with respect to these plans are as follows:

	2022			2021			2020
	(In thousands)
Amounts charged against income, before income tax benefit	$	1,200		$	623		$	680
Amount of related income tax benefit		(436	)		(919	)		(6,764	)
Net (benefit) expense to net income	$	764		$	(296	)	$	(6,084	)

We refer to our restricted stock awards as “non-vested” stock in these consolidated financial statements.

Cash and Cash Equivalents

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash equivalents were $24.9 million and $6.3 million as of December 31, 2022, and 2021, respectively, consisting primarily of money market accounts. At certain times, cash equivalent balances may exceed federally insured limits.

Leases

We determine whether a lease is included in an agreement at inception. We recognize a lease liability and a right-of-use (“ROU”) asset on the balance sheet for our operating leases under which we are lessee. Operating lease ROU assets are included in operating lease right-of-use assets in our consolidated balance sheet. Finance lease assets are included in property and equipment. Operating and finance lease liabilities are included in other current liabilities and other long-term liabilities. Certain lease arrangements may include options to extend or terminate the lease. We include these provisions in the ROU asset and lease liabilities only when it is reasonably certain that we will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term and is included in direct expenses and selling, general and administrative expenses. Our lease agreements do not contain any residual value guarantees.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments during the lease term. ROU assets and lease liabilities are recorded at lease commencement based on the estimated present value of lease payments. Because the rate of interest implicit in each lease is not readily determinable, we use our estimated incremental collateralized borrowing rate at lease commencement, to calculate the present value of lease payments. When determining the appropriate incremental borrowing rate, we consider our available credit facilities, recently issued debt and public interest rate information.

Table of Contents

Due to remote working arrangements, we reassessed our office needs and subleased our Seattle location under an agreement considered to be an operating lease beginning in May 2021. We have not been legally released from our primary obligations under the original lease and therefore we continue to account for the original lease separately. We recorded an ROU asset impairment charge in 2021 of $324,000, which was the amount by which the carrying value of the Seattle office lease ROU asset exceeded the fair value. We estimated the fair value based on the discounted cash flows of estimated net rental income for the office space subleased. The ROU asset impairment charge is included in depreciation, amortization and impairment expenses. There were no ROU asset impairment charges in 2022 or 2020. Rent income from the sublessee are included in the statement of operations on a straight-line basis as an offset to rent expense associated with the original operating lease included in other expenses.

Fair Value Measurements

Our valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. The inputs are then classified into the following hierarchy: (1) Level 1 Inputs—quoted prices in active markets for identical assets and liabilities; (2) Level 2 Inputs—observable market-based inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar or identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; (3) Level 3 Inputs—unobservable inputs.

The following details our financial assets within the fair value hierarchy at December 31, 2022 and 2021:

	Level 1		Level 2		Level 3		Total
	(In thousands)
As of December 31, 2022
Money Market Funds	$	24,927	$	—	$	—	$	24,927
Total Cash Equivalents	$	24,927	$	—	$	—	$	24,927

As of December 31, 2021
Money Market Funds	$	6,306	$	—	$	—	$	6,306
Total Cash Equivalents	$	6,306	$	—	$	—	$	6,306

There were no transfers between levels during the years ended December 31, 2022 and 2021.

Our long-term debt described in Note 8 is recorded at historical cost. The fair value of long-term debt is classified in Level 2 of the fair value hierarchy and was estimated based primarily on estimated current rates available for debt of the same remaining duration and adjusted for nonperformance and credit.

The following are the carrying amount and estimated fair values of long-term debt:

	December 31, 2022		December 31, 2021
	(In thousands)
Total carrying amount of long-term debt	$	22,315	$	26,620
Estimated fair value of long-term debt	$	21,668	$	27,708

The carrying amounts of accounts receivable, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are not recognized or disclosed at fair value in the financial statements on a recurring basis, which includes ROU assets, property and equipment, goodwill, intangibles and cost method investments, are measured at fair value in certain circumstances (for example, when there is evidence of impairment). We estimated the fair value of the Seattle office ROU asset using discounted cash flows of the sublease based on management’s most recent projections, which are considered level 3 inputs in the fair value hierarchy and recorded an ROU asset impairment charge of $324,000 during 2021. As of December 31, 2022 and 2021, there was no indication of impairment related to these assets. As discussed above, we recognized an impairment of $714,000 for the then Canada reporting unit’s goodwill at December 31, 2020. We estimated the fair value of the Canada reporting unit using discounted cash flows based on management’s most recent projections which are considered level 3 inputs in the fair value hierarchy.

Table of Contents

Commitments and Contingencies

From time to time, we are involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable. Legal fees, net of estimated insurance recoveries, are expensed as incurred. We do not believe the final disposition of claims at December 31, 2022 will have a material adverse effect on our consolidated financial position, results of operations or liquidity.

We are self-insured for group medical and dental insurance. We carry excess loss coverage in the amount of $150,000 per covered person per year for group medical insurance. We do not self-insure for any other types of losses, and therefore do not carry any additional excess loss insurance. In addition, we had aggregate claims loss coverage with a minimum aggregate deductible of $4.7 million, $3.2 million and $2.8 million, in 2022, 2021 and 2020, respectively. We record a reserve for our group medical and dental insurance for all unresolved claims and for an estimate of incurred but not reported (“IBNR”) claims. On a quarterly basis, we adjust our accrual based on a review of our claims experience and a third-party actuarial IBNR analysis. As of December 31, 2022 and 2021, our accrual related to self-insurance was $424,000 and $406,000, respectively.

Earnings Per Share

Basic net income per share was computed using the weighted-average number of common shares outstanding during the period.

Diluted net income per share was computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method.

We had 83,070, 127,185 and 65,127 options of Common Stock for the years ended December 31, 2022, 2021 and 2020, respectively which have been excluded from the diluted net income per share computation because their inclusion would be anti-dilutive.

	2022			2021			2020
	(In thousands, except per share data)
Numerator for net income per share - basic:
Net income	$	31,800		$	37,466		$	37,260
Allocation of distributed and undistributed income to unvested restricted stock shareholders		(16	)		(18	)		(57	)
Net income attributable to common shareholders	$	31,784		$	37,448		$	37,203
Denominator for net income per share - basic:
Weighted average common shares outstanding – basic		24,922			25,422			25,170
Net income per share – basic	$	1.28		$	1.47		$	1.48
Numerator for net income per share - diluted:
Net income attributable to common shareholders for basic computation	$	31,784		$	37,448		$	37,203
Denominator for net income per share - diluted:
Weighted average common shares outstanding – basic		24,922			25,422			25,170
Weighted average effect of dilutive securities – stock options		130			218			526
Denominator for diluted earnings per share – adjusted weighted average shares		25,052			25,640			25,696
Net income per share – diluted	$	1.27		$	1.46		$	1.45

Table of Contents

(2)

ACQUISITION

On January 4, 2021, we acquired substantially all assets and assumed certain liabilities of PatientWisdom, Inc., a company with a health engagement solution that will further our purpose of operationalizing human understanding through tangible and actionable insights. $3.0 million of the total $5.0 million all-cash consideration was paid at closing. We paid the remaining $2.0 million in January 2022. All payments were made with cash on hand. The acquisition was accounted for as a business combination, using the acquisition method of accounting, which requires, among other things, certain assets acquired and liabilities assumed to be recognized at their fair values as of the acquisition date. The following table summarizes the fair value of assets acquired and liabilities assumed at the acquisition date.

Amount of Identified Assets Acquired and Liabilities Assumed
	($ in thousands)
Current Assets	$	184
Property and equipment		10
Customer related		100
Technology		600
Goodwill		4,340
Total assets acquired	$	5,234
Current liabilities		284
Net assets acquired	$	4,950

The identifiable intangible assets are being amortized over their estimated useful lives of 5 years. The goodwill and identifiable intangible assets are deductible for tax purposes. Goodwill related to the acquisition was primarily attributable to anticipated synergies and other intangibles that do not qualify for separate recognition.

The financial results associated with the PatientWisdom assets we acquired and liabilities we assumed are included in our consolidated financial statements from the date of acquisition, although the amounts are insignificant for 2022 and 2021. Pro-forma information has not been presented because the amounts for 2021 are insignificant. Acquisition-related costs of $119,000 are included in selling, general and administrative expenses for the year ended December 31, 2021.

Table of Contents

(3)

Contracts with Customers

The following table disaggregates revenue for the years ended December 31, 2022, 2021 and 2020 based on timing of revenue recognition (In thousands):

	2022		2021		2020
Subscription services recognized ratably over time	$	141,981	$	137,008	$	122,499
Services recognized at a point in time		4,231		3,216		2,932
Fixed, non-subscription recognized over time		3,134		3,065		2,907
Unit price services recognized over time		2,222		4,665		4,939
Total revenue	$	151,568	$	147,954	$	133,277

The following table provides information about receivables, contract assets, and contract liabilities from contracts with customers (In thousands):

	December 31, 2022		December 31, 2021
Accounts receivables	$	14,461	$	13,728
Contract assets included in other current assets	$	102	$	99
Deferred revenue	$	15,198	$	17,213

Significant changes in contract assets and contract liabilities during the years ended December 31, 2022 and 2021 are as follows (in thousands):

	2022						2021
	Contract Asset			Deferred Revenue			Contract Asset			Deferred Revenue
	Increase (Decrease)
Revenue recognized that was included in deferred revenue at beginning of year due to completion of services	$	-		$	(17,170	)	$	-		$	(15,631	)
Increases due to invoicing of client, net of amounts recognized as revenue		-			15,081			-			16,694
Decreases due to completion of services (or portion of services) and transferred to accounts receivable		(99	)		-			(311	)		-
Change due to cumulative catch-up adjustments arising from changes in expected contract consideration		-			74			-			326
Increases due to revenue recognized in the period with additional performance obligations before invoicing		102			-			99			-

We have elected to apply the practical expedient to not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less. Total remaining contract revenue for contracts with original duration of greater than one year expected to be recognized in the future related to performance obligations that are unsatisfied at December 31, 2022 approximated $1.6 million of which $972,000, $621,000, and $15,000 is expected to be recognized during 2023, 2024, and 2025, respectively.

Table of Contents

(4)

Equity Investments

We make equity investments to promote business and strategic objectives. For investments that do not have a readily determinable fair value, we apply either cost or equity method of accounting depending on the nature of our investment and our ability to exercise significant influence. Investments are periodically analyzed to determine whether or not there are any indicators of impairment and written down to fair value if the investment has incurred an other than temporary impairment. Our investment of $1.3 million in convertible preferred stock of PracticingExcellence.com, Inc., a privately-held Delaware corporation (“PX”) is included in non-current assets. It is not practicable for us to estimate fair value at each reporting date due to the cost and complexity of the calculations for this non-public entity. Therefore, it is carried at cost less impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer, if any. We have a seat on PX's board of directors and our investment, which is not considered to be in-substance common stock, represents approximately 13.8% of the issued and outstanding equity interests in PX.

(5)

Property and Equipment

At December 31, 2022, and 2021, property and equipment consisted of the following:

	2022		2021
	(In thousands)
Furniture and equipment	$	4,753	$	4,901
Computer equipment		2,639		2,672
Computer software		29,876		27,828
Building		12,561		9,271
Leaseholds		502		502
Land		425		425
Property and equipment at cost		50,756		45,599
Less accumulated depreciation and amortization		33,508		33,208
Net property and equipment	$	17,248	$	12,391

Depreciation and amortization expense related to property and equipment, including assets under capital lease, for the years ended December 31, 2022, 2021, and 2020 was $5.1 million, $5.7 million, and $6.5 million, respectively. We capitalize interest expense on major construction and development projects while in progress. Interest capitalized for 2022 was $216,000. We did not capitalize interest in 2021 or 2020. There were no significant impairments in property and equipment during 2022, 2021, and 2020. However, we did shorten the useful lives of certain assets to reflect our best estimate of when assets are expected to be disposed of or replaced.

Table of Contents

(6)

Goodwill and Intangible Assets

Goodwill and intangible assets consisted of the following at December 31, 2022:

Gross

Accumulated

Impairment

Net

(In thousands)

Goodwill

62,328

(714

)

61,614

	Useful Life			Gross		Accumulated Amortization		Net
	(In years)					(In thousands)
Non-amortizing intangible assets:
Indefinite trade name					1,191				1,191
Amortizing intangible assets:
Customer related	5	-	15		9,192		9,132		60
Technology	3	-	7		1,959		1,599		360
Trade names		10			1,572		1,572		—
Total amortizing intangible assets					12,723		12,303		420
Total intangible assets other than goodwill				$	13,914	$	12,303	$	1,611

Goodwill and intangible assets consisted of the following at December 31, 2021:

Gross

Accumulated

Impairment

Net

(In thousands)

Goodwill

62,328

(714

)

61,614

	Useful Life			Gross		Accumulated Amortization		Net
	(In years)					(In thousands)
Non-amortizing intangible assets:
Indefinite trade name					1,191				1,191
Amortizing intangible assets:
Customer related	5	-	15		9,445		9,325		120
Technology	3	-	7		1,959		1,480		479
Trade names		10			1,572		1,572		—
Total amortizing intangible assets					12,976		12,377		599
Total intangible assets other than goodwill				$	14,167	$	12,377	$	1,790

The following represents a summary of changes in the carrying amount of goodwill for the years ended December 31, 2022 and 2021 (in thousands):

Balance as of December 31, 2020	$	57,255
Goodwill acquired		4,340
Foreign currency translation		19
Balance as of December 31, 2021	$	61,614

There were no changes in goodwill during 2022 from the net carrying amount of $61,614 at December 31, 2021.

Table of Contents

As discussed in Note 1, we recorded an impairment of $714,000 to the Canada reporting unit’s goodwill in December 2020.

Aggregate amortization expense for customer related intangibles, trade names, and technology for the years ended December 31, 2022, 2021 and 2020 was $180,000, $320,000, and $318,000, respectively. Estimated future amortization expense for 2023, 2024, and 2025 is $140,000, $140,000 and $140,000, respectively. No amortization expense is projected beyond 2025.

(7)

Income Taxes

For the years ended December 31, 2022, 2021, and 2020, income before income taxes consists of the following:

	2022			2021		2020
	(In thousands)
U.S. Operations	$	43,156		$	48,145	$	41,357
Foreign Operations		(341	)		476		110
Income before income taxes	$	42,815		$	48,621	$	41,467

Income tax expense consisted of the following components:

	2022			2021			2020
	(In thousands)
Federal:
Current	$	9,988		$	9,092		$	3,546
Deferred		(1,427	)		(224	)		(308	)
Total	$	8,561		$	8,868		$	3,238

Foreign:
Current	$	(90	)	$	143		$	225
Deferred		—			(17	)		(6	)
Total	$	(90	)	$	126		$	219

State:
Current	$	2,846		$	2,197		$	578
Deferred		(302	)		(36	)		172
Total	$	2,544		$	2,161		$	750

Total	$	11,015		$	11,155		$	4,207

As a result of the Tax Cuts and Jobs Act (the “Tax Act”), we determined that we would no longer indefinitely reinvest the earnings of our Canadian subsidiary. Our Canadian subsidiary declared a deemed dividend to the Company for $1.4 million and $9.6 million in 2022 and 2020, respectively. Additionally, a withholding tax of 5% was paid for the dividend distribution. Due to the closure of the Canadian office, we also processed a return of capital from the Canadian subsidiary to the Company of $1.2 million.

We qualify for tax incentives through the Nebraska Advantage LB312 Act (“NAA”). The NAA provides direct refunds of sales tax on qualified property, as well as investment credits and employment credits that can be claimed through credits of Nebraska income tax, employment tax, and sales tax on non-qualified property. For the year ended December 31, 2022, 2021 and 2020, adjustments for credits reduced operating expenses by approximately $510,000, $473,000 and $435,000, respectively. In addition, income tax credits of $36,000, $10,000 and $45,000 were recorded as a reduction to income tax expense for the years ended December 31, 2022, 2021 and 2020, respectively.

Table of Contents

The differences between income taxes expected at the U.S. federal statutory income tax rate of 21 percent and the reported income tax (benefit) expense are summarized as follows:

	2022			2021			2020
	(In thousands)
Expected federal income taxes	$	8,991		$	10,210		$	8,708
Foreign tax rate differential		(24	)		26			6
State income taxes, net of federal benefit and state tax credits		2,100			1,531			607
Share-based compensation		(120	)		(660	)		(5,713	)
Compensation limit for covered employees		—			—			463
Federal tax credits		(408	)		(272	)		(261	)
Uncertain tax positions		22			254			157
Reclassification of cumulative translation adjustment into earnings		539			—			—
Goodwill Impairment		—			—			184
Withholding tax on repatriation of foreign earnings		(100	)		8			18
GILTI		—			—			10
Other		15			58			28
	$	11,015		$	11,155		$	4,207

Deferred tax assets and liabilities at December 31, 2022 and 2021, were comprised of the following:

	2022			2021
	(In thousands)
Deferred tax assets:
Allowance for doubtful accounts	$	16		$	24
Accrued expenses		691			687
Share-based compensation		1,072			740
Accrued bonuses		96			267
Employer payroll tax deferral		—			200
Uncertain tax positions		256			161
Research & experimental expenditures		856			—
Other		78			66
Gross deferred tax assets		3,065			2,145
Less valuation allowance		—			—
Deferred tax assets		3,065			2,145
Deferred tax liabilities:
Prepaid expenses		135			89
Deferred contract costs		601			945
Property and equipment		1,066			1,579
Intangible assets		6,523			6,338
Repatriation withholding		—			182
Deferred tax liabilities		8,325			9,133
Net deferred tax liabilities	$	(5,260	)	$	(6,988	)

In March 27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The CARES Act is an emergency economic stimulus package in response to the coronavirus outbreak which, among other things, contains numerous income tax provisions. As a result of the CARES Act, we had deferred $1.3 million of employer social security tax payments as of December 31, 2020. In accordance with the CARES Act, we paid half of this liability in December 2021, and paid the remaining $656,000 in December 2022. We have had no other impacts to our consolidated financial statements or related disclosures from the CARES Act.

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into U.S. law. The IRA includes implementation of a new alternative minimum tax, an excise tax on stock buybacks, and significant tax incentives for energy and climate initiatives, among other provisions. After evaluating the provisions included under the IRA, the Company does not expect the provisions to have a material impact to the Company’s consolidated financial statements.

Table of Contents

In assessing the realizability of deferred tax assets, we consider whether it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. We consider projected future taxable income, carry-back opportunities, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods which the deferred tax assets are deductible, we believe it is more likely than not that we will realize the benefits of these deductible differences excluding the foreign tax credit carryforward. In 2020, we wrote off the deferred tax asset for prior year foreign tax credit carryforwards of $535,000 and the related valuation allowance. We made the assessment that due to our Canadian subsidiary’s decreased projected future income and the lower US tax rate compared to the Canadian tax rate, it was unlikely we would realize this asset.

The Tax Act amended Section 174 rules for the federal tax treatment of research or experimental (“R&E”) expenditures paid or incurred during the taxable year. The new Section 174 rules require taxpayers to capitalize and amortize specified R&E expenditures over a period of five years (attributable to domestic research) or 15 years (attributable to foreign research), beginning with the midpoint of the taxable year in which the expenses are paid or incurred. Software development costs are expressly included in the definition of specified R&E expenditures after 2021. Due to this change in legislation the Company has deferred costs of $3.5 million for tax purposes, resulting in a deferred tax asset of $856,000 at December 31, 2022. The Company also recorded a deferred tax asset of $52,000 related to software development costs included in the overall fixed asset deferred tax liability.

We had an unrecognized tax benefit at December 31, 2022 and 2021, of $1.6 million and $1.1 million, respectively, excluding interest of $25,000 and $19,000 at December 31, 2022 and 2021, respectively. Of these amounts, $1.3 million and $918,000 at December 31, 2022 and 2021, respectively, represents the net unrecognized tax benefits that, if recognized, would favorably impact the effective income tax rate. The change in the unrecognized tax benefits for 2022 and 2021 was as follows:

	(In thousands)
Balance of unrecognized tax benefits at December 31, 2020	$	768
Reductions due to lapse of applicable statute of limitations		(38	)
Reductions due to tax positions of prior years		—
Reductions due to settlement with taxing authorities		—
Additions based on tax positions related to the current year		345
Balance of unrecognized tax benefits at December 31, 2021	$	1,075
Reductions due to lapse of applicable statute of limitations		(76	)
Additions due to tax positions of prior years		—
Reductions due to settlement with taxing authorities		—
Additions based on tax positions related to the current year		558
Balance of unrecognized tax benefits at December 31, 2022	$	1,557

We file income tax returns in the U.S. federal jurisdiction, various state jurisdictions, and Canada federal and provincial jurisdictions. Tax years 2019 and forward remain subject to U.S. federal examination. Tax years 2016 and forward remain subject to state examination. Tax years 2018 and forward remain subject to Canadian federal and provincial examination.

(8)

Notes Payable

Our long-term debt consists of the following:

	2022			2021
	(In thousands)
Term Loans	$	22,315		$	26,620
Less: current portion		(4,491	)		(4,278	)
Less: unamortized debt issuance costs		(134	)		(73	)
Notes payable, net of current portion	$	17,690		$	22,269

Our amended and restated credit agreement (the “Credit Agreement”) with First National Bank of Omaha (“FNB”) was amended and restated on September 30, 2022 and includes (i) a $30,000,000 revolving credit facility (the “Line of Credit”), (ii) a $23,412,383 term loan (the “Term Loan”) and (iii) a $75,000,000 delayed draw-down term facility (the “Delayed Draw Term Loan” and, together with the Line of Credit and the Term Loan, the “Credit Facilities”). We may use the Delayed Draw Term Loan to fund any permitted future business acquisitions or repurchases of our Common Stock and the Line of Credit to fund ongoing working capital needs and for other general corporate purposes.

Table of Contents

The amended Term Loan revised the remaining payments for the then existing outstanding balance at September 30, 2022 to monthly installments of $462,988 through May 2027. The Term Loan bears interest at a fixed rate per annum of 5%.

Borrowings under the Line of Credit and the Delayed Draw Term Loan, if any, bear interest at a floating rate equal to the 30-day Secured Overnight Financing Rate (“SOFR”) plus 235 basis points (6.10% at December 31, 2022). Interest on the Line of Credit accrues and is payable monthly. Principal amounts outstanding under the Line of Credit are due and payable in full at maturity, in May 2025. As of December 31, 2022, the Line of Credit did not have a balance. There were no borrowings on the Line of Credit during 2022. There have been no borrowings on the Delayed Draw Term Loan since origination.

The Credit Agreement is collateralized by substantially all of our assets, subject to permitted liens and other agreed exceptions, and contains customary representations, warranties, affirmative and negative covenants (including financial covenants) and events of default. The negative covenants include, among other things, restrictions regarding the incurrence of indebtedness and liens, repurchases of our Common Stock and acquisitions, subject in each case to certain exceptions. Pursuant to the Credit Agreement, we are required to maintain a minimum fixed charge coverage ratio of 1.10x for all testing periods throughout the term(s) of the Credit Facilities, which calculation excludes, unless our liquidity falls below a specified threshold, (i) any cash dividend in a fiscal quarter that, together with all other cash dividends paid or declared during such fiscal quarter, exceeds $5,500,000 in total cash dividends paid or declared, (ii) the portion of the purchase price for any permitted share repurchase of our shares paid with cash on hand, and (iii) the portion of any acquisition consideration for a permitted acquisition paid with cash on hand. We are also required to maintain a cash flow leverage ratio of 3.00x or less for all testing periods throughout the term(s) of the Credit Facilities. All obligations under the Credit Facilities are to be guaranteed by each of our direct and indirect wholly owned domestic subsidiaries, if any, and, to the extent required by the Credit Agreement, direct and indirect wholly owned foreign subsidiaries. As of December 31, 2022, we were in compliance with our financial covenants.

Scheduled maturities of notes payable at December 31, 2022 are as follows:

2023	$	4,529
2024		4,762
2025		5,011
2026		5,271
2027		2,742

(9)

Share-Based Compensation

We measure and recognize compensation expense for all share-based payments based on the grant-date fair value of those awards. All of our existing stock option awards and unvested stock awards have been determined to be equity-classified awards. We account for forfeitures as they occur.

Our 2004 Non-Employee Director Stock Plan, as amended (the “2004 Director Plan”), is a nonqualified plan that provides for the granting of options with respect to 3,000,000 shares of our Common Stock. The 2004 Director Plan provides for grants of nonqualified stock options to each of our directors who we do not employ. On the date of each annual meeting of shareholders, options to purchase shares of Common Stock equal to an aggregate grant date fair value of $100,000 are granted to each non-employee director that is elected or retained as a director at each such meeting. Stock options vest approximately one year following the date of grant and option terms are generally the earlier of ten years following the date of grant, or three years from the termination of the outside director’s service. At December 31, 2022, there were 707,862 shares of Common Stock available for issuance pursuant to future grants under the 2004 Director Plan. We have accounted for grants of 2,292,138 shares of Common Stock under the 2004 Director Plan using the date of grant as the measurement date for financial accounting purposes.

Our 2006 Equity Incentive Plan (the “2006 Equity Incentive Plan”), as amended, provides for the granting of stock options, stock appreciation rights, restricted stock, performance shares and other share-based awards and benefits up to an aggregate of 1,800,000 shares of Common Stock. Stock options granted may be either incentive stock options or nonqualified stock options. Vesting terms vary with each grant and option terms are generally five to ten years following the date of grant. At December 31, 2022, there were 751,778 shares of Common Stock available for issuance pursuant to future grants under the 2006 Equity Incentive Plan. We have accounted for grants of 1,048,222 shares of Common Stock and restricted stock under the 2006 Equity Incentive Plan using the date of grant as the measurement date for financial accounting purposes.

Table of Contents

During 2022, 2021 and 2020, we granted options to purchase 127,227, 101,091, and 70,471 shares of Common Stock, respectively. Options to purchase shares of common stock are typically granted with exercise prices equal to the fair value of the common stock on the date of grant. We do, in certain limited situations, grant options with exercise prices that exceed the fair value of the common shares on the date of grant. The fair value of stock options granted was estimated using a Black-Scholes valuation model with the following weighted average assumptions:

	2022			2021			2020
Expected dividend yield at date of grant		3.39	%		2.15	%		1.84	%
Expected stock price volatility		35.52	%		34.85	%		33.62	%
Risk-free interest rate		2.33	%		0.91	%		1.35	%
Expected life of options (in years)		6.3			7.01			7.39

The risk-free interest rate assumptions were based on the U.S. Treasury yield curve in effect at the time of the grant. The expected volatility was based on historical monthly price changes of our stock based on the expected life of the options at the date of grant. The expected life of options is the average number of years we estimate that options will be outstanding. We consider groups of associates that have similar historical exercise behavior separately for valuation purposes.

The following table summarizes stock option activity under 2006 Equity Incentive Plan and the 2004 Director Plan for the year ended December 31, 2022:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value (In thousands)
Common Stock
Outstanding at December 31, 2021		477,640	$	30.88
Granted		127,227	$	36.67
Exercised		23,581	$	13.17
Outstanding at December 31, 2022		581,286	$	32.86		5.44	$	4,739
Exercisable at December 31, 2022		323,140	$	26.97		3.55	$	4,369

The following table summarizes information related to stock options for the years ended December 31, 2022, 2021 and 2020:

	2022		2021		2020
Weighted average grant date fair value of stock options granted	$	9.43	$	12.55	$	18.67
Intrinsic value of stock options exercised (in thousands)	$	648	$	3,535	$	25,912
Intrinsic value of stock options vested (in thousands)	$	4,369	$	4,805	$	1,965

As of December 31, 2022, the total unrecognized compensation cost related to non-vested stock option awards was approximately $1.2 million which was expected to be recognized over a weighted average period of 2.63 years.

There was $446,000 and $1.7 million in cash received from stock options exercised for the years ended December 31, 2021 and 2020, respectively. No cash was received for stock options exercised for the year ended December 31, 2022. We recognized $1.1 million, $607,000, and $680,000 of non-cash compensation for the years ended December 31, 2022, 2021, and 2020, respectively, related to options, which is included in direct and selling, general and administrative expenses. The actual tax benefit realized for the tax deduction from stock options exercised was $160,000, $862,000, and $6.3 million for the years ended December 31, 2022, 2021, and 2020, respectively.

Table of Contents

During 2021 we granted 12,698 non-vested shares of Common Stock under the 2006 Equity Incentive Plan. No shares of non-vested Common Stock were granted during the years ended December 31, 2022 or 2020. As of December 31, 2022, we had 12,698 non-vested shares of Common Stock outstanding under the 2006 Equity Incentive Plan. These shares vest five years following the date of grant and holders thereof are entitled to receive dividends from the date of grant, whether or not vested. The fair value of the awards is calculated as the fair market value of the shares on the date of grant. We recognized $109,000, $17,000, and $23,000 of non-cash compensation for the years ended December 31, 2022, 2021, and 2020, respectively, related to this non-vested stock, which is included in direct and selling, general and administrative expenses. The actual tax benefit realized for the tax deduction from vesting of restricted stock was $235,000 for the year ended December 31, 2020. No restricted stock vested during the years end December 31, 2022 and 2021.

The following table summarizes information regarding non-vested stock granted to associates under the 2006 Equity Incentive Plans for the year ended December 31, 2022:

	Common Stock Outstanding		Common Stock Weighted Average Grant Date Fair Value Per Share
Outstanding at December 31, 2021		12,698	$	42.92
Granted		—	$	—
Vested		—	$	—
Forfeited		—	$	—
Outstanding at December 31, 2022		12,698	$	42.92

As of December 31, 2022, the total unrecognized compensation cost related to non-vested stock awards was approximately $327,000 and is expected to be recognized over a weighted average period of 3.00 years.

(10)

Leases

We lease printing, computer, other equipment and office space in the United States and Canada. The leases remaining terms as of December 31, 2022 range from less than one year to 3.93 years.

Certain equipment and office lease agreements include provisions for periodic adjustments to rates and charges. The rates and charges are adjusted based on actual usage or actual costs for internet, common area maintenance, taxes or insurance, as determined by the lessor and are considered variable lease costs.

The components of lease expense for the years ended December 31, 2022, 2021 and 2020 included (in thousands):

	2022			2021			2020
Operating leases	$	527		$	669		$	600
Finance leases:
Asset amortization		462			489			355
Interest on lease liabilities		19			34			37
Variable lease cost		95			99			62
Short-term lease cost		87			59			42
Sublease income		(123	)		(81	)		—
Total net lease cost	$	1,067		$	1,269		$	1,096

In 2020, we adjusted the useful life of the operating right of use assets associated with our Atlanta, Georgia and Markham, Ontario office leases based on the expectation that we will vacate the office space before the end of the lease term.

Table of Contents

Supplemental balance sheet information related to leases (in thousands):

	December 31, 2022		December 31, 2021
Operating leases:
Operating ROU assets	$	556	$	975

Current operating lease liabilities		522		493
Noncurrent operating lease liabilities		333		820
Total operating lease liabilities	$	855	$	1,313

	December 31, 2022			December 31, 2021
Finance leases:
Furniture and equipment	$	1,042		$	1,042
Computer Equipment		659			659
Computer Software		207			207
Property and equipment under finance lease, gross		1,908			1,908
Less accumulated amortization		1,537			1,074
Property and equipment under finance lease, net	$	371		$	834

Current obligations of finance leases	$	311		$	470
Noncurrent obligations of finance leases		39			348
Total finance lease liabilities	$	350		$	818

Weighted average remaining lease term (in years):
Operating leases		1.95			2.80
Finance leases		1.15			1.93

Weighted average discount rate:
Operating leases		3.97	%		3.85	%
Finance leases		3.54	%		3.42	%

Supplemental cash flow and other information related to leases were as follows (in thousands):

	2022		2021		2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	563	$	680	$	596
Operating cash flows from finance leases		18		34		36
Financing cash flows from finance leases		469		493		332

ROU assets obtained in exchange for operating lease liabilities		83		560		276
ROU assets obtained in exchange for finance lease liabilities		—		40		817

Table of Contents

Undiscounted payments under non-cancelable finance and operating leases at December 31, 2022 were as follows (in thousands):

	Finance Leases		Operating Leases
2023	$	315	$	547
2024		23		227
2025		11		118
2026		10		—
2027		—		—
Thereafter		—		—
Total minimum lease payments		359		892
Less: Amount representing interest		9		37
Present value of minimum lease payments		350		855
Less: Current portion		311		522
Lease obligations, net of current portion	$	39	$	333

Undiscounted cash receipts due under the sublease agreement at December 31, 2022 are as follows (in thousands):

	Operating Lease
2023	$	122
2024		127
2025		65
Total minimum lease receipts	$	314

(11)

Related Party

Mr. Hays, our Chief Executive Officer and director, is an owner of approximately 13% of the equity interests of Nebraska Global Investment Company LLC (“Nebraska Global”). We purchased certain services from Don’t Panic Labs, LLC, which was a subsidiary of Nebraska Global for a portion of the year ended December 31, 2022. The total value of these purchases was $196,000 in the year ended December 31, 2022.

A director who began serving on our board in May 2021, also served until her retirement at the end of 2021 as chief executive officer of Allina Health, a not-for-profit healthcare system. In connection with its routine business operations, Allina Health purchases certain of our products and services. Total revenue we earned from Allina Health in the year ended December 31, 2021 approximated $1.7 million.

A director, who served on our board through October 2021, also served as an officer and director of Ameritas Life Insurance Corp. (“Ameritas”) until January 2020 and continued to serve on the board of directors of Ameritas until October 2021. In connection with our regular assessment of our insurance-based associate benefits, which is conducted by an independent insurance broker, and the costs associated therewith, we purchase dental and vision insurance for certain of our associates from Ameritas. The total value of these purchases was $278,000 and $248,000 in 2021 and 2020 respectively.

A director, who served on our board through May 2020, also served as a board member of IMA Financial Group. In connection with our regular assessment of our liability coverage, during 2020 we began purchasing directors and officers and employment practices liability insurance through IMA Financial Group. Total payments for these services totaled $1.1 million in 2020.

During 2017, we acquired a cost method investment in convertible preferred stock of Practicing Excellence.com, Inc., a privately-held Delaware Corporation (“PX”), which is included in other non-current assets and is carried at cost, adjusted for changes resulting from observable price changes in orderly transactions of the same investment in PX, if any. We also have an agreement with PX which commenced in 2016 under which we act as a reseller of PX services and PX receives a portion of the revenues. The total revenue earned from the PX reseller agreement in the years ended December 31, 2021 and 2020 was $35,000, and $294,000, respectively. We no longer earn revenue under this agreement after June 30, 2021 due to termination of the reseller agreement.

Table of Contents

(12)

Associate Benefits

We sponsor a qualified 401(k) plan covering substantially all associates with no eligibility service requirement. Under the 401(k) plan, we match 25.0% of the first 6.0% of compensation contributed by each associate. Employer contributions, which are discretionary, vest to participants at a rate of 20% per year. We contributed $588,000, $531,000, and $521,000 in 2022, 2021, and 2020, respectively, as a matching percentage of associate 401(k) contributions.

(13)

Segment Information

Our Canada office was closed in 2022. As a result, no Canadian revenue is expected to be generated after 2022. The table below presents entity-wide information regarding our revenue and assets by geographic area (in thousands):

	2022		2021		2020
Revenue:
United States	$	150,775	$	144,987	$	130,305
Canada		793		2,967		2,972
Total	$	151,568	$	147,954	$	133,277
Long-lived assets:
United States	$	86,718	$	83,722	$	77,448
Canada		27		111		1,863
Total	$	86,745	$	83,833	$	79,311
Total assets:
United States	$	130,151	$	153,879	$	128,319
Canada		310		3,661		5,104
Total	$	130,461	$	157,540	$	133,423

Table of Contents

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Not applicable.

Item 9A.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2022. Based upon their evaluation of these disclosure controls and procedures, the Chief Executive Officer and the Chief Financial Officer concluded that the disclosure controls and procedures were effective as of December 31, 2022.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act). Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, however, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies of procedures may deteriorate. Accordingly, even effective internal control over financial reporting can only provide reasonable assurance of achieving its control objectives.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our internal control over financial reporting using the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on such evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2022.

The effectiveness of our internal control over financial reporting as of December 31, 2022, has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report, a copy of which is included in this Annual Report on Form 10-K.

We have confidence in our internal controls and procedures. Nevertheless, our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure procedures and controls or our internal controls will prevent all errors or intentional fraud. An internal control system, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of such internal controls are met. Further, the design of an internal control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. As a result of the inherent limitations in all internal control systems, no evaluation of controls can provide absolute assurance that all our control issues and instances of fraud, if any, have been detected.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarter ended December 31, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Item 9B.

Other Information

We have no other information to report pursuant to this item.

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

Table of Contents

PART III

Item 10.

Directors, Executive Officers and Corporate Governance

We have adopted a Code of Business Conduct and Ethics that applies to all of our associates, including our Chief Executive Officer and Chief Financial Officer and other persons performing similar functions. We have posted a copy of the Code of Business Conduct and Ethics on our website at www.nrchealth.com, and such Code of Business Conduct and Ethics is available, in print, without charge, to any shareholder who requests it from our Secretary. We intend to satisfy the disclosure requirements under Item 5.05 of Form 8-K regarding amendments to, or waivers from, the Code of Business Conduct and Ethics by posting such information on our website at www.nrchealth.com. We are not including the information contained on our website as part of, or incorporating it by reference into, this report.

The remaining information required by this Item will be included in our definitive proxy statement to be filed with the SEC within 120 days after December 31, 2022, in connection with the solicitation of proxies for the Company’s 2023 Annual Meeting of Stockholders (the “2023 Proxy Statement”), and is incorporated herein by reference.

Item 11.

Executive Compensation

The information required by this Item will be included in our definitive 2023 Proxy Statement, and is incorporated herein by reference.

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

The following table sets forth information with respect to compensation plans under which equity securities of the Company are authorized for issuance as of December 31, 2022.

Plan Category Common Shares	Number of Securities to be issued upon the exercise of outstanding options, warrants and rights		Weighted- average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column)
Equity compensation plans approved by security holders(1)		581,286	$	32.86		1,459,640	(2	)
Equity compensation plans not approved by security holders		—		—		—
Total		581,286	$	32.86		1,459,640

(1)	Includes our 2006 Equity Incentive Plan and 2004 Director Plan.

(2)

Under the 2006 Equity Incentive Plan, we had authority to award up to 325,181 additional shares of restricted Common Stock provided that the total of such shares awarded may not exceed the total number of shares remaining available for issuance under the 2006 Equity Incentive Plan, which totaled 751,778 shares of Common Stock as of December 31, 2022. The Director Plan provides for granting options for 3,000,000 shares of Common Stock. Option awards through December 31, 2022 totaled 2,292,138 shares of Common Stock.

The remaining information required by this Item will be included in our definitive 2023 Proxy Statement and is incorporated herein by reference.

Item 13.

Certain Relationships and Related Transactions, and Director Independence

The information required by this Item will be included in our definitive 2023 Proxy Statement and is incorporated herein by reference.

Item 14.

Principal Accountant Fees and Services

The information required by this Item will be included in our definitive 2023 Proxy Statement, and is incorporated herein by reference.

Table of Contents

PART IV

Item 15.

Exhibits, Financial Statement Schedules

1.	Consolidated financial statements. The consolidated financial statements listed in the accompanying index to the consolidated financial statements are filed as part of this Annual Report on Form 10-K.

2.	Financial statement schedules. All financial statement schedules have been omitted because they are not applicable or the required information is included in the consolidated financial statements and the related notes thereto.

3.	Exhibits. The exhibits listed in the exhibit index below are filed as part of this Annual Report on Form 10-K.

EXHIBIT INDEX

Exhibit Number	Exhibit Description

(3.1)	Certificate of Incorporation of National Research Corporation, effective June 30, 2021 [Incorporated by reference to Exhibit 3.3 to National Research Corporation’s Current Report on Form 8-K dated June 29, 2021, and filed on July 2, 2021 (File No. 001-35929)]

(3.2)	Bylaws of National Research Corporation, as amended to date [Incorporated by reference to Exhibit 3.4 to National Research Corporation’s Current Report on Form 8-K dated June 29, 2021 and filed on July 2, 2021 (File No. 001-35929)]

(4.1)	Certificate of Incorporation of National Research Corporation, effective June 30, 2021 [Incorporated by reference to Exhibit 3.3 to National Research Corporation’s Current Report on Form 8-K dated June 29, 2021, and filed on July 2, 2021 (File No. 001-35929)]

(4.2)	Bylaws of National Research Corporation, as amended to date [Incorporated by reference to Exhibit 3.4 to National Research Corporation’s Current Report on Form 8-K dated June 29, 2021 and filed on July 2, 2021 (File No. 001-35929)]

(4.3)	Description of the Securities of the Registrant. [Incorporated by reference to Exhibit 4.3 to National Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2021 and filed on March 4, 2022 (File No. 001-35929)]

(10.1)	Amended and Restated Credit Agreement dated May 28, 2020, between National Research Corporation and First National Bank of Omaha [Incorporated by reference to Exhibit 10.1 to National Research Corporation’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 and filed on August 7, 2020 (File No. 001-35929)]

(10.2)	First Amendment to Amended and Restated Credit Agreement between National Research Corporation and First National Bank of Omaha dated September 30, 2022 [Incorporated by reference to Exhibit 10.1 to National Research Corporation’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 and filed on November 4, 2022 (File No. 001-35929)]

(10.3)*	National Research Corporation 2004 Non-Employee Director Stock Plan, as amended [Incorporated by reference to Appendix A to National Research Corporation’s Proxy Statement for the 2018 Annual Meeting of Shareholders filed on April 27, 2018 (File No. 001-35929)]

(10.4)*	Form of Nonqualified Stock Option Agreement used in connection with the National Research Corporation 2006 Equity Incentive Plan [Incorporated by reference to Exhibit 10.14 to National Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2006 and filed on April 2, 2007 (File No. 000-29466)]

(10.5)*	Form of Restricted Stock Agreement used in connection with the National Research Corporation 2006 Equity Incentive Plan [Incorporated by reference to Exhibit 10.15 to National Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2006 and filed on April 2, 2007 (File No. 000-29466)]

(10.6)*	National Research Corporation 2006 Equity Incentive Plan, [Incorporated by reference to Appendix A to National Research Corporation’s Proxy Statement for the 2006 Annual Meeting of Shareholders filed on April 3, 2006 (File No. 000-29466)]

Table of Contents

Exhibit Number	Exhibit Description

(10.7)*	Form of Grant used in connection with the National Research Corporation 2004 Non-Employee Director Stock Plan, as amended [Incorporated by reference to Exhibit 10.1 to National Research Corporation’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 and filed on November 5, 2021 (File No. 001-35929)]

(21)**	Subsidiary of National Research Corporation

(23)**	Consent of Independent Registered Public Accounting Firm

(31.1)**	Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

(31.2)**	Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

(32)***	Certification of Periodic Financial Report by the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


(101)**	Financial statements from the Annual Report on Form 10-K of National Research Corporation for the year ended December 31, 2022, formatted in Inline eXtensible Business Reporting Language (iXBRL): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Shareholders’ Equity, (v) the Consolidated Statements of Cash Flows, (vi) the Notes to the Consolidated Financial Statements, and (vii) document and entity information.

(104)**	Cover Page Interactive Data File (formatted in the Inline XBRL and contained in Exhibit 101).

*	A management contract or compensatory plan or arrangement.

**	Filed herewith.
***	Furnished herewith.

Item 16.

Form 10-K Summary

None.

Table of Contents

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

	Page in this Form 10-K

Report of Independent Registered Public Accounting Firm (KPMG LLP, PCAOB ID: 185)	24

Consolidated Balance Sheets as of December 31, 2022 and 2021	26

Consolidated Statements of Income for the Three Years Ended December 31, 2022	27

Consolidated Statements of Comprehensive Income for the Three Years Ended December 31, 2022	28

Consolidated Statements of Shareholders’ Equity for the Three Years Ended December 31, 2022	29

Consolidated Statements of Cash Flows for the Three Years Ended December 31, 2022	30

Notes to Consolidated Financial Statements	31

All other financial statement schedules are omitted since the required information is not present or is not present in amounts sufficient to require submission of the schedules, or because the information required is included in the consolidated financial statements and notes thereto.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 3rd day of March 2023.

	NATIONAL RESEARCH CORPORATION

	By:	/s/ Michael D. Hays
		Michael D. Hays
		Chief Executive Officer and President

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature	Title	Date

/s/ Michael D. Hays	Chief Executive Officer, President and Director	March 3, 2023
Michael D. Hays	(Principal Executive Officer)


/s/ Kevin R. Karas	Senior Vice President Finance, Chief Financial	March 3, 2023
Kevin R. Karas	Officer, Treasurer and Secretary (Principal
	Financial and Accounting Officer)

/s/ Donald M. Berwick	Director	March 3, 2023
Donald M. Berwick


/s/ John N. Nunnelly	Director	March 3, 2023
John N. Nunnelly


/s/ Penny A. Wheeler	Director	March 3, 2023
Penny A. Wheeler


/s/ Stephen H. Lockhart	Director	March 3, 2023
Stephen H. Lockhart


/s/ Parul Bhandari	Director	March 3, 2023
Parul Bhandari

EX-21 2 ex_477815.htm EXHIBIT 21 ex_477815.htm

Exhibit 21

Subsidiary of National Research Corp.

National Research Corporation’s subsidiary as of December 31, 2022 is listed below:

Subsidiary	Jurisdiction of organization

National Research Corporation Canada	Ontario

EX-23 3 ex_477816.htm EXHIBIT 23 ex_477816.htm

Exhibit 23

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (Nos. 333-52143, 333-52135, 333-120530, 333-137763, 333-137769, 333-173097, 333-189139, 333-189140, 333-189141, 333-209934, 333-226715, and 333-226716) on Form S-8 and (Nos. 333-120529 and 333-232534) on Form S-3 of our report dated March 3, 2023, with respect to the consolidated financial statements of National Research Corporation and the effectiveness of internal control over financial reporting.

/s/ KPMG LLP

Lincoln, Nebraska

March 3, 2023

EX-31.1 4 ex_477817.htm EXHIBIT 31.1 ex_477817.htm

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

I, Michael D. Hays, certify that:

1.	I have reviewed this Annual Report on Form 10-K of National Research Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 3, 2023	By:	/s/ Michael D. Hays
		Michael D. Hays
		Chief Executive Officer and President

EX-31.2 5 ex_477818.htm EXHIBIT 31.2 ex_477818.htm

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934

I, Kevin R. Karas, certify that:

1.	I have reviewed this Annual Report on Form 10-K of National Research Corporation;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 3, 2023	By:	/s/ Kevin R. Karas
		Kevin R. Karas
		Chief Financial Officer

EX-32 6 ex_477819.htm EXHIBIT 32 ex_477819.htm

Exhibit 32

Certification Pursuant to 18 U.S.C. Section 1350
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the accompanying Annual Report on Form 10-K of National Research Corporation (the “Company”) for the year ended December 31, 2022 (the “Report”), I, Michael D. Hays, Chief Executive Officer and President of the Company, and I, Kevin R. Karas, Chief Financial Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, based on my knowledge, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

		/s/ Michael D. Hays
		Michael D. Hays
		Chief Executive Officer and President


		/s/ Kevin R. Karas
		Kevin R. Karas
		Chief Financial Officer

Date: March 3, 2023

A signed original of this written statement required by Section 906 has been provided to National Research Corporation and will be retained by National Research Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.SCH 7 nrc-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Income link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Comprehensive Income link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Shareholders' Equity link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 007 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 1 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 2 - Acquisition link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 3 - Contracts With Customers link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 4 - Equity Investments link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 5 - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 6 - Goodwill and Intangible Assets link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 7 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 8 - Notes Payable link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 9 - Share-based Compensation link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 10 - Leases link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 12 - Associate Benefits link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 13 - Segment Information link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 2 - Acquisition (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 3 - Contracts With Customers (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 5 - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 6 - Goodwill and Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 7 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 8 - Notes Payable (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 9 - Share-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 10 - Leases (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 13 - Segment Information (Tables) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Amortization Expense Classification (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Share-based Compensation Amounts Recognized in Financial Statements (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 2 - Acquisition (Details Textual) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 2 - Acquisition - Fair Value of Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 3 - Contracts With Customers 1 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 3 - Contracts With Customers 2 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 3 - Contracts With Customers - Disaggregation of Revenue (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 3 - Contracts With Customers - Information About Receivables, Contract Assets, and Contract Liabilities From Contracts With Customers (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 4 - Equity Investments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 5 - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 5 - Property and Equipment - Summary of Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 6 - Goodwill and Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 6 - Goodwill and Intangible Assets - Summary of Goodwill and Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 6 - Goodwill and Intangible Assets - Summary of Changes in the Carrying Amount of Goodwill (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 7 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 7 - Income Taxes - Income Before Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 7 - Income Taxes - Income Tax Expense (Details) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 7 - Income Taxes - Income Tax Reconciliation (Details) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 8 - Notes Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 8 - Notes Payable - Summary of Notes Payable (Details) link:calculationLink link:definitionLink link:presentationLink 058 - Disclosure - Note 8 - Notes Payable - Scheduled Maturities of Notes Payable (Details) link:calculationLink link:definitionLink link:presentationLink 059 - Disclosure - Note 9 - Share-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 060 - Disclosure - Note 9 - Share-based Compensation - Stock Options Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 061 - Disclosure - Note 9 - Share-based Compensation - Stock Option Activity Under Equity Incentive Plans and Director Plan (Details) link:calculationLink link:definitionLink link:presentationLink 062 - Disclosure - Note 9 - Share-based compensation - Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 063 - Disclosure - Note 9 - Share-based Compensation - Non-vested Stock (Details) link:calculationLink link:definitionLink link:presentationLink 064 - Disclosure - Note 10 - Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink 065 - Disclosure - Note 10 - Leases - Lease Expense (Details) link:calculationLink link:definitionLink link:presentationLink 068 - Disclosure - Note 10 - Leases - Undiscounted Payments Under Non-cancelable Leases (Details) link:calculationLink link:definitionLink link:presentationLink 069 - Disclosure - Note 10 - Leases - Undiscounted Payments Under Sublease (Details) link:calculationLink link:definitionLink link:presentationLink 071 - Disclosure - Note 12 - Associate Benefits (Details Textual) link:calculationLink link:definitionLink link:presentationLink 072 - Disclosure - Note 13 - Segment Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink 073 - Disclosure - Note 13 - Segment Information - Assets by Geographic Area (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 nrc-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 nrc-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 nrc-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Expected dividend yield at date of grant us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Intangible assets Note To Financial Statement Details Textual Significant Accounting Policies Note 1 - Summary of Significant Accounting Policies Expected federal income taxes Note 2 - Acquisition Risk-free interest rate us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets Current Assets Note 3 - Contracts With Customers Note 5 - Property and Equipment Note 6 - Goodwill and Intangible Assets Note 7 - Income Taxes Note 8 - Notes Payable Note 9 - Share-based Compensation Income Tax Disclosure [Text Block] Note 10 - Leases Note 13 - Segment Information us-gaap_SelfInsuranceReserveCurrent Self Insurance Reserve, Current Note 1 - Summary of Significant Accounting Policies - Amortization Expense Classification (Details) nrc_DebtInstrumentPercentageBearingVariableInterestPercentageRate Debt Instrument, Percentage Bearing Variable Interest, Percentage Rate The interest rate applicable to the portion of the carrying amount of debt instrument borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time. Expected stock price volatility Note 1 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) us-gaap_LiabilitiesCurrent Total current liabilities Note 1 - Summary of Significant Accounting Policies - Share-based Compensation Amounts Recognized in Financial Statements (Details) Schedule of Maturities of Long-Term Debt [Table Text Block] Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) Schedule of Debt [Table Text Block] Note 1 - Summary of Significant Accounting Policies - Net Income Per Share Computation (Details) Note 2 - Acquisition - Fair Value of Assets and Liabilities (Details) Note 3 - Contracts With Customers - Disaggregation of Revenue (Details) Expected life of options (in years) (Year) Other current liabilities Note 3 - Contracts With Customers - Information About Receivables, Contract Assets, and Contract Liabilities From Contracts With Customers (Details) Note 5 - Property and Equipment - Summary of Property and Equipment (Details) us-gaap_BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred, Total Lease, Cash flow [Table Text Block] Tabular disclosure of supplemental cash flow and other information related to leases. Note 6 - Goodwill and Intangible Assets - Summary of Goodwill and Intangible Assets (Details) Note 6 - Goodwill and Intangible Assets - Summary of Changes in the Carrying Amount of Goodwill (Details) nrc_GainOnPropertyInsuranceRecoveries Gain on insurance recoveries for damaged property The net amount by which an insurance settlement exceeds net book value of property damaged from an event, such as a natural catastrophe, explosion or fire. Note 7 - Income Taxes - Income Before Income Taxes (Details) Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Note 7 - Income Taxes - Income Tax Expense (Details) Note 7 - Income Taxes - Income Tax Reconciliation (Details) Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) Note 8 - Notes Payable - Summary of Notes Payable (Details) Note 8 - Notes Payable - Scheduled Maturities of Notes Payable (Details) Insurance recoveries The amount recovered from insurance for lost revenues that are reported as a separate line item. Share-Based Payment Arrangement, Activity [Table Text Block] Note 9 - Share-based Compensation - Stock Options Valuation Assumptions (Details) Other comprehensive loss, foreign currency translation adjustment Granted (in dollars per share) Note 9 - Share-based Compensation - Stock Option Activity Under Equity Incentive Plans and Director Plan (Details) Note 9 - Share-based compensation - Stock Option Activity (Details) Vested (in dollars per share) Note 9 - Share-based Compensation - Non-vested Stock (Details) Forfeited (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Outstanding (in dollars per share) Outstanding (in dollars per share) Note 10 - Leases - Lease Expense (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Forfeited (in shares) Note 10 - Leases - Supplemental Balance Sheet Information Related to Leases (Details) us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Reclassification of cumulative foreign currency translation adjustment into earnings Note 10 - Leases - Supplemental Cash Flow and Other Information Related to Leases (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Outstanding (in shares) Outstanding (in shares) Note 10 - Leases - Undiscounted Payments Under Non-cancelable Leases (Details) Note 10 - Leases - Undiscounted Payments Under Sublease (Details) Schedule of Nonvested Share Activity [Table Text Block] Note 13 - Segment Information - Assets by Geographic Area (Details) Notes To Financial Statements Granted (in shares) Notes To Financial Statements [Abstract] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Vested (in shares) First National Bank of Omaha [Member] Related to the entity First National Bank of Omaha. Other comprehensive income (loss): Weighted average exercise price (in dollars per share) Exercisable, weighted average remaining contractual term (Year) Current portion of notes payable, net of unamortized debt issuance costs Exercisable, aggregate intrinsic value Intrinsic value of stock options exercised (in thousands) Exercisable, number of options (in shares) Outstanding, weighted average remaining contractual term (Year) Outstanding, aggregate intrinsic value Weighted average grant date fair value of stock options granted (in dollars per share) nrc_CostMethodInvestmentOwnershipPercentage Cost Method Investment, Ownership Percentage The percentage of ownership of common stock or equity participation in the investee accounted for under the cost method of accounting. us-gaap_GoodwillGross Goodwill us-gaap_GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Accumulated Depreciation us-gaap_SecuredDebtCurrent Less: current portion us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Beginning balance, outstanding, weighted average exercise price (in dollars per share) Ending balance, outstanding, weighted average exercise price (in dollars per share) Deferred revenue Deferred revenue Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Goodwill [Table Text Block] Granted, weighted average exercise price (in dollars per share) Exercised, weighted average exercise price (in dollars per share) Accrued expenses Accrued wages and bonuses nrc_ClaimsLossCoverageMinimumAggregateDeductible Claims Loss Coverage, Minimum Aggregate Deductible The amount of minimum aggregate deductible for claims loss coverage. Dividends payable Accounts payable Revolving Credit Facility [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Beginning balance, outstanding, number of options (in shares) Ending balance, outstanding, number of options (in shares) Purchase of property and equipment in accounts payable and accrued expenses Credit Facility [Axis] Credit Facility [Domain] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] us-gaap_PolicyTextBlockAbstract Accounting Policies Trade Names [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares) Indefinite-Lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets, Major Class Name [Domain] us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchases of property and equipment Finance lease obligations originated for property and equipment us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Weighted average effect of dilutive securities – stock options (in shares) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) Weighted average shares and share equivalents outstanding Income taxes nrc_ContractWithCustomerLiabilityRevenueRecognizedFromDeferredRevenue Revenue recognized that was included in deferred revenue at beginning of year due to completion of services The amount of revenue recognized that was previously included in the balance of deferred revenue under contract with customer liabilities due to the completion of services. Current liabilities: us-gaap_Assets Total assets Total assets nrc_DeferredTaxAssetsUncertainTaxPositions Uncertain tax positions Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from uncertain tax positions. us-gaap_OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss Estimated fair value of long-term debt Plan Name [Axis] Technology-Based Intangible Assets [Member] Plan Name [Domain] Compensation and Employee Benefit Plans [Text Block] us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) us-gaap_SubleaseIncome Sublease income us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic Net income attributable to common shareholders us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions Share-Based Payment Arrangement, Exercise of Option, Tax Benefit Customer Relationships [Member] Investment [Text Block] us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Amount of related income tax benefit Depreciation, amortization and impairment The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets and the total loss recognized during the period from impairments. Recoveries Received Direct by the Company [Member] Related to recoveries received direct by the company. Reimbursement for Lost Revenue [Member] Related to reimbursement for lost revenue. Recoveries Paid Directly by Insurer to Outside Vendor [Member] Related to recoveries paid directly by insurer to outside vendor. us-gaap_DeferredIncomeTaxAssetsNet Deferred income taxes Finite-Lived Intangible Assets by Major Class [Axis] Share-Based Payment Arrangement [Text Block] Finite-Lived Intangible Assets, Major Class Name [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Direct, Selling, General and Administrative Expenses [Member] Related to direct, selling, general and administrative expenses. Property Damage Excluding Cyber Attack [Member] Related to property damage excluding cyber attack. Award Type [Domain] Award Type [Axis] us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-lived intangible assets, accumulated amortization us-gaap_FiniteLivedIntangibleAssetsNet Finite-lived intangible assets, net Intangible assets, net Total intangible assets other than goodwill Numerator for net income per share - basic: Insurance proceeds for damaged property us-gaap_FiniteLivedIntangibleAssetsGross Finite-lived intangible assets, gross us-gaap_InterestCostsCapitalized Interest Costs Capitalized Common Stock Options [Member] Related to common stock options. Restricted Stock [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value, Intrinsic Value of Exercised and Vested in Period, and Fair Value of Vested in Period [Table Text Block] Tabular disclosure of the weighted-average grant-date fair value, aggregate intrinsic value of equity options exercised and intrinsic value and fair value of options vested. us-gaap_GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease), Total Share-Based Payment Arrangement, Option [Member] Foreign currency translation Goodwill acquired us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite trade name Business Combination Disclosure [Text Block] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less accumulated depreciation and amortization Net property and equipment Net property and equipment Property and equipment under finance lease, net Goodwill Goodwill, Ending Balance Goodwill Goodwill us-gaap_PropertyPlantAndEquipmentGross Property and equipment at cost Canada Revenue Agency [Member] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Domain] Net income Net income Net income us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic Allocation of distributed and undistributed income to unvested restricted stock shareholders Cash flows from investing activities: us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount us-gaap_RevenueFromRelatedParties Revenue from Related Parties Earnings per share of common stock: Don’t Panic Labs, LLC [Member] Don’t Panic Labs, LLC us-gaap_RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction CANADA Related Party Transactions Disclosure [Text Block] Provision for income taxes Income Tax Expense (Benefit), Total us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay us-gaap_CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value, Total Cash and cash equivalents us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax Net (benefit) expense to net income EX-101.PRE 11 nrc-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 12 img02.jpg begin 644 img02.jpg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end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.4

Document And Entity Information - USD ($)
12 Months Ended

Dec. 31, 2022

Feb. 23, 2023

Jun. 30, 2022

Document Information [Line Items]

Entity Central Index Key 0000070487

Entity Registrant Name National Research Corporation

Amendment Flag false

Current Fiscal Year End Date --12-31

Document Fiscal Period Focus FY

Document Fiscal Year Focus 2022

Document Type 10-K

Document Annual Report true

Document Period End Date Dec. 31, 2022

Document Transition Report false

Entity File Number 001-35929

Entity Incorporation, State or Country Code DE

Entity Tax Identification Number 47-0634000

Entity Address, Address Line One 1245 Q Street

Entity Address, City or Town Lincoln

Entity Address, State or Province NE

Entity Address, Postal Zip Code 68508

City Area Code 402

Local Phone Number 475-2525

Title of 12(b) Security Common Stock, $.001 par value

Trading Symbol NRC

Security Exchange Name NASDAQ

Entity Well-known Seasoned Issuer No

Entity Voluntary Filers No

Entity Current Reporting Status Yes

Entity Interactive Data Current Yes

Entity Filer Category Accelerated Filer

Entity Small Business false

Entity Emerging Growth Company false

ICFR Auditor Attestation Flag true

Entity Shell Company false

Entity Public Float $ 444,018,792

Entity Common Stock, Shares Outstanding 24,594,390

Auditor Name KPMG LLP

Auditor Firm ID 1997

Auditor Location Lincoln, Nebraska

XML 14 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 25,026	$ 54,361
Trade accounts receivable, less allowance for doubtful accounts of $65 and $94, respectively	14,461	13,728
Prepaid expenses	2,386	3,884
Income taxes receivable	733	752
Other current assets	1,110	982
Total current assets	43,716	73,707
Net property and equipment	17,248	12,391
Intangible assets, net	1,611	1,790
Goodwill, Ending Balance	61,614	61,614
Operating lease right-of-use assets	556	975
Deferred contract costs, net	2,441	3,772
Deferred income taxes	14	14
Other	3,261	3,277
Total assets	130,461	157,540
Current liabilities:
Current portion of notes payable, net of unamortized debt issuance costs	4,491	4,278
Accounts payable	1,153	1,943
Accrued wages and bonuses	4,551	7,139
Accrued expenses	3,983	5,450
Dividends payable	2,956	3,044
Deferred revenue	15,198	17,213
Other current liabilities	1,085	1,321
Total current liabilities	33,417	40,388
Notes payable, net of current portion and unamortized debt issuance costs	17,690	22,269
Deferred income taxes	5,274	7,002
Other long-term liabilities	2,047	2,544
Total liabilities	58,428	72,203
Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued	0	0
Common stock, $0.001 par value; authorized 110,000,000 shares, issued 30,922,181 in 2022 and 30,898,600 in 2021, outstanding 24,628,173 in 2022 and 25,361,409 in 2021	31	31
Additional paid-in capital	175,453	173,942
Retained earnings (accumulated deficit)	(25,184)	(36,112)
Accumulated other comprehensive loss, foreign currency translation adjustment		(2,375)
Treasury stock, at cost; 6,294,008 Common shares in 2022 and 5,537,191 Common shares in 2021	(78,267)	(50,149)
Total shareholders’ equity	72,033	85,337
Total liabilities and shareholders’ equity	$ 130,461	$ 157,540

XML 15 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Allowance for doubtful accounts	$ 65	$ 94
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	2,000,000	2,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	110,000,000	110,000,000
Common stock, shares issued (in shares)	30,922,181	30,898,600
Common stock, shares outstanding (in shares)	24,628,173	25,361,409
Treasury stock, shares (in shares)	6,294,008	5,537,191

XML 16 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue	$ 151,568	$ 147,954	$ 133,277
Insurance recoveries			533
Operating expenses:
Direct	57,049	52,350	49,187
Selling, general and administrative	42,699	38,960	34,441
Depreciation, amortization and impairment	5,277	6,374	7,505
Total operating expenses	105,025	97,684	91,133
Operating income	46,543	50,270	42,677
Other income (expense):
Interest income	168	14	18
Interest expense	(1,209)	(1,667)	(1,813)
Reclassification of cumulative foreign currency translation adjustment into earnings	(2,569)
Other, net	(118)	4	585
Total other income (expense)	(3,728)	(1,649)	(1,210)
Income before income taxes	42,815	48,621	41,467
Provision for income taxes	11,015	11,155	4,207
Net income	$ 31,800	$ 37,466	$ 37,260
Earnings per share of common stock:
Basic earnings per share (in dollars per share)	$ 1.28	$ 1.47	$ 1.48
Diluted earnings per share (in dollars per share)	$ 1.27	$ 1.46	$ 1.45
Weighted average shares and share equivalents outstanding
Basic (in shares)	24,922	25,422	25,170
Diluted (in shares)	25,052	25,640	25,696

XML 17 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net income	$ 31,800	$ 37,466	$ 37,260
Other comprehensive income (loss):
Other comprehensive loss, foreign currency translation adjustment	(194)	24	(190)
Reclassification of cumulative foreign currency translation adjustment into earnings	2,569	0	0
Other comprehensive income (loss)	2,375	24	(190)
Comprehensive income	$ 34,175	$ 37,490	$ 37,070

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 31: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

+ Details

XML 18 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Total
Balances at Dec. 31, 2019	$ 30	$ 162,154	$ (93,357)	$ (2,209)	$ (33,726)	$ 32,892
Purchase of shares treasury stock	0	0	0	0	(10,001)	(10,001)
Issuance of common shares for the exercise of stock options	1	8,951	0	0	0	8,952
Forfeiture of restricted common shares	0	0	0	0	0	0
Non-cash stock compensation expense	0	680	0	0	0	680
Dividends declared	0	0	(5,278)	0	0	(5,278)
Other comprehensive loss, foreign currency translation adjustment	0	0	0	(190)	0	(190)
Net income	0	0	37,260	0	0	37,260
Reclassification of cumulative foreign currency translation adjustment into earnings						0
Balances at Dec. 31, 2020	31	171,785	(61,375)	(2,399)	(43,727)	64,315
Purchase of shares treasury stock	0	0	0	0	(6,422)	(6,422)
Issuance of common shares for the exercise of stock options	0	1,534	0	0	0	1,534
Non-cash stock compensation expense	0	623	0	0	0	623
Dividends declared	0	0	(12,203)	0	0	(12,203)
Other comprehensive loss, foreign currency translation adjustment	0	0	0	24	0	24
Net income	0	0	37,466	0	0	37,466
Reclassification of cumulative foreign currency translation adjustment into earnings						0
Balances at Dec. 31, 2021	31	173,942	(36,112)	(2,375)	(50,149)	85,337
Purchase of shares treasury stock	0	0	0	0	(28,118)	(28,118)
Issuance of common shares for the exercise of stock options	0	311	0	0	0	311
Non-cash stock compensation expense	0	1,200	0	0	0	1,200
Dividends declared	0	0	(20,872)	0	0	(20,872)
Other comprehensive loss, foreign currency translation adjustment	0	0	0	(194)	0	(194)
Net income	0	0	31,800	0	0	31,800
Reclassification of cumulative foreign currency translation adjustment into earnings	0	0	0	$ 2,569	0	2,569
Balances at Dec. 31, 2022	$ 31	$ 175,453	$ (25,184)		$ (78,267)	$ 72,033

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 19 R7.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Shareholders' Equity (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Purchase of shares of treasury stock (in shares)	756,817	153,005	180,112
Shares of common stock for the exercise of stock options (in shares)	23,581	116,753	630,373
Issuance of restricted common shares, net of forfeitures (in shares)			6,793
Dividends declared per common share (in dollars per share)	$ 0.84	$ 0.48	$ 0.21

XML 20 R8.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 31,800,000	$ 37,466,000	$ 37,260,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and impairment	5,277,000	6,374,000	7,505,000
Reclassification of cumulative translation adjustment into earnings	2,569,000
Deferred income taxes	(1,729,000)	(277,000)	(134,000)
Reserve for uncertain tax positions	488,000	310,000	185,000
Gain on insurance recoveries for damaged property			(260,000)
Loss on disposal of property and equipment	11,000	7,000	12,000
Non-cash share-based compensation expense	1,200,000	623,000	680,000
Change in assets and liabilities:
Trade accounts receivable	(733,000)	343,000	(2,271,000)
Prepaid expenses and other current and long-term assets	1,634,000	(842,000)	(827,000)
Operating lease assets and liability, net	(39,000)	(34,000)	16,000
Deferred contract costs, net	1,331,000	783,000	(351,000)
Accounts payable	(589,000)	4,000	(247,000)
Accrued expenses, wages and bonuses	(2,947,000)	(285,000)	1,370,000
Income taxes receivable and payable	6,000	484,000	(1,529,000)
Deferred revenue	(2,014,000)	1,388,000	(773,000)
Net cash provided by operating activities	36,265,000	46,344,000	40,636,000
Cash flows from investing activities:
Purchases of property and equipment	(9,835,000)	(5,514,000)	(3,984,000)
Acquisition consideration		(3,000,000)
Insurance proceeds for damaged property			260,000
Net cash used in investing activities	(9,835,000)	(8,514,000)	(3,724,000)
Cash flows from financing activities:
Payments on notes payable	(4,305,000)	(4,093,000)	(3,568,000)
Payment of debt issuance costs	(92,000)		(36,000)
Payments on finance lease obligations	(469,000)	(493,000)	(332,000)
Proceeds from the exercise of stock options	0	446,000	1,734,000
Payment of payroll tax withholdings on share-based awards exercised	(190,000)	(721,000)	(2,784,000)
Payment of deferred acquisition consideration	(1,950,000)
Repurchase of shares for treasury	(27,616,000)	(4,142,000)
Payment of dividends on common stock	(20,961,000)	(9,159,000)	(10,517,000)
Net cash used in financing activities	(55,583,000)	(18,162,000)	(15,503,000)
Effect of exchange rate changes on cash	(182,000)	3,000	(236,000)
Net increase (decrease) in cash and cash equivalents	(29,335,000)	19,671,000	21,173,000
Cash and cash equivalents at beginning of period	54,361,000	34,690,000	13,517,000
Cash and cash equivalents at end of period	25,026,000	54,361,000	34,690,000
Supplemental disclosure of cash paid for:
Interest expense, net of capitalized amounts	1,342,000	1,554,000	1,735,000
Income taxes	12,233,000	10,644,000	5,217,000
Supplemental disclosure of non-cash investing and financing activities:
Finance lease obligations originated for property and equipment		40,000	817,000
Purchase of property and equipment in accounts payable and accrued expenses	1,109,000	979,000	127,000
Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans	$ 311,000	1,088,000	$ 7,217,000
Deferred acquisition consideration		$ 1,950,000

XML 21 R9.htm IDEA: XBRL DOCUMENT

Note 1 - Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Significant Accounting Policies [Text Block]

(1)

Summary of Significant Accounting Policies

Description of Business and Basis of Presentation

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and our wholly-owned subsidiary, National Research Corporation Canada. All significant intercompany transactions and balances have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Translation of Foreign Currencies

Gains and losses related to transactions denominated in a currency other than the functional currency of the country in which we operate and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income. Our Canadian subsidiary uses Canadian dollars as its functional currency. We translate its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. We translate its revenue and expenses at the average exchange rate during the period. We included foreign currency translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. During December 2022, we substantially liquidated our investment in Canada. As a result, we reclassified the cumulative foreign currency translation adjustment balance into earnings and recognized a net cumulative foreign currency translation loss of $2.6 million, which is included in Other income (expense), net in our Consolidated Statements of Income. Any future currency changes, will be recognized in Other income (expense), net in our Consolidated Statements of Income.

Revenue Recognition

We derive a majority of our revenues from our annually renewable subscription-based service agreements with our customers, which include performance measurement and improvement services, healthcare analytics and governance education services. Such agreements are generally cancelable on short or no notice without penalty. See Note 3 for further information about our contracts with customers. We account for revenue using the following steps:

●

Identify the contract, or contracts, with a customer;

●

Identify the performance obligations in the contract;

●

Determine the transaction price;

●

Allocate the transaction price to the identified performance obligations; and

●

Recognize revenue when, or as, we satisfy the performance obligations.

Our revenue arrangements with a client may include combinations of more than one service offering which may be executed at the same time, or within close proximity of one another. We combine contracts with the same customer into a single contract for accounting purposes when the contract is entered into at or near the same time and the contracts are negotiated together. For contracts that contain more than one separately identifiable performance obligation, the total transaction price is allocated to the identified performance obligations based upon the relative stand-alone selling prices of the performance obligations. The stand-alone selling prices are based on an observable price for services sold to other comparable customers, when available, or an estimated selling price using a cost-plus margin or residual approach. We estimate the amount of total contract consideration we expect to receive for variable arrangements based on the most likely amount we expect to earn from the arrangement based on the expected quantities of services we expect to provide and the contractual pricing based on those quantities. We only include some or a portion of variable consideration in the transaction price when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. We consider the sensitivity of the estimate, our relationship and experience with the client and variable services being performed, the range of possible revenue amounts and the magnitude of the variable consideration to the overall arrangement. Our revenue arrangements do not contain any significant financing element due to the contract terms and the timing between when consideration is received and when the service is provided.

Our arrangements with customers consist principally of four different types of arrangements: 1) subscription-based service agreements; 2) one-time specified services performed at a single point in time; 3) fixed, non-subscription service agreements; and 4) unit-priced service agreements.

Subscription-based services - Services that are provided under subscription-based service agreements are usually for a twelve- month period and represent a single promise to stand ready to provide reporting, tools and services throughout the subscription period as requested by the customer. These agreements are renewable at the option of the customer at the completion of the initial contract term for an agreed upon price increase each year. These agreements represent a series of distinct monthly services that are substantially the same, with the same pattern of transfer to the customer as the customer receives and consumes the benefits throughout the contract period. Accordingly, subscription services are recognized ratably over the subscription period. Subscription services are typically billed either annually or quarterly in advance but may also be billed on a monthly basis.

One-time services – These agreements typically require us to perform a specific one-time service in a particular month. We are entitled to a fixed payment upon completion of the service. Under these arrangements, we recognize revenue at the point in time we complete the service and it is accepted by the customer.

Fixed, non-subscription services – These arrangements typically require us to perform an unspecified amount of services for a fixed price during a fixed period of time. Revenues are recognized over time based upon the costs incurred to date in relation to the total estimated contract costs. In determining cost estimates, management uses historical and forecasted cost information which is based on estimated volumes, external and internal costs and other factors necessary in estimating the total costs over the term of the contract. Changes in estimates are accounted for using a cumulative catch-up adjustment which could impact the amount and timing of revenue for any period.

Unit-price services – These arrangements typically require us to perform certain services on a periodic basis as requested by the customer for a per-unit amount which is typically billed in the month following the performance of the service. Revenue under these arrangements is recognized over the time the services are performed at the per-unit amount.

Revenue is presented net of any sales tax charged to our clients that we are required to remit to taxing authorities. We recognize contract assets or unbilled receivables related to revenue recognized for services completed but not invoiced to the clients. Unbilled receivables are classified as receivables when we have an unconditional right to contract consideration. A contract liability is recognized as deferred revenue when we invoice clients in advance of performing the related services under the terms of a contract. Deferred revenue is recognized as revenue when we have satisfied the related performance obligation.

Deferred Contract Costs

Deferred contract costs, net is stated at gross deferred costs less accumulated amortization. We defer commissions and incentives, including payroll taxes, if they are incremental and recoverable costs of obtaining a renewable customer contract. Deferred contract costs are amortized over the estimated term of the contract, including renewals, which generally ranges from three to five years. The contract term was estimated by considering factors such as historical customer attrition rates and product life. The amortization period is adjusted for significant changes in the estimated remaining term of a contract. An impairment of deferred contract costs is recognized when the unamortized balance of deferred contract costs exceeds the remaining amount of consideration we expect to receive net of the expected future costs directly related to providing those services. We have elected the practical expedient to expense contract costs when incurred for any nonrenewable contracts with a term of one year or less. We deferred incremental costs of obtaining a contract of $454,000, $1.9 million and $3.7 million in the years ended December 31, 2022, 2021 and 2020, respectively. Deferred contract costs, net of accumulated amortization was $2.4 million and $3.8 million at December 31, 2022 and 2021, respectively. In 2021 we changed our sales compensation structure, reducing the incremental costs associated with obtaining a contract, decreasing the amount of incremental costs to defer and the balance of deferred contract costs. Total amortization by expense classification for the years ended December 31, 2022, 2021 and 2020 was as follows:

2022

2021

2020

(In thousands)

Direct expenses
$ 146 $ 157 $ 272

Selling, general and administrative expenses
$ 1,625 $ 2,494 $ 2,970

Total amortization
$ 1,771 $ 2,651 $ 3,242

Additional expense included in selling, general and administrative expenses for impairment of costs capitalized due to lost clients was $14,000, $31,000 and $63,000 for the years December 31, 2022, 2021 and 2020, respectively.

Trade Accounts Receivable

The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable, determined based on our historical write-off experience, current economic conditions and reasonable and supportable forecasts about the future. We review the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

The following table provides the activity in the allowance for doubtful accounts for the years ended December 31, 2022, 2021 and 2020 (in thousands):

Balance at

Beginning

of Year

Bad Debt

Expense

Write-offs,

net of

Recoveries

Balance

at End

of Year

Year Ended December 31, 2020
$ 144 $ 46 $ 70 $ 120

Year Ended December 31, 2021
$ 120 $ 38 $ 64 $ 94

Year Ended December 31, 2022
$ 94 $ 19 $ 48 $ 65

Property and Equipment

Property and equipment is stated at cost. Major expenditures to purchase property or to substantially increase useful lives of property are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income.

We capitalize certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software projects and external direct costs of materials and services. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs are expensed as incurred. We capitalized approximately $3.6 million, $2.8 million and $2.7 million of costs incurred for the development of internal-use software for the years ended December 31, 2022, 2021 and 2020, respectively.

When a software license is included in a cloud computing arrangement and we have the legal right, ability and feasibility to download the software, it is accounted for as software, included in property and equipment, and amortized. If a software license is not included or we do not have the ability or feasibility to download software included in a cloud computing arrangement, it is accounted for as a service contract, which is expensed to direct expenses or selling, general and administrative expenses during the service period.

We provide for depreciation and amortization of property and equipment using annual rates which are sufficient to amortize the cost of depreciable assets over their estimated useful lives. We use the straight-line method of depreciation and amortization over estimated useful lives of two to ten years for furniture and equipment, three to five years for computer equipment, one to five years for capitalized software, and seven to forty years for our office building and related improvements. Software licenses are amortized over the term of the license.

Impairment of Long-Lived Assets and Amortizing Intangible Assets

Long-lived assets, such as property and equipment and purchased intangible assets subject to depreciation or amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, we first compare undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. No significant impairments were recorded during the years ended December 31, 2022, 2021, or 2020.

Among others, management believes the following circumstances are important indicators of potential impairment of such assets and as a result may trigger an impairment review:

●

Significant underperformance in comparison to historical or projected operating results;

●

Significant changes in the manner or use of acquired assets or our overall strategy;

●

Significant negative trends in our industry or the overall economy;

●

A significant decline in the market price for our common stock for a sustained period; and

●

Our market capitalization falling below the book value of our net assets.

Goodwill and Intangible Assets

Intangible assets include customer relationships, trade names, technology, and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. We review intangible assets with indefinite lives for impairment annually as of October 1 and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable.

When performing the impairment assessment, we will first assess qualitative factors to determine whether it is necessary to determine the fair value of the intangible assets with indefinite lives. If we believe, as a result of the qualitative assessment, that it is more likely than not that the fair value of an indefinite-lived intangible is less than its carrying amount, we calculate the fair value using a market or income approach. If the carrying value of the indefinite-lived intangible asset exceeds its fair value, then the intangible asset is written-down to its fair value. We did not recognize any impairments related to indefinite-lived intangibles during 2022, 2021 or 2020.

Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. All of our goodwill is allocated to our reporting unit, which is the same as our operating segment. Goodwill is reviewed for impairment at least annually, as of October 1, and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable.

We review goodwill for impairment by first assessing qualitative factors to determine whether any impairment may exist. If we believe, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the carrying value of the reporting unit exceeds the fair value, then goodwill is written down by this difference. We performed a qualitative analysis as of October 1, 2022 and determined the fair value of our reporting unit likely exceeded the carrying value. No impairments were recorded during the years ended December 31, 2022 or 2021. A substantial portion of the revenue earned by our Canadian subsidiary was concentrated with one customer. While the customer exercised its option to extend its existing contract to September 2022, during December 2020 we chose not to enter into a new contract with this customer or otherwise extend the term of the contract beyond September 2022. We closed the Canada office at the end of the contract in September 2022. As a result, we tested for impairment of the then Canada reporting unit’s goodwill at December 31, 2020. We recognized an impairment of $714,000 for the excess of the then Canada reporting unit’s carrying value over the fair value, using discounted cash flows.

In March 2021, we changed our operating segments from six to one to reflect a change in the way we operated and managed our business, including changes to our corporate reporting structure to the Company’s Chief Executive Officer and chief operating decision maker. In connection with this change, our previous reporting units were combined into one reporting unit. We performed an interim qualitative analysis immediately before and after the reorganization and concluded that the fair value of our reporting units likely exceeded the carrying values and no impairments were recorded. Following the reorganization, we considered the current and expected future economic and market conditions, including the impact of the COVID-19 pandemic, on our reporting unit. We also assessed our current market capitalization compared to book value, forecasts and margins in our last quantitative impairment testing. We concluded that a triggering event has not occurred which would require an additional interim impairment test to be performed as it is not more likely than not that an impairment loss had been incurred at December 31, 2022.

Insurance Recoveries

We record insurance recoveries when the realization of the claim is probable. In 2020 we received $3.3 million in insurance recoveries, and $447,000 was paid directly to certain vendors from the insurer related to a cyber-attack in February 2020 (the “February incident”). We recorded $533,000, representing reimbursement for lost revenues, as insurance recoveries, and the remainder as a reduction to operating expenses. Due to insurance recoveries, the February incident did not have a significant impact on our consolidated financial statements. In 2020, we also recorded a gain in other income of $260,000 from insurance recoveries for property damage due to a flooding.

Income Taxes

We use the asset and liability method of accounting for income taxes. Under that method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances, if any, are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. We use the deferral method of accounting for our investment tax credits related to state tax incentives. During the years ended December 31, 2022, 2021, and 2020, we recorded income tax benefits relating to these tax credits of $36,000, $10,000, and $45,000, respectively. Interest and penalties related to income taxes are included in income taxes in the Consolidated Statements of Income.

We recognize the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

In 2021, we adopted ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). Among other clarifications and simplifications related to income tax accounting, this ASU simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, hybrid taxes and the recognition of deferred tax liabilities for outside basis differences. The adoption of this standard had no material impact to our consolidated financial statements.

Share-Based Compensation

All of our existing stock option awards and non-vested stock awards have been determined to be equity-classified awards. The compensation expense on share-based payments is recognized based on the grant-date fair value of those awards. We recognize the excess tax benefits and tax deficiencies in the income statement when options are exercised. Amounts recognized in the financial statements with respect to these plans are as follows:

2022

2021

2020

(In thousands)

Amounts charged against income, before income tax benefit
$ 1,200 $ 623 $ 680

Amount of related income tax benefit
(436
)
(919
)
(6,764
)

Net (benefit) expense to net income
$ 764 $ (296
)
$ (6,084
)

We refer to our restricted stock awards as “non-vested” stock in these consolidated financial statements.

Cash and Cash Equivalents

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash equivalents were $24.9 million and $6.3 million as of December 31, 2022, and 2021, respectively, consisting primarily of money market accounts. At certain times, cash equivalent balances may exceed federally insured limits.

Leases

We determine whether a lease is included in an agreement at inception. We recognize a lease liability and a right-of-use (“ROU”) asset on the balance sheet for our operating leases under which we are lessee. Operating lease ROU assets are included in operating lease right-of-use assets in our consolidated balance sheet. Finance lease assets are included in property and equipment. Operating and finance lease liabilities are included in other current liabilities and other long-term liabilities. Certain lease arrangements may include options to extend or terminate the lease. We include these provisions in the ROU asset and lease liabilities only when it is reasonably certain that we will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term and is included in direct expenses and selling, general and administrative expenses. Our lease agreements do not contain any residual value guarantees.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments during the lease term. ROU assets and lease liabilities are recorded at lease commencement based on the estimated present value of lease payments. Because the rate of interest implicit in each lease is not readily determinable, we use our estimated incremental collateralized borrowing rate at lease commencement, to calculate the present value of lease payments. When determining the appropriate incremental borrowing rate, we consider our available credit facilities, recently issued debt and public interest rate information.

Due to remote working arrangements, we reassessed our office needs and subleased our Seattle location under an agreement considered to be an operating lease beginning in May 2021. We have not been legally released from our primary obligations under the original lease and therefore we continue to account for the original lease separately. We recorded an ROU asset impairment charge in 2021 of $324,000, which was the amount by which the carrying value of the Seattle office lease ROU asset exceeded the fair value. We estimated the fair value based on the discounted cash flows of estimated net rental income for the office space subleased. The ROU asset impairment charge is included in depreciation, amortization and impairment expenses. There were no ROU asset impairment charges in 2022 or 2020. Rent income from the sublessee are included in the statement of operations on a straight-line basis as an offset to rent expense associated with the original operating lease included in other expenses.

Fair Value Measurements

Our valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. The inputs are then classified into the following hierarchy: (1) Level 1 Inputs—quoted prices in active markets for identical assets and liabilities; (2) Level 2 Inputs—observable market-based inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar or identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; (3) Level 3 Inputs—unobservable inputs.

The following details our financial assets within the fair value hierarchy at December 31, 2022 and 2021:

Level 1

Level 2

Level 3

Total

(In thousands)

As of December 31, 2022

Money Market Funds
$ 24,927 $ — $ — $ 24,927

Total Cash Equivalents
$ 24,927 $ — $ — $ 24,927

As of December 31, 2021

Money Market Funds
$ 6,306 $ — $ — $ 6,306

Total Cash Equivalents
$ 6,306 $ — $ — $ 6,306

There were no transfers between levels during the years ended December 31, 2022 and 2021.

Our long-term debt described in Note 8 is recorded at historical cost. The fair value of long-term debt is classified in Level 2 of the fair value hierarchy and was estimated based primarily on estimated current rates available for debt of the same remaining duration and adjusted for nonperformance and credit.

The following are the carrying amount and estimated fair values of long-term debt:

December 31,

2022

December 31,

2021

(In thousands)

Total carrying amount of long-term debt
$ 22,315 $ 26,620

Estimated fair value of long-term debt
$ 21,668 $ 27,708

The carrying amounts of accounts receivable, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are not recognized or disclosed at fair value in the financial statements on a recurring basis, which includes ROU assets, property and equipment, goodwill, intangibles and cost method investments, are measured at fair value in certain circumstances (for example, when there is evidence of impairment). We estimated the fair value of the Seattle office ROU asset using discounted cash flows of the sublease based on management’s most recent projections, which are considered level 3 inputs in the fair value hierarchy and recorded an ROU asset impairment charge of $324,000 during 2021. As of December 31, 2022 and 2021, there was no indication of impairment related to these assets. As discussed above, we recognized an impairment of $714,000 for the then Canada reporting unit’s goodwill at December 31, 2020. We estimated the fair value of the Canada reporting unit using discounted cash flows based on management’s most recent projections which are considered level 3 inputs in the fair value hierarchy.

Commitments and Contingencies

From time to time, we are involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable. Legal fees, net of estimated insurance recoveries, are expensed as incurred. We do not believe the final disposition of claims at December 31, 2022 will have a material adverse effect on our consolidated financial position, results of operations or liquidity.

We are self-insured for group medical and dental insurance. We carry excess loss coverage in the amount of $150,000 per covered person per year for group medical insurance. We do not self-insure for any other types of losses, and therefore do not carry any additional excess loss insurance. In addition, we had aggregate claims loss coverage with a minimum aggregate deductible of $4.7 million, $3.2 million and $2.8 million, in 2022, 2021 and 2020, respectively. We record a reserve for our group medical and dental insurance for all unresolved claims and for an estimate of incurred but not reported (“IBNR”) claims. On a quarterly basis, we adjust our accrual based on a review of our claims experience and a third-party actuarial IBNR analysis. As of December 31, 2022 and 2021, our accrual related to self-insurance was $424,000 and $406,000, respectively.

Earnings Per Share

Basic net income per share was computed using the weighted-average number of common shares outstanding during the period.

Diluted net income per share was computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method.

We had 83,070, 127,185 and 65,127 options of Common Stock for the years ended December 31, 2022, 2021 and 2020, respectively which have been excluded from the diluted net income per share computation because their inclusion would be anti-dilutive.

2022

2021

2020

(In thousands, except per share data)

Numerator for net income per share - basic:

Net income
$ 31,800 $ 37,466 $ 37,260

Allocation of distributed and undistributed income to unvested restricted stock shareholders
(16
)
(18
)
(57
)

Net income attributable to common shareholders
$ 31,784 $ 37,448 $ 37,203

Denominator for net income per share - basic:

Weighted average common shares outstanding – basic
24,922 25,422 25,170

Net income per share – basic
$ 1.28 $ 1.47 $ 1.48

Numerator for net income per share - diluted:

Net income attributable to common shareholders for basic computation
$ 31,784 $ 37,448 $ 37,203

Denominator for net income per share - diluted:

Weighted average common shares outstanding – basic
24,922 25,422 25,170

Weighted average effect of dilutive securities – stock options
130 218 526

Denominator for diluted earnings per share – adjusted weighted average shares
25,052 25,640 25,696

Net income per share – diluted
$ 1.27 $ 1.46 $ 1.45

XML 22 R10.htm IDEA: XBRL DOCUMENT

Note 2 - Acquisition

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Business Combination Disclosure [Text Block]

(2)

ACQUISITION

Amount of Identified Assets Acquired and Liabilities Assumed
	($ in thousands)
Current Assets	$	184
Property and equipment		10
Customer related		100
Technology		600
Goodwill		4,340
Total assets acquired	$	5,234
Current liabilities		284
Net assets acquired	$	4,950

XML 23 R11.htm IDEA: XBRL DOCUMENT

Note 3 - Contracts With Customers

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

(3)

Contracts with Customers

The following table disaggregates revenue for the years ended December 31, 2022, 2021 and 2020 based on timing of revenue recognition (In thousands):

	2022		2021		2020
Subscription services recognized ratably over time	$	141,981	$	137,008	$	122,499
Services recognized at a point in time		4,231		3,216		2,932
Fixed, non-subscription recognized over time		3,134		3,065		2,907
Unit price services recognized over time		2,222		4,665		4,939
Total revenue	$	151,568	$	147,954	$	133,277

The following table provides information about receivables, contract assets, and contract liabilities from contracts with customers (In thousands):

	December 31, 2022		December 31, 2021
Accounts receivables	$	14,461	$	13,728
Contract assets included in other current assets	$	102	$	99
Deferred revenue	$	15,198	$	17,213

Significant changes in contract assets and contract liabilities during the years ended December 31, 2022 and 2021 are as follows (in thousands):

	2022						2021
	Contract Asset			Deferred Revenue			Contract Asset			Deferred Revenue
	Increase (Decrease)
Revenue recognized that was included in deferred revenue at beginning of year due to completion of services	$	-		$	(17,170	)	$	-		$	(15,631	)
Increases due to invoicing of client, net of amounts recognized as revenue		-			15,081			-			16,694
Decreases due to completion of services (or portion of services) and transferred to accounts receivable		(99	)		-			(311	)		-
Change due to cumulative catch-up adjustments arising from changes in expected contract consideration		-			74			-			326
Increases due to revenue recognized in the period with additional performance obligations before invoicing		102			-			99			-

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

XML 24 R12.htm IDEA: XBRL DOCUMENT

Note 4 - Equity Investments

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Investment [Text Block]

(4)

Equity Investments

XML 25 R13.htm IDEA: XBRL DOCUMENT

Note 5 - Property and Equipment

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]

(5)

Property and Equipment

At December 31, 2022, and 2021, property and equipment consisted of the following:

	2022		2021
	(In thousands)
Furniture and equipment	$	4,753	$	4,901
Computer equipment		2,639		2,672
Computer software		29,876		27,828
Building		12,561		9,271
Leaseholds		502		502
Land		425		425
Property and equipment at cost		50,756		45,599
Less accumulated depreciation and amortization		33,508		33,208
Net property and equipment	$	17,248	$	12,391

XML 26 R14.htm IDEA: XBRL DOCUMENT

Note 6 - Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Goodwill and Intangible Assets Disclosure [Text Block]

(6)

Goodwill and Intangible Assets

Goodwill and intangible assets consisted of the following at December 31, 2022:

Gross

Accumulated

Impairment

Net

(In thousands)

Goodwill

62,328

(714

)

61,614

	Useful Life			Gross		Accumulated Amortization		Net
	(In years)					(In thousands)
Non-amortizing intangible assets:
Indefinite trade name					1,191				1,191
Amortizing intangible assets:
Customer related	5	-	15		9,192		9,132		60
Technology	3	-	7		1,959		1,599		360
Trade names		10			1,572		1,572		—
Total amortizing intangible assets					12,723		12,303		420
Total intangible assets other than goodwill				$	13,914	$	12,303	$	1,611

Goodwill and intangible assets consisted of the following at December 31, 2021:

Gross

Accumulated

Impairment

Net

(In thousands)

Goodwill

62,328

(714

)

61,614

	Useful Life			Gross		Accumulated Amortization		Net
	(In years)					(In thousands)
Non-amortizing intangible assets:
Indefinite trade name					1,191				1,191
Amortizing intangible assets:
Customer related	5	-	15		9,445		9,325		120
Technology	3	-	7		1,959		1,480		479
Trade names		10			1,572		1,572		—
Total amortizing intangible assets					12,976		12,377		599
Total intangible assets other than goodwill				$	14,167	$	12,377	$	1,790

The following represents a summary of changes in the carrying amount of goodwill for the years ended December 31, 2022 and 2021 (in thousands):

Balance as of December 31, 2020	$	57,255
Goodwill acquired		4,340
Foreign currency translation		19
Balance as of December 31, 2021	$	61,614

There were no changes in goodwill during 2022 from the net carrying amount of $61,614 at December 31, 2021.

As discussed in Note 1, we recorded an impairment of $714,000 to the Canada reporting unit’s goodwill in December 2020.

XML 27 R15.htm IDEA: XBRL DOCUMENT

Note 7 - Income Taxes

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Income Tax Disclosure [Text Block]

(7)

Income Taxes

For the years ended December 31, 2022, 2021, and 2020, income before income taxes consists of the following:

	2022			2021		2020
	(In thousands)
U.S. Operations	$	43,156		$	48,145	$	41,357
Foreign Operations		(341	)		476		110
Income before income taxes	$	42,815		$	48,621	$	41,467

Income tax expense consisted of the following components:

	2022			2021			2020
	(In thousands)
Federal:
Current	$	9,988		$	9,092		$	3,546
Deferred		(1,427	)		(224	)		(308	)
Total	$	8,561		$	8,868		$	3,238

Foreign:
Current	$	(90	)	$	143		$	225
Deferred		—			(17	)		(6	)
Total	$	(90	)	$	126		$	219

State:
Current	$	2,846		$	2,197		$	578
Deferred		(302	)		(36	)		172
Total	$	2,544		$	2,161		$	750

Total	$	11,015		$	11,155		$	4,207

The differences between income taxes expected at the U.S. federal statutory income tax rate of 21 percent and the reported income tax (benefit) expense are summarized as follows:

	2022			2021			2020
	(In thousands)
Expected federal income taxes	$	8,991		$	10,210		$	8,708
Foreign tax rate differential		(24	)		26			6
State income taxes, net of federal benefit and state tax credits		2,100			1,531			607
Share-based compensation		(120	)		(660	)		(5,713	)
Compensation limit for covered employees		—			—			463
Federal tax credits		(408	)		(272	)		(261	)
Uncertain tax positions		22			254			157
Reclassification of cumulative translation adjustment into earnings		539			—			—
Goodwill Impairment		—			—			184
Withholding tax on repatriation of foreign earnings		(100	)		8			18
GILTI		—			—			10
Other		15			58			28
	$	11,015		$	11,155		$	4,207

Deferred tax assets and liabilities at December 31, 2022 and 2021, were comprised of the following:

	2022			2021
	(In thousands)
Deferred tax assets:
Allowance for doubtful accounts	$	16		$	24
Accrued expenses		691			687
Share-based compensation		1,072			740
Accrued bonuses		96			267
Employer payroll tax deferral		—			200
Uncertain tax positions		256			161
Research & experimental expenditures		856			—
Other		78			66
Gross deferred tax assets		3,065			2,145
Less valuation allowance		—			—
Deferred tax assets		3,065			2,145
Deferred tax liabilities:
Prepaid expenses		135			89
Deferred contract costs		601			945
Property and equipment		1,066			1,579
Intangible assets		6,523			6,338
Repatriation withholding		—			182
Deferred tax liabilities		8,325			9,133
Net deferred tax liabilities	$	(5,260	)	$	(6,988	)

	(In thousands)
Balance of unrecognized tax benefits at December 31, 2020	$	768
Reductions due to lapse of applicable statute of limitations		(38	)
Reductions due to tax positions of prior years		—
Reductions due to settlement with taxing authorities		—
Additions based on tax positions related to the current year		345
Balance of unrecognized tax benefits at December 31, 2021	$	1,075
Reductions due to lapse of applicable statute of limitations		(76	)
Additions due to tax positions of prior years		—
Reductions due to settlement with taxing authorities		—
Additions based on tax positions related to the current year		558
Balance of unrecognized tax benefits at December 31, 2022	$	1,557

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 28 R16.htm IDEA: XBRL DOCUMENT

Note 8 - Notes Payable

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Debt Disclosure [Text Block]

(8)

Notes Payable

Our long-term debt consists of the following:

	2022			2021
	(In thousands)
Term Loans	$	22,315		$	26,620
Less: current portion		(4,491	)		(4,278	)
Less: unamortized debt issuance costs		(134	)		(73	)
Notes payable, net of current portion	$	17,690		$	22,269

Borrowings under the Line of Credit and the Delayed Draw Term Loan, if any, bear interest at a floating rate equal to the 30-day Secured Overnight Financing Rate (“SOFR”) plus 235 basis points (6.10% at December 31, 2022). Interest on the Line of Credit accrues and is payable monthly. Principal amounts outstanding under the Line of Credit are due and payable in full at maturity, in May 2025. As of December 31, 2022, the Line of Credit did not have a balance. There were no borrowings on the Line of Credit during 2022. There have been no borrowings on the Delayed Draw Term Loan since origination.

Scheduled maturities of notes payable at December 31, 2022 are as follows:

2023	$	4,529
2024		4,762
2025		5,011
2026		5,271
2027		2,742

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

XML 29 R17.htm IDEA: XBRL DOCUMENT

Note 9 - Share-based Compensation

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

(9)

Share-Based Compensation

	2022			2021			2020
Expected dividend yield at date of grant		3.39	%		2.15	%		1.84	%
Expected stock price volatility		35.52	%		34.85	%		33.62	%
Risk-free interest rate		2.33	%		0.91	%		1.35	%
Expected life of options (in years)		6.3			7.01			7.39

The following table summarizes stock option activity under 2006 Equity Incentive Plan and the 2004 Director Plan for the year ended December 31, 2022:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value (In thousands)
Common Stock
Outstanding at December 31, 2021		477,640	$	30.88
Granted		127,227	$	36.67
Exercised		23,581	$	13.17
Outstanding at December 31, 2022		581,286	$	32.86		5.44	$	4,739
Exercisable at December 31, 2022		323,140	$	26.97		3.55	$	4,369

The following table summarizes information related to stock options for the years ended December 31, 2022, 2021 and 2020:

	2022		2021		2020
Weighted average grant date fair value of stock options granted	$	9.43	$	12.55	$	18.67
Intrinsic value of stock options exercised (in thousands)	$	648	$	3,535	$	25,912
Intrinsic value of stock options vested (in thousands)	$	4,369	$	4,805	$	1,965

The following table summarizes information regarding non-vested stock granted to associates under the 2006 Equity Incentive Plans for the year ended December 31, 2022:

	Common Stock Outstanding		Common Stock Weighted Average Grant Date Fair Value Per Share
Outstanding at December 31, 2021		12,698	$	42.92
Granted		—	$	—
Vested		—	$	—
Forfeited		—	$	—
Outstanding at December 31, 2022		12,698	$	42.92

XML 30 R18.htm IDEA: XBRL DOCUMENT

Note 10 - Leases

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Leases Disclosure [Text Block]

(10)

Leases

We lease printing, computer, other equipment and office space in the United States and Canada. The leases remaining terms as of December 31, 2022 range from less than one year to 3.93 years.

The components of lease expense for the years ended December 31, 2022, 2021 and 2020 included (in thousands):

	2022			2021			2020
Operating leases	$	527		$	669		$	600
Finance leases:
Asset amortization		462			489			355
Interest on lease liabilities		19			34			37
Variable lease cost		95			99			62
Short-term lease cost		87			59			42
Sublease income		(123	)		(81	)		—
Total net lease cost	$	1,067		$	1,269		$	1,096

Supplemental balance sheet information related to leases (in thousands):

	December 31, 2022		December 31, 2021
Operating leases:
Operating ROU assets	$	556	$	975

Current operating lease liabilities		522		493
Noncurrent operating lease liabilities		333		820
Total operating lease liabilities	$	855	$	1,313

	December 31, 2022			December 31, 2021
Finance leases:
Furniture and equipment	$	1,042		$	1,042
Computer Equipment		659			659
Computer Software		207			207
Property and equipment under finance lease, gross		1,908			1,908
Less accumulated amortization		1,537			1,074
Property and equipment under finance lease, net	$	371		$	834

Current obligations of finance leases	$	311		$	470
Noncurrent obligations of finance leases		39			348
Total finance lease liabilities	$	350		$	818

Weighted average remaining lease term (in years):
Operating leases		1.95			2.80
Finance leases		1.15			1.93

Weighted average discount rate:
Operating leases		3.97	%		3.85	%
Finance leases		3.54	%		3.42	%

Supplemental cash flow and other information related to leases were as follows (in thousands):

	2022		2021		2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	563	$	680	$	596
Operating cash flows from finance leases		18		34		36
Financing cash flows from finance leases		469		493		332

ROU assets obtained in exchange for operating lease liabilities		83		560		276
ROU assets obtained in exchange for finance lease liabilities		—		40		817

Undiscounted payments under non-cancelable finance and operating leases at December 31, 2022 were as follows (in thousands):

	Finance Leases		Operating Leases
2023	$	315	$	547
2024		23		227
2025		11		118
2026		10		—
2027		—		—
Thereafter		—		—
Total minimum lease payments		359		892
Less: Amount representing interest		9		37
Present value of minimum lease payments		350		855
Less: Current portion		311		522
Lease obligations, net of current portion	$	39	$	333

Undiscounted cash receipts due under the sublease agreement at December 31, 2022 are as follows (in thousands):

	Operating Lease
2023	$	122
2024		127
2025		65
Total minimum lease receipts	$	314

XML 31 R19.htm IDEA: XBRL DOCUMENT

Note 11 - Related Party

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

(11)

Related Party

XML 32 R20.htm IDEA: XBRL DOCUMENT

Note 12 - Associate Benefits

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Compensation and Employee Benefit Plans [Text Block]

(12)

Associate Benefits

XML 33 R21.htm IDEA: XBRL DOCUMENT

Note 13 - Segment Information

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

(13)

Segment Information

	2022		2021		2020
Revenue:
United States	$	150,775	$	144,987	$	130,305
Canada		793		2,967		2,972
Total	$	151,568	$	147,954	$	133,277
Long-lived assets:
United States	$	86,718	$	83,722	$	77,448
Canada		27		111		1,863
Total	$	86,745	$	83,833	$	79,311
Total assets:
United States	$	130,151	$	153,879	$	128,319
Canada		310		3,661		5,104
Total	$	130,461	$	157,540	$	133,423

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

XML 34 R22.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

Principles of Consolidation

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Translation of Foreign Currencies

Revenue [Policy Text Block]

Revenue Recognition

	●	Identify the contract, or contracts, with a customer;
	●	Identify the performance obligations in the contract;
	●	Determine the transaction price;
	●	Allocate the transaction price to the identified performance obligations; and
	●	Recognize revenue when, or as, we satisfy the performance obligations.

Deferred Charges, Policy [Policy Text Block]

Deferred Contract Costs

	2022		2021		2020
	(In thousands)
Direct expenses	$	146	$	157	$	272
Selling, general and administrative expenses	$	1,625	$	2,494	$	2,970
Total amortization	$	1,771	$	2,651	$	3,242

Accounts Receivable [Policy Text Block]

Trade Accounts Receivable

The following table provides the activity in the allowance for doubtful accounts for the years ended December 31, 2022, 2021 and 2020 (in thousands):

	Balance at Beginning of Year		Bad Debt Expense		Write-offs, net of Recoveries		Balance at End of Year

Year Ended December 31, 2020	$	144	$	46	$	70	$	120
Year Ended December 31, 2021	$	120	$	38	$	64	$	94
Year Ended December 31, 2022	$	94	$	19	$	48	$	65

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of Long-Lived Assets and Amortizing Intangible Assets

Among others, management believes the following circumstances are important indicators of potential impairment of such assets and as a result may trigger an impairment review:

	●	Significant underperformance in comparison to historical or projected operating results;
	●	Significant changes in the manner or use of acquired assets or our overall strategy;
	●	Significant negative trends in our industry or the overall economy;
	●	A significant decline in the market price for our common stock for a sustained period; and
	●	Our market capitalization falling below the book value of our net assets.

Goodwill and Intangible Assets, Policy [Policy Text Block]

Goodwill and Intangible Assets

Insurance Recoveries [Policy Text Block]

Insurance Recoveries

Income Tax, Policy [Policy Text Block]

Income Taxes

Share-Based Payment Arrangement [Policy Text Block]

Share-Based Compensation

	2022			2021			2020
	(In thousands)
Amounts charged against income, before income tax benefit	$	1,200		$	623		$	680
Amount of related income tax benefit		(436	)		(919	)		(6,764	)
Net (benefit) expense to net income	$	764		$	(296	)	$	(6,084	)

We refer to our restricted stock awards as “non-vested” stock in these consolidated financial statements.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents

Lessee, Leases [Policy Text Block]

Leases

Fair Value Measurement, Policy [Policy Text Block]

Fair Value Measurements

The following details our financial assets within the fair value hierarchy at December 31, 2022 and 2021:

	Level 1		Level 2		Level 3		Total
	(In thousands)
As of December 31, 2022
Money Market Funds	$	24,927	$	—	$	—	$	24,927
Total Cash Equivalents	$	24,927	$	—	$	—	$	24,927

As of December 31, 2021
Money Market Funds	$	6,306	$	—	$	—	$	6,306
Total Cash Equivalents	$	6,306	$	—	$	—	$	6,306

There were no transfers between levels during the years ended December 31, 2022 and 2021.

The following are the carrying amount and estimated fair values of long-term debt:

	December 31, 2022		December 31, 2021
	(In thousands)
Total carrying amount of long-term debt	$	22,315	$	26,620
Estimated fair value of long-term debt	$	21,668	$	27,708

Commitments and Contingencies, Policy [Policy Text Block]

Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share

Basic net income per share was computed using the weighted-average number of common shares outstanding during the period.

	2022			2021			2020
	(In thousands, except per share data)
Numerator for net income per share - basic:
Net income	$	31,800		$	37,466		$	37,260
Allocation of distributed and undistributed income to unvested restricted stock shareholders		(16	)		(18	)		(57	)
Net income attributable to common shareholders	$	31,784		$	37,448		$	37,203
Denominator for net income per share - basic:
Weighted average common shares outstanding – basic		24,922			25,422			25,170
Net income per share – basic	$	1.28		$	1.47		$	1.48
Numerator for net income per share - diluted:
Net income attributable to common shareholders for basic computation	$	31,784		$	37,448		$	37,203
Denominator for net income per share - diluted:
Weighted average common shares outstanding – basic		24,922			25,422			25,170
Weighted average effect of dilutive securities – stock options		130			218			526
Denominator for diluted earnings per share – adjusted weighted average shares		25,052			25,640			25,696
Net income per share – diluted	$	1.27		$	1.46		$	1.45

XML 35 R23.htm IDEA: XBRL DOCUMENT

Note 1 - Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Amortization of Capitalized Contract Cost [Table Text Block]

	2022		2021		2020
	(In thousands)
Direct expenses	$	146	$	157	$	272
Selling, general and administrative expenses	$	1,625	$	2,494	$	2,970
Total amortization	$	1,771	$	2,651	$	3,242

Financing Receivable, Allowance for Credit Loss [Table Text Block]

	Balance at Beginning of Year		Bad Debt Expense		Write-offs, net of Recoveries		Balance at End of Year

Year Ended December 31, 2020	$	144	$	46	$	70	$	120
Year Ended December 31, 2021	$	120	$	38	$	64	$	94
Year Ended December 31, 2022	$	94	$	19	$	48	$	65

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	2022			2021			2020
	(In thousands)
Amounts charged against income, before income tax benefit	$	1,200		$	623		$	680
Amount of related income tax benefit		(436	)		(919	)		(6,764	)
Net (benefit) expense to net income	$	764		$	(296	)	$	(6,084	)

Fair Value, by Balance Sheet Grouping [Table Text Block]

	Level 1		Level 2		Level 3		Total
	(In thousands)
As of December 31, 2022
Money Market Funds	$	24,927	$	—	$	—	$	24,927
Total Cash Equivalents	$	24,927	$	—	$	—	$	24,927

As of December 31, 2021
Money Market Funds	$	6,306	$	—	$	—	$	6,306
Total Cash Equivalents	$	6,306	$	—	$	—	$	6,306

	December 31, 2022		December 31, 2021
	(In thousands)
Total carrying amount of long-term debt	$	22,315	$	26,620
Estimated fair value of long-term debt	$	21,668	$	27,708

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	2022			2021			2020
	(In thousands, except per share data)
Numerator for net income per share - basic:
Net income	$	31,800		$	37,466		$	37,260
Allocation of distributed and undistributed income to unvested restricted stock shareholders		(16	)		(18	)		(57	)
Net income attributable to common shareholders	$	31,784		$	37,448		$	37,203
Denominator for net income per share - basic:
Weighted average common shares outstanding – basic		24,922			25,422			25,170
Net income per share – basic	$	1.28		$	1.47		$	1.48
Numerator for net income per share - diluted:
Net income attributable to common shareholders for basic computation	$	31,784		$	37,448		$	37,203
Denominator for net income per share - diluted:
Weighted average common shares outstanding – basic		24,922			25,422			25,170
Weighted average effect of dilutive securities – stock options		130			218			526
Denominator for diluted earnings per share – adjusted weighted average shares		25,052			25,640			25,696
Net income per share – diluted	$	1.27		$	1.46		$	1.45

XML 36 R24.htm IDEA: XBRL DOCUMENT

Note 2 - Acquisition (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Amount of Identified Assets Acquired and Liabilities Assumed
	($ in thousands)
Current Assets	$	184
Property and equipment		10
Customer related		100
Technology		600
Goodwill		4,340
Total assets acquired	$	5,234
Current liabilities		284
Net assets acquired	$	4,950

XML 37 R25.htm IDEA: XBRL DOCUMENT

Note 3 - Contracts With Customers (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Disaggregation of Revenue [Table Text Block]

	2022		2021		2020
Subscription services recognized ratably over time	$	141,981	$	137,008	$	122,499
Services recognized at a point in time		4,231		3,216		2,932
Fixed, non-subscription recognized over time		3,134		3,065		2,907
Unit price services recognized over time		2,222		4,665		4,939
Total revenue	$	151,568	$	147,954	$	133,277

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

	December 31, 2022		December 31, 2021
Accounts receivables	$	14,461	$	13,728
Contract assets included in other current assets	$	102	$	99
Deferred revenue	$	15,198	$	17,213

	2022						2021
	Contract Asset			Deferred Revenue			Contract Asset			Deferred Revenue
	Increase (Decrease)
Revenue recognized that was included in deferred revenue at beginning of year due to completion of services	$	-		$	(17,170	)	$	-		$	(15,631	)
Increases due to invoicing of client, net of amounts recognized as revenue		-			15,081			-			16,694
Decreases due to completion of services (or portion of services) and transferred to accounts receivable		(99	)		-			(311	)		-
Change due to cumulative catch-up adjustments arising from changes in expected contract consideration		-			74			-			326
Increases due to revenue recognized in the period with additional performance obligations before invoicing		102			-			99			-

XML 38 R26.htm IDEA: XBRL DOCUMENT

Note 5 - Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Property, Plant and Equipment [Table Text Block]

	2022		2021
	(In thousands)
Furniture and equipment	$	4,753	$	4,901
Computer equipment		2,639		2,672
Computer software		29,876		27,828
Building		12,561		9,271
Leaseholds		502		502
Land		425		425
Property and equipment at cost		50,756		45,599
Less accumulated depreciation and amortization		33,508		33,208
Net property and equipment	$	17,248	$	12,391

XML 39 R27.htm IDEA: XBRL DOCUMENT

Note 6 - Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Schedule of Intangible Assets and Goodwill [Table Text Block]

Gross

Accumulated

Impairment

Net

(In thousands)

Goodwill

62,328

(714

)

61,614

	Useful Life			Gross		Accumulated Amortization		Net
	(In years)					(In thousands)
Non-amortizing intangible assets:
Indefinite trade name					1,191				1,191
Amortizing intangible assets:
Customer related	5	-	15		9,192		9,132		60
Technology	3	-	7		1,959		1,599		360
Trade names		10			1,572		1,572		—
Total amortizing intangible assets					12,723		12,303		420
Total intangible assets other than goodwill				$	13,914	$	12,303	$	1,611

Gross

Accumulated

Impairment

Net

(In thousands)

Goodwill

62,328

(714

)

61,614

	Useful Life			Gross		Accumulated Amortization		Net
	(In years)					(In thousands)
Non-amortizing intangible assets:
Indefinite trade name					1,191				1,191
Amortizing intangible assets:
Customer related	5	-	15		9,445		9,325		120
Technology	3	-	7		1,959		1,480		479
Trade names		10			1,572		1,572		—
Total amortizing intangible assets					12,976		12,377		599
Total intangible assets other than goodwill				$	14,167	$	12,377	$	1,790

Schedule of Goodwill [Table Text Block]

Balance as of December 31, 2020	$	57,255
Goodwill acquired		4,340
Foreign currency translation		19
Balance as of December 31, 2021	$	61,614

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

+ Details

XML 40 R28.htm IDEA: XBRL DOCUMENT

Note 7 - Income Taxes (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]

	2022			2021		2020
	(In thousands)
U.S. Operations	$	43,156		$	48,145	$	41,357
Foreign Operations		(341	)		476		110
Income before income taxes	$	42,815		$	48,621	$	41,467

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	2022			2021			2020
	(In thousands)
Federal:
Current	$	9,988		$	9,092		$	3,546
Deferred		(1,427	)		(224	)		(308	)
Total	$	8,561		$	8,868		$	3,238

Foreign:
Current	$	(90	)	$	143		$	225
Deferred		—			(17	)		(6	)
Total	$	(90	)	$	126		$	219

State:
Current	$	2,846		$	2,197		$	578
Deferred		(302	)		(36	)		172
Total	$	2,544		$	2,161		$	750

Total	$	11,015		$	11,155		$	4,207

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	2022			2021			2020
	(In thousands)
Expected federal income taxes	$	8,991		$	10,210		$	8,708
Foreign tax rate differential		(24	)		26			6
State income taxes, net of federal benefit and state tax credits		2,100			1,531			607
Share-based compensation		(120	)		(660	)		(5,713	)
Compensation limit for covered employees		—			—			463
Federal tax credits		(408	)		(272	)		(261	)
Uncertain tax positions		22			254			157
Reclassification of cumulative translation adjustment into earnings		539			—			—
Goodwill Impairment		—			—			184
Withholding tax on repatriation of foreign earnings		(100	)		8			18
GILTI		—			—			10
Other		15			58			28
	$	11,015		$	11,155		$	4,207

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	2022			2021
	(In thousands)
Deferred tax assets:
Allowance for doubtful accounts	$	16		$	24
Accrued expenses		691			687
Share-based compensation		1,072			740
Accrued bonuses		96			267
Employer payroll tax deferral		—			200
Uncertain tax positions		256			161
Research & experimental expenditures		856			—
Other		78			66
Gross deferred tax assets		3,065			2,145
Less valuation allowance		—			—
Deferred tax assets		3,065			2,145
Deferred tax liabilities:
Prepaid expenses		135			89
Deferred contract costs		601			945
Property and equipment		1,066			1,579
Intangible assets		6,523			6,338
Repatriation withholding		—			182
Deferred tax liabilities		8,325			9,133
Net deferred tax liabilities	$	(5,260	)	$	(6,988	)

Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]

	(In thousands)
Balance of unrecognized tax benefits at December 31, 2020	$	768
Reductions due to lapse of applicable statute of limitations		(38	)
Reductions due to tax positions of prior years		—
Reductions due to settlement with taxing authorities		—
Additions based on tax positions related to the current year		345
Balance of unrecognized tax benefits at December 31, 2021	$	1,075
Reductions due to lapse of applicable statute of limitations		(76	)
Additions due to tax positions of prior years		—
Reductions due to settlement with taxing authorities		—
Additions based on tax positions related to the current year		558
Balance of unrecognized tax benefits at December 31, 2022	$	1,557

XML 41 R29.htm IDEA: XBRL DOCUMENT

Note 8 - Notes Payable (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Schedule of Debt [Table Text Block]

	2022			2021
	(In thousands)
Term Loans	$	22,315		$	26,620
Less: current portion		(4,491	)		(4,278	)
Less: unamortized debt issuance costs		(134	)		(73	)
Notes payable, net of current portion	$	17,690		$	22,269

Schedule of Maturities of Long-Term Debt [Table Text Block]

2023	$	4,529
2024		4,762
2025		5,011
2026		5,271
2027		2,742

XML 42 R30.htm IDEA: XBRL DOCUMENT

Note 9 - Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	2022			2021			2020
Expected dividend yield at date of grant		3.39	%		2.15	%		1.84	%
Expected stock price volatility		35.52	%		34.85	%		33.62	%
Risk-free interest rate		2.33	%		0.91	%		1.35	%
Expected life of options (in years)		6.3			7.01			7.39

Share-Based Payment Arrangement, Activity [Table Text Block]

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (Years)		Aggregate Intrinsic Value (In thousands)
Common Stock
Outstanding at December 31, 2021		477,640	$	30.88
Granted		127,227	$	36.67
Exercised		23,581	$	13.17
Outstanding at December 31, 2022		581,286	$	32.86		5.44	$	4,739
Exercisable at December 31, 2022		323,140	$	26.97		3.55	$	4,369

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value, Intrinsic Value of Exercised and Vested in Period, and Fair Value of Vested in Period [Table Text Block]

	2022		2021		2020
Weighted average grant date fair value of stock options granted	$	9.43	$	12.55	$	18.67
Intrinsic value of stock options exercised (in thousands)	$	648	$	3,535	$	25,912
Intrinsic value of stock options vested (in thousands)	$	4,369	$	4,805	$	1,965

Schedule of Nonvested Share Activity [Table Text Block]

	Common Stock Outstanding		Common Stock Weighted Average Grant Date Fair Value Per Share
Outstanding at December 31, 2021		12,698	$	42.92
Granted		—	$	—
Vested		—	$	—
Forfeited		—	$	—
Outstanding at December 31, 2022		12,698	$	42.92

XML 43 R31.htm IDEA: XBRL DOCUMENT

Note 10 - Leases (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Lease, Cost [Table Text Block]

	2022			2021			2020
Operating leases	$	527		$	669		$	600
Finance leases:
Asset amortization		462			489			355
Interest on lease liabilities		19			34			37
Variable lease cost		95			99			62
Short-term lease cost		87			59			42
Sublease income		(123	)		(81	)		—
Total net lease cost	$	1,067		$	1,269		$	1,096

Lessee, Lease, Balance Sheet Information [Table Text Block]

	December 31, 2022		December 31, 2021
Operating leases:
Operating ROU assets	$	556	$	975

Current operating lease liabilities		522		493
Noncurrent operating lease liabilities		333		820
Total operating lease liabilities	$	855	$	1,313

	December 31, 2022			December 31, 2021
Finance leases:
Furniture and equipment	$	1,042		$	1,042
Computer Equipment		659			659
Computer Software		207			207
Property and equipment under finance lease, gross		1,908			1,908
Less accumulated amortization		1,537			1,074
Property and equipment under finance lease, net	$	371		$	834

Current obligations of finance leases	$	311		$	470
Noncurrent obligations of finance leases		39			348
Total finance lease liabilities	$	350		$	818

Weighted average remaining lease term (in years):
Operating leases		1.95			2.80
Finance leases		1.15			1.93

Weighted average discount rate:
Operating leases		3.97	%		3.85	%
Finance leases		3.54	%		3.42	%

Lease, Cash flow [Table Text Block]

	2022		2021		2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	563	$	680	$	596
Operating cash flows from finance leases		18		34		36
Financing cash flows from finance leases		469		493		332

ROU assets obtained in exchange for operating lease liabilities		83		560		276
ROU assets obtained in exchange for finance lease liabilities		—		40		817

Lessee, Operating and Finance Lease, Liability, Maturity [Table Text Block]

	Finance Leases		Operating Leases
2023	$	315	$	547
2024		23		227
2025		11		118
2026		10		—
2027		—		—
Thereafter		—		—
Total minimum lease payments		359		892
Less: Amount representing interest		9		37
Present value of minimum lease payments		350		855
Less: Current portion		311		522
Lease obligations, net of current portion	$	39	$	333

Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]

	Operating Lease
2023	$	122
2024		127
2025		65
Total minimum lease receipts	$	314

XML 44 R32.htm IDEA: XBRL DOCUMENT

Note 13 - Segment Information (Tables)

12 Months Ended

Dec. 31, 2022

Notes Tables

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

	2022		2021		2020
Revenue:
United States	$	150,775	$	144,987	$	130,305
Canada		793		2,967		2,972
Total	$	151,568	$	147,954	$	133,277
Long-lived assets:
United States	$	86,718	$	83,722	$	77,448
Canada		27		111		1,863
Total	$	86,745	$	83,833	$	79,311
Total assets:
United States	$	130,151	$	153,879	$	128,319
Canada		310		3,661		5,104
Total	$	130,461	$	157,540	$	133,423

XML 45 R33.htm IDEA: XBRL DOCUMENT

Note 1 - Summary of Significant Accounting Policies (Details Textual)	1 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($) shares
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax		$ (2,569,000)	$ (0)	$ (0)
Incremental Costs of Obtaining a Contract, Deferred During Period		454,000	1,900,000	3,700,000
Capitalized Contract Cost, Net, Noncurrent		2,441,000	3,772,000
Capitalized Contract Cost, Impairment Loss		14,000	31,000	63,000
Capitalized Computer Software, Additions		3,600,000	2,800,000	2,700,000
Asset Impairment Charges, Total		0	0
Impairment of Intangible Assets (Excluding Goodwill), Total		0	0	$ 0
Goodwill, Impairment Loss		0	$ 0
Number of Operating Segments	1		1	6
Number of Reporting Units	1
Income Tax Credits and Adjustments		36,000	$ 10,000	$ 45,000
Cash Equivalents, at Carrying Value, Total		24,900,000	6,300,000
Operating Lease, Impairment Loss			324,000
Excess Loss Coverage Per Person		150,000
Claims Loss Coverage, Minimum Aggregate Deductible		4,700,000	3,200,000	$ 2,800,000
Self Insurance Reserve, Current		$ 424,000	$ 406,000
Common Class A [Member]
Stock Options Excluded from Computation of Earnings Per Share, Amount (in shares) \| shares		83,070	127,185	65,127
Cyber Attack [Member] \| Recoveries Received Direct by the Company [Member]
Proceeds from Insurance Settlement, Operating Activities				$ 3,300,000
Cyber Attack [Member] \| Recoveries Paid Directly by Insurer to Outside Vendor [Member]
Proceeds from Insurance Settlement, Operating Activities				447,000
Cyber Attack [Member] \| Reimbursement for Lost Revenue [Member]
Insurance Recoveries				533,000
Property Damage Excluding Cyber Attack [Member] \| Other Income [Member]
Insurance Recoveries				260,000
Canadian Subsidiary [Member]
Goodwill, Impairment Loss				$ 714,000
Number of Customers		1
Minimum [Member]
Capitalized Contract Cost, Amortization Period (Year)			3 years
Minimum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment, Useful Life (Year)		2 years
Minimum [Member] \| Computer Equipment [Member]
Property, Plant and Equipment, Useful Life (Year)		3 years
Minimum [Member] \| Software and Software Development Costs [Member]
Property, Plant and Equipment, Useful Life (Year)		1 year
Minimum [Member] \| Building and Building Improvements [Member]
Property, Plant and Equipment, Useful Life (Year)		7 years
Maximum [Member]
Capitalized Contract Cost, Amortization Period (Year)			5 years
Maximum [Member] \| Furniture and Fixtures [Member]
Property, Plant and Equipment, Useful Life (Year)		10 years
Maximum [Member] \| Computer Equipment [Member]
Property, Plant and Equipment, Useful Life (Year)		5 years
Maximum [Member] \| Software and Software Development Costs [Member]
Property, Plant and Equipment, Useful Life (Year)		5 years
Maximum [Member] \| Building and Building Improvements [Member]
Property, Plant and Equipment, Useful Life (Year)		40 years

XML 46 R34.htm IDEA: XBRL DOCUMENT

Note 1 - Summary of Significant Accounting Policies - Amortization Expense Classification (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Capitalized contract cost	$ 1,771	$ 2,651	$ 3,242
Direct Expenses [Member]
Capitalized contract cost	146	157	272
Selling, General and Administrative Expenses [Member]
Capitalized contract cost	$ 1,625	$ 2,494	$ 2,970

XML 47 R35.htm IDEA: XBRL DOCUMENT

Note 1 - Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Balance	$ 94	$ 120	$ 144
Bad debt expense	19	38	46
Write-offs	48	64	70
Balance	$ 65	$ 94	$ 120

XML 48 R36.htm IDEA: XBRL DOCUMENT

Note 1 - Summary of Significant Accounting Policies - Share-based Compensation Amounts Recognized in Financial Statements (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Non-cash share-based compensation expense	$ 1,200	$ 623	$ 680
Amount of related income tax benefit	(436)	(919)	(6,764)
Net (benefit) expense to net income	$ 764	$ (296)	$ (6,084)

XML 49 R37.htm IDEA: XBRL DOCUMENT

Note 1 - Summary of Significant Accounting Policies - Fair Value of Financial Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Total carrying amount of long-term debt	$ 22,315	$ 26,620
Estimated fair value of long-term debt	21,668	27,708
Fair Value, Recurring [Member]
Assets, fair value	24,927	6,306
Money Market Funds [Member] \| Fair Value, Recurring [Member]
Assets, fair value	24,927	6,306
Fair Value, Inputs, Level 1 [Member] \| Fair Value, Recurring [Member]
Assets, fair value	24,927	6,306
Fair Value, Inputs, Level 1 [Member] \| Money Market Funds [Member] \| Fair Value, Recurring [Member]
Assets, fair value	$ 24,927	$ 6,306

- Definition

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

XML 50 R38.htm IDEA: XBRL DOCUMENT

Note 1 - Summary of Significant Accounting Policies - Net Income Per Share Computation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Numerator for net income per share - basic:
Net income	$ 31,800	$ 37,466	$ 37,260
Allocation of distributed and undistributed income to unvested restricted stock shareholders	(16)	(18)	(57)
Net income attributable to common shareholders	$ 31,784	$ 37,448	$ 37,203
Denominator for net income per share - basic:
Weighted average common shares outstanding – basic (in shares)	24,922	25,422	25,170
Net income per share – basic (in dollars per share)	$ 1.28	$ 1.47	$ 1.48
Numerator for net income per share - diluted:
Net income attributable to common shareholders	$ 31,784	$ 37,448	$ 37,203
Weighted average common shares outstanding – basic (in shares)	24,922	25,422	25,170
Weighted average effect of dilutive securities – stock options (in shares)	130	218	526
Denominator for diluted earnings per share – adjusted weighted average shares (in shares)	25,052	25,640	25,696
Net income per share – diluted (in dollars per share)	$ 1.27	$ 1.46	$ 1.45

XML 51 R39.htm IDEA: XBRL DOCUMENT

Note 2 - Acquisition (Details Textual) - USD ($)		1 Months Ended	12 Months Ended
Note 2 - Acquisition (Details Textual) - USD ($)	Jan. 04, 2021	Jan. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Payments to Acquire Businesses, Gross				$ 3,000,000
Payment for Contingent Consideration Liability, Financing Activities			$ 1,950,000
Selling, General and Administrative Expenses [Member]
Business Combination, Acquisition Related Costs				$ 119,000
PatientWisdom, Inc. [Member]
Payments to Acquire Businesses, Gross	$ 3,000,000.0
Business Combination, Consideration Transferred, Total	$ 5,000,000.0
Payment for Contingent Consideration Liability, Financing Activities		$ 2,000,000.0
Finite-Lived Intangible Asset, Useful Life (Year)	5 years

XML 52 R40.htm IDEA: XBRL DOCUMENT

Note 2 - Acquisition - Fair Value of Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Jan. 04, 2021	Dec. 31, 2020
Goodwill	$ 61,614	$ 61,614		$ 57,255
PatientWisdom, Inc. [Member]
Current Assets			$ 184
Property and equipment			10
Goodwill			4,340
Total assets acquired			5,234
Current liabilities			284
Net assets acquired			4,950
PatientWisdom, Inc. [Member] \| Customer Relationships [Member]
Intangible assets			100
PatientWisdom, Inc. [Member] \| Technology-Based Intangible Assets [Member]
Intangible assets			$ 600

XML 53 R41.htm IDEA: XBRL DOCUMENT

Note 3 - Contracts With Customers 1 (Details Textual) $ in Millions	Dec. 31, 2022 USD ($)
Long-Term Contract with Customer [Member]
Revenue, Remaining Performance Obligation, Amount	$ 1.6

XML 54 R42.htm IDEA: XBRL DOCUMENT

Note 3 - Contracts With Customers 2 (Details Textual) - Long-Term Contract with Customer [Member]	Dec. 31, 2022 USD ($)
Revenue, Remaining Performance Obligation, Amount	$ 1,600,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Amount	$ 972,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Amount	$ 621,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Amount	$ 15,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Year)	1 year

XML 55 R43.htm IDEA: XBRL DOCUMENT

Note 3 - Contracts With Customers - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue	$ 151,568	$ 147,954	$ 133,277
Transferred over Time [Member] \| Subscription Services [Member]
Revenue	141,981	137,008	122,499
Transferred over Time [Member] \| Fixed, Non-subscription Services [Member]
Revenue	3,134	3,065	2,907
Transferred over Time [Member] \| Unit Price Services [Member]
Revenue	2,222	4,665	4,939
Transferred at Point in Time [Member] \| Service [Member]
Revenue	$ 4,231	$ 3,216	$ 2,932

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

XML 56 R44.htm IDEA: XBRL DOCUMENT

Note 3 - Contracts With Customers - Information About Receivables, Contract Assets, and Contract Liabilities From Contracts With Customers (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Accounts receivables	$ 14,461	$ 13,728
Deferred revenue	15,198	17,213
Revenue recognized that was included in deferred revenue at beginning of year due to completion of services	(17,170)	(15,631)
Increases due to invoicing of client, net of amounts recognized as revenue	15,081	16,694
Decreases due to completion of services (or portion of services) and transferred to accounts receivable	(99)	(311)
Change due to cumulative catch-up adjustments arising from changes in expected contract consideration	74	326
Increases due to revenue recognized in the period with additional performance obligations before invoicing	102	99
Other Current Assets [Member]
Contract assets included in other current assets	$ 102	$ 99

XML 57 R45.htm IDEA: XBRL DOCUMENT

Note 4 - Equity Investments (Details Textual) $ in Millions	Dec. 31, 2022 USD ($)
Equity Securities without Readily Determinable Fair Value, Amount	$ 1.3
Cost Method Investment, Ownership Percentage	13.80%

XML 58 R46.htm IDEA: XBRL DOCUMENT

Note 5 - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Interest Costs Capitalized	$ 216,000	$ 0	$ 0
Impairment, Long-Lived Asset, Held-for-Use, Total	0	0	0
Including Assets Held under Capital Lease [Member]
Depreciation, Depletion and Amortization, Nonproduction, Total	$ 5,100,000	$ 5,700,000	$ 6,500,000

XML 59 R47.htm IDEA: XBRL DOCUMENT

Note 5 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Property and equipment at cost	$ 50,756	$ 45,599
Less accumulated depreciation and amortization	33,508	33,208
Net property and equipment	17,248	12,391
Furniture and Fixtures [Member]
Property and equipment at cost	4,753	4,901
Computer Equipment [Member]
Property and equipment at cost	2,639	2,672
Software and Software Development Costs [Member]
Property and equipment at cost	29,876	27,828
Building and Building Improvements [Member]
Property and equipment at cost	12,561	9,271
Leasehold Improvements [Member]
Property and equipment at cost	502	502
Land [Member]
Property and equipment at cost	$ 425	$ 425

XML 60 R48.htm IDEA: XBRL DOCUMENT

Note 6 - Goodwill and Intangible Assets (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill, Period Increase (Decrease), Total	$ 0
Goodwill, Ending Balance	61,614,000	$ 61,614,000	$ 57,255,000
Goodwill, Impairment Loss	0	0
Amortization of Intangible Assets	180,000	$ 320,000	318,000
Finite-Lived Intangible Asset, Expected Amortization, Year Two	140,000
Finite-Lived Intangible Asset, Expected Amortization, Year Three	140,000
Finite-Lived Intangible Asset, Expected Amortization, Year Four	140,000
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	$ 0
Canadian Subsidiary [Member]
Goodwill, Impairment Loss			$ 714,000

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

XML 61 R49.htm IDEA: XBRL DOCUMENT

Note 6 - Goodwill and Intangible Assets - Summary of Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill	$ 62,328	$ 62,328
Goodwill, Accumulated Depreciation	(714)	(714)
Goodwill, Ending Balance	61,614	61,614	$ 57,255
Finite-lived intangible assets, gross	12,723	12,976
Finite-lived intangible assets, accumulated amortization	12,303	12,377
Finite-lived intangible assets, net	420	599
Total intangible assets other than goodwill	13,914	14,167
Total intangible assets other than goodwill	1,611	1,790
Customer Relationships [Member]
Finite-lived intangible assets, gross	9,192	9,445
Finite-lived intangible assets, accumulated amortization	9,132	9,325
Finite-lived intangible assets, net	$ 60	$ 120
Customer Relationships [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	5 years	5 years
Customer Relationships [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	15 years	15 years
Technology-Based Intangible Assets [Member]
Finite-lived intangible assets, gross	$ 1,959	$ 1,959
Finite-lived intangible assets, accumulated amortization	1,599	1,480
Finite-lived intangible assets, net	$ 360	$ 479
Technology-Based Intangible Assets [Member] \| Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	3 years	3 years
Technology-Based Intangible Assets [Member] \| Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	7 years	7 years
Trade Names [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	10 years	10 years
Finite-lived intangible assets, gross	$ 1,572	$ 1,572
Finite-lived intangible assets, accumulated amortization	1,572	1,572
Finite-lived intangible assets, net	0	0
Trade Names 1 [Member]
Indefinite trade name	$ 1,191	$ 1,191

XML 62 R50.htm IDEA: XBRL DOCUMENT

Note 6 - Goodwill and Intangible Assets - Summary of Changes in the Carrying Amount of Goodwill (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($)
Goodwill	$ 57,255
Goodwill acquired	4,340
Foreign currency translation	19
Goodwill	$ 61,614

- Definition

+ References + Details

XML 63 R51.htm IDEA: XBRL DOCUMENT

Note 7 - Income Taxes (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
Note 7 - Income Taxes (Details Textual) - USD ($)	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Deemed Dividend Paid by Foreign Subsidiary		$ 1,400,000		$ 9,600,000
Withholding Tax on Dividend Distribution, Percent	5.00%	5.00%
Cumulative Tax Incentives		$ 510,000	$ 473,000	435,000
Income Tax Credits and Adjustments		36,000	10,000	45,000
Social Security Tax Payable, Current			656,000	1,300,000
Deferred Social Security Tax Paid	$ 656,000
Deferred Tax Asset, Prior Year Foreign Tax Credit Carryforwards, Write Off				535,000
Reserach and Experimentation Costs Deferred	3,500,000	3,500,000
Deferred Tax Assets, Research and Expenditures	856,000	856,000	0
Deferred Tax Assets, Software Development Costs	52,000	52,000
Unrecognized Tax Benefits, Ending Balance	1,557,000	1,557,000	1,075,000	$ 768,000
Unrecognized Tax Benefits, Interest on Income Taxes Accrued	25,000	25,000	19,000
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 1,300,000	$ 1,300,000	$ 918,000
Domestic Tax Authority [Member]
Open Tax Year		2019 2020 2021 2022
State and Local Jurisdiction [Member]
Open Tax Year		2016 2017 2018 2019 2020 2021 2022
Foreign Tax Authority [Member] \| Canada Revenue Agency [Member]
Open Tax Year		2018 2019 2020 2021 2022
Domestic Research [Member]
Tax Amortization Period (Year)		5 years
Foreign Research [Member]
Tax Amortization Period (Year)		15 years
Canadian Subsidiary [Member]
Capital Returns from Subsidiary		$ 1,200,000

XML 64 R52.htm IDEA: XBRL DOCUMENT

Note 7 - Income Taxes - Income Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
U.S. Operations	$ 43,156	$ 48,145	$ 41,357
Foreign Operations	(341)	476	110
Income before income taxes	$ 42,815	$ 48,621	$ 41,467

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

XML 65 R53.htm IDEA: XBRL DOCUMENT

Note 7 - Income Taxes - Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current	$ 9,988	$ 9,092	$ 3,546
Deferred	(1,427)	(224)	(308)
Total	8,561	8,868	3,238
Current	(90)	143	225
Deferred	0	(17)	(6)
Total	(90)	126	219
Current	2,846	2,197	578
Deferred	(302)	(36)	172
Total	2,544	2,161	750
Income Tax Expense (Benefit), Total	$ 11,015	$ 11,155	$ 4,207

XML 66 R54.htm IDEA: XBRL DOCUMENT

Note 7 - Income Taxes - Income Tax Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Expected federal income taxes	$ 8,991	$ 10,210	$ 8,708
Foreign tax rate differential	(24)	26	6
State income taxes, net of federal benefit and state tax credits	2,100	1,531	607
Share-based compensation	(120)	(660)	(5,713)
Compensation limit for covered employees	0	0	463
Federal tax credits	(408)	(272)	(261)
Uncertain tax positions	22	254	157
Reclassification of cumulative translation adjustment into earnings	539	0	0
Goodwill Impairment	0	0	184
Withholding tax on repatriation of foreign earnings	(100)	8	18
GILTI	0	0	10
Other	15	58	28
Income Tax Expense (Benefit), Total	$ 11,015	$ 11,155	$ 4,207

XML 67 R55.htm IDEA: XBRL DOCUMENT

Note 7 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Allowance for doubtful accounts	$ 16,000	$ 24,000
Accrued expenses	691,000	687,000
Share-based compensation	1,072,000	740,000
Accrued bonuses	96,000	267,000
Employer payroll tax deferral	0	200,000
Uncertain tax positions	256,000	161,000
Deferred Tax Assets, Research and Expenditures	856,000	0
Other	78,000	66,000
Gross deferred tax assets	3,065,000	2,145,000
Deferred tax assets	3,065,000	2,145,000
Deferred tax liabilities:
Prepaid expenses	135,000	89,000
Deferred contract costs	601,000	945,000
Property and equipment	1,066,000	1,579,000
Intangible assets	6,523,000	6,338,000
Repatriation withholding	0	182,000
Deferred tax liabilities	8,325,000	9,133,000
Net deferred tax liabilities	$ (5,260,000)	$ (6,988,000)

XML 68 R56.htm IDEA: XBRL DOCUMENT

Note 7 - Income Taxes - Change in Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Balance of unrecognized tax benefits	$ 1,075	$ 768
Reductions due to lapse of applicable statute of limitations	(76)	(38)
Reductions due to tax positions of prior years		0
Additions based on tax positions related to the current year	558	345
Balance of unrecognized tax benefits	$ 1,557	$ 1,075

XML 69 R57.htm IDEA: XBRL DOCUMENT

Note 8 - Notes Payable (Details Textual) - Credit Agreement [Member] - First National Bank of Omaha [Member]	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Debt Instrument, Covenant, Minimum Fixed Charge Coverage Ratio		1.10
Debt Instrument, Covenant, Exception, Fixed Charge Coverage Ratio, Dividend Threshold		$ 5,500,000
Debt Instrument, Covenant, Maximum Cash Flow Leverage Ratio		3.00
Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Basis Spread on Variable Rate		2.35%
Term Loan [Member]
Debt Instrument, Face Amount	$ 23,412,383
Debt Instrument, Periodic Payment, Total	$ 462,988
Debt Instrument, Interest Rate, Stated Percentage	5.00%
Delayed Draw Term Loan [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 75,000,000
Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 30,000,000
Debt Instrument, Percentage Bearing Variable Interest, Percentage Rate		6.10%
Long-Term Line of Credit, Total		$ 0
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage		0.20%

XML 70 R58.htm IDEA: XBRL DOCUMENT

Note 8 - Notes Payable - Summary of Notes Payable (Details) - Term Loan [Member] - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Term Loans	$ 22,315	$ 26,620
Less: current portion	(4,491)	(4,278)
Less: unamortized debt issuance costs	(134)	(73)
Notes payable, net of current portion	$ 17,690	$ 22,269

XML 71 R59.htm IDEA: XBRL DOCUMENT

Note 8 - Notes Payable - Scheduled Maturities of Notes Payable (Details) $ in Thousands	Dec. 31, 2022 USD ($)
2023	$ 4,529
2024	4,762
2025	5,011
2026	5,271
2027	$ 2,742

XML 72 R60.htm IDEA: XBRL DOCUMENT

Note 9 - Share-based Compensation (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Proceeds from Stock Options Exercised	$ 0	$ 446,000	$ 1,734,000
Share-Based Payment Arrangement, Exercise of Option, Tax Benefit	$ 160,000	$ 862,000	$ 6,300,000
Common Stock Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	127,227	101,091	70,471
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total	$ 1,200,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	2 years 7 months 17 days
Share-Based Payment Arrangement, Option [Member] \| Direct, Selling, General and Administrative Expenses [Member]
Share-Based Payment Arrangement, Expense	$ 1,100,000	$ 607,000	$ 680,000
Nonvested [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	5 years
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total	$ 327,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	3 years
Nonvested [Member] \| Direct, Selling, General and Administrative Expenses [Member]
Share-Based Payment Arrangement, Expense	$ 109,000	17,000	23,000
Restricted Stock [Member]
Share-Based Payment Arrangement, Expense	$ 0	$ 0
Tax Benefit Realized Restricted Stock Vested			$ 235,000
Director Plan 2004 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)	707,862
Share-based Compensation Arrangement by Share-based Payment Award, Options Grants Cumulative (in shares)	2,292,138
Director Plan 2004 [Member] \| Nonqualified Stock Options [Member] \| Director [Member]
Share Based Compensation, Arrangement By Share Based Payment Award, Options Grant, Amount	$ 100,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)	1 year
Director Plan 2004 [Member] \| Nonqualified Stock Options [Member] \| Director [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	10 years
Director Plan 2004 [Member] \| Nonqualified Stock Options [Member] \| Director [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	3 years
Director Plan 2004 [Member] \| Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)	3,000,000
The 2006 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)	751,778
Share-based Compensation Arrangement by Share-based Payment Award, Options Grants Cumulative (in shares)	1,048,222
The 2006 Equity Incentive Plan [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	10 years
The 2006 Equity Incentive Plan [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	5 years
The 2006 Equity Incentive Plan [Member] \| Nonvested [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in shares)		12,698
Share-based Compensation Arrangement by Share-based Payment Award, Nonvested Restricted Stock, Outstanding Number (in shares)	12,698
The 2006 Equity Incentive Plan [Member] \| Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)	1,800,000

XML 73 R61.htm IDEA: XBRL DOCUMENT

Note 9 - Share-based Compensation - Stock Options Valuation Assumptions (Details) - Common Stock [Member]	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Expected dividend yield at date of grant	3.39%	2.15%	1.84%
Expected stock price volatility	35.52%	34.85%	33.62%
Risk-free interest rate	2.33%	0.91%	1.35%
Expected life of options (in years) (Year)	6 years 3 months 18 days	7 years 3 days	7 years 4 months 20 days

XML 74 R62.htm IDEA: XBRL DOCUMENT

Note 9 - Share-based Compensation - Stock Option Activity Under Equity Incentive Plans and Director Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Exercised, number of options (in shares)	23,581	116,753	630,373
Common Stock Options [Member]
Beginning balance, outstanding, number of options (in shares)	477,640
Beginning balance, outstanding, weighted average exercise price (in dollars per share)	$ 30.88
Granted, number of options (in shares)	127,227	101,091	70,471
Granted, weighted average exercise price (in dollars per share)	$ 36.67
Exercised, number of options (in shares)	23,581
Exercised, weighted average exercise price (in dollars per share)	$ 13.17
Ending balance, outstanding, number of options (in shares)	581,286	477,640
Ending balance, outstanding, weighted average exercise price (in dollars per share)	$ 32.86	$ 30.88
Outstanding, weighted average remaining contractual term (Year)	5 years 5 months 8 days
Outstanding, aggregate intrinsic value	$ 4,739
Exercisable, number of options (in shares)	323,140
Weighted average exercise price (in dollars per share)	$ 26.97
Exercisable, weighted average remaining contractual term (Year)	3 years 6 months 18 days
Exercisable, aggregate intrinsic value	$ 4,369

XML 75 R63.htm IDEA: XBRL DOCUMENT

Note 9 - Share-based compensation - Stock Option Activity (Details) - Common Stock [Member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted average grant date fair value of stock options granted (in dollars per share)	$ 9.43	$ 12.55	$ 18.67
Intrinsic value of stock options exercised (in thousands)	$ 648	$ 3,535	$ 25,912
Intrinsic value of stock options vested (in thousands)	$ 4,369	$ 4,805	$ 1,965

XML 76 R64.htm IDEA: XBRL DOCUMENT

Note 9 - Share-based Compensation - Non-vested Stock (Details) - Common Stock [Member]	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Outstanding (in shares) \| shares	12,698
Outstanding (in dollars per share) \| $ / shares	$ 42.92
Granted (in shares) \| shares	0
Granted (in dollars per share) \| $ / shares	$ 0
Vested (in shares) \| shares	0
Vested (in dollars per share) \| $ / shares	$ 0
Forfeited (in shares) \| shares	0
Forfeited (in dollars per share) \| $ / shares	$ 0
Outstanding (in shares) \| shares	12,698
Outstanding (in dollars per share) \| $ / shares	$ 42.92

XML 77 R65.htm IDEA: XBRL DOCUMENT

Note 10 - Leases (Details Textual)	Dec. 31, 2022
Minimum [Member]
Lessee, Operating Lease, Remaining Lease Term (Year)	1 year
Maximum [Member]
Lessee, Operating Lease, Remaining Lease Term (Year)	3 years 11 months 4 days

XML 78 R66.htm IDEA: XBRL DOCUMENT

Note 10 - Leases - Lease Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating leases	$ 527	$ 669	$ 600
Asset amortization	462	489	355
Interest on lease liabilities	19	34	37
Variable lease cost	95	99	62
Short-term lease cost	87	59	42
Sublease income	(123)	(81)	0
Total net lease cost	$ 1,067	$ 1,269	$ 1,096

XML 79 R67.htm IDEA: XBRL DOCUMENT

Note 10 - Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Operating lease right-of-use assets	$ 556	$ 975
Property and equipment at cost	50,756	45,599
Less accumulated depreciation and amortization	33,508	33,208
Property and equipment under finance lease, net	$ 17,248	$ 12,391
Operating leases (Year)	1 year 11 months 12 days	2 years 9 months 18 days
Finance leases (Year)	1 year 1 month 24 days	1 year 11 months 4 days
Operating leases	3.97%	3.85%
Finance leases	3.54%	3.42%
Other Current Liabilities [Member]
Current portion, operating leases	$ 522	$ 493
Current portion, finance leases	311
Other Noncurrent Liabilities [Member]
Operating lease obligations, net of current portion	333	820
Noncurrent obligations of finance leases	39
Other Current Liabilities and Other Noncurrent Liabilities [Member]
Total operating lease liabilities	855	1,313
Total finance lease liabilities	350
Property and Equipment [Member]
Current portion, finance leases	311	470
Noncurrent obligations of finance leases	39	348
Total finance lease liabilities	350	818
Furniture and Equipment Held under Finance Leases [Member]
Property and equipment at cost	1,042	1,042
Computer Equipment Held under Finance Leases [Member]
Property and equipment at cost	659	659
Computer Software Held under Finance Leases [Member]
Property and equipment at cost	207	207
Assets Held under Finance Leases [Member]
Property and equipment at cost	1,908	1,908
Less accumulated depreciation and amortization	1,537	1,074
Property and equipment under finance lease, net	$ 371	$ 834

XML 80 R68.htm IDEA: XBRL DOCUMENT

Note 10 - Leases - Supplemental Cash Flow and Other Information Related to Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating cash flows from operating leases	$ 563	$ 680	$ 596
Operating cash flows from finance leases	18	34	36
Financing cash flows from finance leases	469	493	332
ROU assets obtained in exchange for operating lease liabilities	83	560	276
ROU assets obtained in exchange for finance lease liabilities	$ 0	$ 40	$ 817

XML 81 R69.htm IDEA: XBRL DOCUMENT

Note 10 - Leases - Undiscounted Payments Under Non-cancelable Leases (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
2023, finance leases	$ 315
2023, operating leases	547
2024, finance leases	23
2024, operating leases	227
2025, finance leases	11
2025, operating leases	118
2026, finance leases	10
2027, finance leases	0
Finance leases, total minimum lease payments	359
Operating leases, total minimum lease payments	892
Finance leases, less: Amount representing interest	9
Operating leases, less: Amount representing interest	37
Other Current Liabilities and Other Noncurrent Liabilities [Member]
Present value of minimum finance lease payments	350
Present value of minimum operating lease payments	855	$ 1,313
Other Current Liabilities [Member]
Current portion, finance leases	311
Current portion, operating leases	522	493
Other Noncurrent Liabilities [Member]
Finance leases obligations, net of current portion	39
Operating lease obligations, net of current portion	$ 333	$ 820

XML 82 R70.htm IDEA: XBRL DOCUMENT

Note 10 - Leases - Undiscounted Payments Under Sublease (Details) $ in Thousands	Dec. 31, 2022 USD ($)
2023	$ 122
2024	127
2025	65
Total minimum lease receipts	$ 314

XML 83 R71.htm IDEA: XBRL DOCUMENT

Note 11 - Related Party (Details Textual) - USD ($)	12 Months Ended
Note 11 - Related Party (Details Textual) - USD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Chief Executive Officer [Member] \| Nebraska Global Investment Company LLC [Member]
Officer Ownership Percentage in Vendor	13.00%
Don’t Panic Labs, LLC [Member]
Related Party Transaction, Amounts of Transaction	$ 196,000
Allina Health [Member]
Revenue from Related Parties		$ 1,700,000
Ameritas Life Insurance Corp [Member]
Related Party Transaction, Amounts of Transaction		278,000	$ 248,000
IMA Financial Group [Member] \| Purchasing Directors and Officers and Employment Practices Liability Insurance [Member]
Related Party Transaction, Amounts of Transaction			1,100,000
PracticingExcellence.com [Member]
Revenue from Related Parties		$ 35,000	$ 294,000

XML 84 R72.htm IDEA: XBRL DOCUMENT

Note 12 - Associate Benefits (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	25.00%
Defined Contribution Plan, Maximum Percentage of Annual Contribution Employee Subject to Match	6.00%
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage	20.00%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 588,000	$ 531,000	$ 521,000

XML 85 R73.htm IDEA: XBRL DOCUMENT

Note 13 - Segment Information (Details Textual)	1 Months Ended	12 Months Ended
Note 13 - Segment Information (Details Textual)	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Number of Operating Segments	1	1	6

XML 86 R74.htm IDEA: XBRL DOCUMENT

Note 13 - Segment Information - Assets by Geographic Area (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue	$ 151,568	$ 147,954	$ 133,277
Long-lived assets	86,745	83,833	79,311
Total assets	130,461	157,540	133,423
UNITED STATES
Revenue	150,775	144,987	130,305
Long-lived assets	86,718	83,722	77,448
Total assets	130,151	153,879	128,319
CANADA
Revenue	793	2,967	2,972
Long-lived assets	27	111	1,863
Total assets	$ 310	$ 3,661	$ 5,104

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

XML 87 nrc20221231_10k_htm.xml IDEA: XBRL DOCUMENT 0000070487 2022-01-01 2022-12-31 0000070487 2022-06-30 0000070487 2023-02-23 0000070487 2022-12-31 0000070487 2021-12-31 0000070487 2021-01-01 2021-12-31 0000070487 2020-01-01 2020-12-31 0000070487 us-gaap:CommonStockMember 2019-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000070487 us-gaap:RetainedEarningsMember 2019-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000070487 us-gaap:TreasuryStockMember 2019-12-31 0000070487 2019-12-31 0000070487 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000070487 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000070487 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0000070487 us-gaap:CommonStockMember 2020-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000070487 us-gaap:RetainedEarningsMember 2020-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000070487 us-gaap:TreasuryStockMember 2020-12-31 0000070487 2020-12-31 0000070487 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000070487 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0000070487 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0000070487 us-gaap:CommonStockMember 2021-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000070487 us-gaap:RetainedEarningsMember 2021-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000070487 us-gaap:TreasuryStockMember 2021-12-31 0000070487 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000070487 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000070487 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000070487 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0000070487 us-gaap:CommonStockMember 2022-12-31 0000070487 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000070487 us-gaap:RetainedEarningsMember 2022-12-31 0000070487 us-gaap:TreasuryStockMember 2022-12-31 0000070487 srt:MinimumMember 2021-12-31 0000070487 srt:MaximumMember 2021-12-31 0000070487 nrc:DirectExpensesMember 2022-01-01 2022-12-31 0000070487 nrc:DirectExpensesMember 2021-01-01 2021-12-31 0000070487 nrc:DirectExpensesMember 2020-01-01 2020-12-31 0000070487 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0000070487 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0000070487 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000070487 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0000070487 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0000070487 srt:MinimumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0000070487 srt:MaximumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0000070487 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-01-01 2022-12-31 0000070487 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-01-01 2022-12-31 0000070487 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2022-01-01 2022-12-31 0000070487 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2022-01-01 2022-12-31 0000070487 nrc:CanadianSubsidiaryMember 2022-12-31 0000070487 nrc:CanadianSubsidiaryMember 2020-01-01 2020-12-31 0000070487 2021-03-01 2021-03-31 0000070487 nrc:CyberAttackMember nrc:RecoveriesReceivedDirectByTheCompanyMember 2020-01-01 2020-12-31 0000070487 nrc:CyberAttackMember nrc:RecoveriesPaidDirectlyByInsurerToOutsideVendorMember 2020-01-01 2020-12-31 0000070487 nrc:CyberAttackMember nrc:ReimbursementForLostRevenueMember 2020-01-01 2020-12-31 0000070487 us-gaap:OtherIncomeMember nrc:PropertyDamageExcludingCyberAttackMember 2020-01-01 2020-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000070487 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000070487 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000070487 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000070487 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000070487 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0000070487 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0000070487 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0000070487 us-gaap:CommonClassAMember 2020-01-01 2020-12-31 0000070487 nrc:PatientWisdomIncMember 2021-01-04 2021-01-04 0000070487 nrc:PatientWisdomIncMember 2022-01-01 2022-01-31 0000070487 nrc:PatientWisdomIncMember 2021-01-04 0000070487 nrc:PatientWisdomIncMember us-gaap:CustomerRelationshipsMember 2021-01-04 0000070487 nrc:PatientWisdomIncMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-04 0000070487 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0000070487 nrc:SubscriptionServicesMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-12-31 0000070487 nrc:SubscriptionServicesMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0000070487 nrc:SubscriptionServicesMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0000070487 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-12-31 0000070487 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-12-31 0000070487 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-12-31 0000070487 nrc:FixedNonSubscriptionServicesMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-12-31 0000070487 nrc:FixedNonSubscriptionServicesMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0000070487 nrc:FixedNonSubscriptionServicesMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0000070487 nrc:UnitPriceServicesMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-12-31 0000070487 nrc:UnitPriceServicesMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-12-31 0000070487 nrc:UnitPriceServicesMember us-gaap:TransferredOverTimeMember 2020-01-01 2020-12-31 0000070487 us-gaap:OtherCurrentAssetsMember 2022-12-31 0000070487 us-gaap:OtherCurrentAssetsMember 2021-12-31 0000070487 us-gaap:LongTermContractWithCustomerMember

2023-01-01

2022-12-31 0000070487 us-gaap:LongTermContractWithCustomerMember

2024-01-01

2022-12-31 0000070487 us-gaap:LongTermContractWithCustomerMember

2025-01-01

2022-12-31 0000070487 us-gaap:LongTermContractWithCustomerMember 2022-12-31 0000070487 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000070487 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000070487 us-gaap:ComputerEquipmentMember 2022-12-31 0000070487 us-gaap:ComputerEquipmentMember 2021-12-31 0000070487 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-12-31 0000070487 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-12-31 0000070487 us-gaap:BuildingAndBuildingImprovementsMember 2022-12-31 0000070487 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0000070487 us-gaap:LeaseholdImprovementsMember 2022-12-31 0000070487 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000070487 us-gaap:LandMember 2022-12-31 0000070487 us-gaap:LandMember 2021-12-31 0000070487 nrc:IncludingAssetsHeldUnderCapitalLeaseMember 2022-01-01 2022-12-31 0000070487 nrc:IncludingAssetsHeldUnderCapitalLeaseMember 2021-01-01 2021-12-31 0000070487 nrc:IncludingAssetsHeldUnderCapitalLeaseMember 2020-01-01 2020-12-31 0000070487 nrc:TradeNames1Member 2022-12-31 0000070487 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0000070487 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0000070487 us-gaap:CustomerRelationshipsMember 2022-12-31 0000070487 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-01-01 2022-12-31 0000070487 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-01-01 2022-12-31 0000070487 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0000070487 us-gaap:TradeNamesMember 2022-01-01 2022-12-31 0000070487 us-gaap:TradeNamesMember 2022-12-31 0000070487 nrc:TradeNames1Member 2021-12-31 0000070487 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0000070487 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0000070487 us-gaap:CustomerRelationshipsMember 2021-12-31 0000070487 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-12-31 0000070487 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-12-31 0000070487 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-12-31 0000070487 us-gaap:TradeNamesMember 2021-01-01 2021-12-31 0000070487 us-gaap:TradeNamesMember 2021-12-31 0000070487 nrc:CanadianSubsidiaryMember 2022-01-01 2022-12-31 0000070487 2022-12-01 2022-12-31 0000070487 nrc:DomesticResearchMember 2022-01-01 2022-12-31 0000070487 nrc:ForeignResearchMember 2022-01-01 2022-12-31 0000070487 us-gaap:DomesticCountryMember 2022-01-01 2022-12-31 0000070487 us-gaap:StateAndLocalJurisdictionMember 2022-01-01 2022-12-31 0000070487 us-gaap:ForeignCountryMember us-gaap:CanadaRevenueAgencyMember 2022-01-01 2022-12-31 0000070487 nrc:TermLoanMember 2022-12-31 0000070487 nrc:TermLoanMember 2021-12-31 0000070487 us-gaap:RevolvingCreditFacilityMember nrc:CreditAgreementMember nrc:FirstNationalBankOfOmahaMember 2022-09-30 0000070487 nrc:CreditAgreementMember nrc:FirstNationalBankOfOmahaMember nrc:TermLoanMember 2022-09-30 0000070487 nrc:CreditAgreementMember nrc:FirstNationalBankOfOmahaMember nrc:DelayedDrawTermLoanMember 2022-09-30 0000070487 nrc:CreditAgreementMember nrc:FirstNationalBankOfOmahaMember nrc:TermLoanMember 2022-01-01 2022-09-30 0000070487 nrc:CreditAgreementMember nrc:FirstNationalBankOfOmahaMember nrc:SecuredOvernightFinancingRateSOFRMember 2022-01-01 2022-12-31 0000070487 us-gaap:RevolvingCreditFacilityMember nrc:CreditAgreementMember nrc:FirstNationalBankOfOmahaMember 2022-12-31 0000070487 us-gaap:RevolvingCreditFacilityMember nrc:CreditAgreementMember nrc:FirstNationalBankOfOmahaMember 2022-01-01 2022-12-31 0000070487 nrc:CreditAgreementMember nrc:FirstNationalBankOfOmahaMember 2022-01-01 2022-12-31 0000070487 nrc:DirectorPlan2004Member us-gaap:CommonStockMember 2022-12-31 0000070487 srt:DirectorMember nrc:NonqualifiedStockOptionsMember nrc:DirectorPlan2004Member 2022-01-01 2022-12-31 0000070487 srt:MaximumMember srt:DirectorMember nrc:NonqualifiedStockOptionsMember nrc:DirectorPlan2004Member 2022-01-01 2022-12-31 0000070487 srt:MinimumMember srt:DirectorMember nrc:NonqualifiedStockOptionsMember nrc:DirectorPlan2004Member 2022-01-01 2022-12-31 0000070487 nrc:DirectorPlan2004Member 2022-12-31 0000070487 nrc:The2006EquityIncentivePlanMember us-gaap:CommonStockMember 2022-12-31 0000070487 srt:MinimumMember nrc:The2006EquityIncentivePlanMember 2022-01-01 2022-12-31 0000070487 srt:MaximumMember nrc:The2006EquityIncentivePlanMember 2022-01-01 2022-12-31 0000070487 nrc:The2006EquityIncentivePlanMember 2022-12-31 0000070487 nrc:CommonStockOptionsMember 2022-01-01 2022-12-31 0000070487 nrc:CommonStockOptionsMember 2021-01-01 2021-12-31 0000070487 nrc:CommonStockOptionsMember 2020-01-01 2020-12-31 0000070487 nrc:CommonStockOptionsMember 2021-12-31 0000070487 nrc:CommonStockOptionsMember 2022-12-31 0000070487 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000070487 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000070487 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000070487 us-gaap:EmployeeStockOptionMember 2022-12-31 0000070487 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0000070487 us-gaap:EmployeeStockOptionMember nrc:DirectSellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0000070487 us-gaap:EmployeeStockOptionMember nrc:DirectSellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0000070487 us-gaap:EmployeeStockOptionMember nrc:DirectSellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000070487 nrc:NonvestedMember nrc:The2006EquityIncentivePlanMember 2021-01-01 2021-12-31 0000070487 nrc:NonvestedMember nrc:The2006EquityIncentivePlanMember 2022-12-31 0000070487 nrc:NonvestedMember 2022-01-01 2022-12-31 0000070487 nrc:NonvestedMember nrc:DirectSellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0000070487 nrc:NonvestedMember nrc:DirectSellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0000070487 nrc:NonvestedMember nrc:DirectSellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000070487 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000070487 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0000070487 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0000070487 us-gaap:CommonStockMember 2021-12-31 0000070487 us-gaap:CommonStockMember 2022-12-31 0000070487 nrc:NonvestedMember 2022-12-31 0000070487 srt:MinimumMember 2022-12-31 0000070487 srt:MaximumMember 2022-12-31 0000070487 us-gaap:OtherCurrentLiabilitiesMember 2022-12-31 0000070487 us-gaap:OtherCurrentLiabilitiesMember 2021-12-31 0000070487 us-gaap:OtherNoncurrentLiabilitiesMember 2022-12-31 0000070487 us-gaap:OtherNoncurrentLiabilitiesMember 2021-12-31 0000070487 nrc:OtherCurrentLiabilitiesAndOtherNoncurrentLiabilitiesMember 2022-12-31 0000070487 nrc:OtherCurrentLiabilitiesAndOtherNoncurrentLiabilitiesMember 2021-12-31 0000070487 nrc:FurnitureAndEquipmentHeldUnderFinanceLeasesMember 2022-12-31 0000070487 nrc:FurnitureAndEquipmentHeldUnderFinanceLeasesMember 2021-12-31 0000070487 nrc:ComputerEquipmentHeldUnderFinanceLeasesMember 2022-12-31 0000070487 nrc:ComputerEquipmentHeldUnderFinanceLeasesMember 2021-12-31 0000070487 nrc:ComputerSoftwareHeldUnderFinanceLeasesMember 2022-12-31 0000070487 nrc:ComputerSoftwareHeldUnderFinanceLeasesMember 2021-12-31 0000070487 nrc:AssetsHeldUnderFinanceLeasesMember 2022-12-31 0000070487 nrc:AssetsHeldUnderFinanceLeasesMember 2021-12-31 0000070487 nrc:PropertyAndEquipmentMember 2022-12-31 0000070487 nrc:PropertyAndEquipmentMember 2021-12-31 0000070487 nrc:NebraskaGlobalInvestmentCompanyLLCMember srt:ChiefExecutiveOfficerMember 2022-12-31 0000070487 nrc:DontPanicLabsLlcMember 2022-01-01 2022-12-31 0000070487 nrc:AllinaHealthMember 2021-01-01 2021-12-31 0000070487 nrc:AmeritasLifeInsuranceCorpMember 2021-01-01 2021-12-31 0000070487 nrc:AmeritasLifeInsuranceCorpMember 2020-01-01 2020-12-31 0000070487 nrc:PurchasingDirectorsAndOfficersAndEmploymentPracticesLiabilityInsuranceMember nrc:IMAFinancialGroupMember 2020-01-01 2020-12-31 0000070487 nrc:PracticingExcellencecomMember 2021-01-01 2021-12-31 0000070487 nrc:PracticingExcellencecomMember 2020-01-01 2020-12-31 0000070487 country:US 2022-01-01 2022-12-31 0000070487 country:US 2021-01-01 2021-12-31 0000070487 country:US 2020-01-01 2020-12-31 0000070487 country:CA 2022-01-01 2022-12-31 0000070487 country:CA 2021-01-01 2021-12-31 0000070487 country:CA 2020-01-01 2020-12-31 0000070487 country:US 2022-12-31 0000070487 country:US 2021-12-31 0000070487 country:US 2020-12-31 0000070487 country:CA 2022-12-31 0000070487 country:CA 2021-12-31 0000070487 country:CA 2020-12-31 iso4217:USD thunderdome:item iso4217:USD shares utr:Y pure 0000070487 National Research Corporation false --12-31 FY 2022

65000

94000

0.01

2000000

0.001

110000000

30922181

30898600

24628173

25361409

6294008

5537191

180112

630373

6793

0.21

153005

116753

0.48

756817

23581

0.84

P3Y

P5Y

P2Y

P10Y

P3Y

P5Y

P1Y

P5Y

P7Y

P40Y

P1Y

656000 P5Y

2019 2020 2021 2022

2016 2017 2018 2019 2020 2021 2022

2018 2019 2020 2021 2022

1.10 3.00

P1Y

P10Y

P3Y

P5Y

P10Y

P5Y

P1Y

0.13

10-K true 2022-12-31 false 001-35929 DE 47-0634000 1245 Q Street Lincoln NE 68508 402 475-2525 Common Stock, $.001 par value NRC NASDAQ No No Yes Yes Accelerated Filer false false true false 444018792 24594390 KPMG LLP 1997 Lincoln, Nebraska

25026000

54361000

14461000

13728000

2386000

3884000

733000

752000

1110000

982000

43716000

73707000

17248000

12391000

1611000

1790000

61614000

556000

975000

2441000

3772000

14000

3261000

3277000

130461000

157540000

4491000

4278000

1153000

1943000

4551000

7139000

3983000

5450000

2956000

3044000

15198000

17213000

1085000

1321000

33417000

40388000

17690000

22269000

5274000

7002000

2047000

2544000

58428000

72203000

31000

175453000

173942000

-25184000

-36112000

-2375000

78267000

50149000

72033000

85337000

130461000

157540000

151568000

147954000

133277000

533000

57049000

52350000

49187000

42699000

38960000

34441000

5277000 6374000 7505000

105025000

97684000

91133000

46543000

50270000

42677000

168000

14000

18000

1209000

1667000

1813000

2569000

-118000

4000

585000

-3728000

-1649000

-1210000

42815000

48621000

41467000

11015000

11155000

4207000

31800000

37466000

37260000

1.28

1.47

1.48

1.27

1.46

1.45

24922000

25422000

25170000

25052000

25640000

25696000

31800000

37466000

37260000

-194000

24000

-190000

-2569000

-0

2375000

24000

-190000

34175000

37490000

37070000

30000

162154000

-93357000

-2209000

-33726000

32892000

-0

10001000

1000

8951000

8952000

680000

-0

5278000

-0

5278000

-190000

37260000

31000

171785000

-61375000

-2399000

-43727000

64315000

-0

6422000

1534000

623000

-0

12203000

-0

12203000

24000

37466000

31000

173942000

-36112000

-2375000

-50149000

85337000

-0

28118000

311000

1200000

-0

20872000

-0

20872000

-194000

-0

-2569000

-0

-2569000

31800000

31000

175453000

-25184000

-78267000

72033000

31800000

37466000

37260000

5277000 6374000 7505000 2569000

-1729000

-277000

-134000

488000 310000 185000 260000

-11000

-7000

-12000

1200000

623000

680000

733000

-343000

2271000

-1634000

842000

827000

39000 34000 -16000

-1331000

-783000

351000

-589000

4000

-247000

-2947000 -285000 1370000

6000

484000

-1529000

-2014000

1388000

-773000

36265000

46344000

40636000

9835000

5514000

3984000

3000000

260000

-9835000

-8514000

-3724000

4305000

4093000

3568000

92000

36000

469000

493000

332000

446000

1734000

190000

721000

2784000

1950000

27616000

4142000

20961000

9159000

10517000

-55583000

-18162000

-15503000

-182000

3000

-236000

-29335000

19671000

21173000

54361000

34690000

13517000

25026000

54361000

34690000

1342000

1554000

1735000

12233000

10644000

5217000

40000

817000

1109000

979000

127000

311000 1088000 7217000 1950000

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> (1) </td><td style="width: auto;"> Summary of Significant Accounting Policies </td></tr> </tbody></table> Description of Business and Basis of Presentation National Research Corporation, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Our purpose is to humanize healthcare and support organizations in their understanding of each person they serve not as point-in-time insights, but as an ongoing relationship We believe that understanding the story is the key to unlocking the highest-quality and truly personalized care. Our end-to-end solutions enable health care organizations to understand what matters most to each person they serve – before, during, after, and outside of clinical encounters – to gain a longitudinal understanding of how life and health intersect, with the goal of developing lasting, trusting relationships. Our portfolio of solutions represents a unique set of capabilities that individually and collectively provide value to our clients. Principles of Consolidation The consolidated financial statements include the accounts of the Company and our wholly-owned subsidiary, National Research Corporation Canada. All significant intercompany transactions and balances have been eliminated. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Translation of Foreign Currencies Gains and losses related to transactions denominated in a currency other than the functional currency of the country in which we operate and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income. Our Canadian subsidiary uses Canadian dollars as its functional currency. We translate its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. We translate its revenue and expenses at the average exchange rate during the period. We included foreign currency translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. During December 2022, we substantially liquidated our investment in Canada. As a result, we reclassified the cumulative foreign currency translation adjustment balance into earnings and recognized a net cumulative foreign currency translation loss of $2.6 million, which is included in Other income (expense), net in our Consolidated Statements of Income. Any future currency changes, will be recognized in Other income (expense), net in our Consolidated Statements of Income. Revenue Recognition We derive a majority of our revenues from our annually renewable subscription-based service agreements with our customers, which include performance measurement and improvement services, healthcare analytics and governance education services. Such agreements are generally cancelable on short or no notice without penalty. See Note 3 for further information about our contracts with customers. We account for revenue using the following steps: <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Identify the contract, or contracts, with a customer; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Identify the performance obligations in the contract; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Determine the transaction price; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Allocate the transaction price to the identified performance obligations; and </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Recognize revenue when, or as, we satisfy the performance obligations. </td></tr> </tbody></table> Our revenue arrangements with a client may include combinations of more than one service offering which may be executed at the same time, or within close proximity of one another. We combine contracts with the same customer into a single contract for accounting purposes when the contract is entered into at or near the same time and the contracts are negotiated together. For contracts that contain more than one separately identifiable performance obligation, the total transaction price is allocated to the identified performance obligations based upon the relative stand-alone selling prices of the performance obligations. The stand-alone selling prices are based on an observable price for services sold to other comparable customers, when available, or an estimated selling price using a cost-plus margin or residual approach. We estimate the amount of total contract consideration we expect to receive for variable arrangements based on the most likely amount we expect to earn from the arrangement based on the expected quantities of services we expect to provide and the contractual pricing based on those quantities. We only include some or a portion of variable consideration in the transaction price when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. We consider the sensitivity of the estimate, our relationship and experience with the client and variable services being performed, the range of possible revenue amounts and the magnitude of the variable consideration to the overall arrangement. Our revenue arrangements do not contain any significant financing element due to the contract terms and the timing between when consideration is received and when the service is provided. Our arrangements with customers consist principally of four different types of arrangements: 1) subscription-based service agreements; 2) one-time specified services performed at a single point in time; 3) fixed, non-subscription service agreements; and 4) unit-priced service agreements. Subscription-based services - Services that are provided under subscription-based service agreements are usually for a twelve- month period and represent a single promise to stand ready to provide reporting, tools and services throughout the subscription period as requested by the customer. These agreements are renewable at the option of the customer at the completion of the initial contract term for an agreed upon price increase each year. These agreements represent a series of distinct monthly services that are substantially the same, with the same pattern of transfer to the customer as the customer receives and consumes the benefits throughout the contract period. Accordingly, subscription services are recognized ratably over the subscription period. Subscription services are typically billed either annually or quarterly in advance but may also be billed on a monthly basis. One-time services – These agreements typically require us to perform a specific one-time service in a particular month. We are entitled to a fixed payment upon completion of the service. Under these arrangements, we recognize revenue at the point in time we complete the service and it is accepted by the customer. Fixed, non-subscription services – These arrangements typically require us to perform an unspecified amount of services for a fixed price during a fixed period of time. Revenues are recognized over time based upon the costs incurred to date in relation to the total estimated contract costs. In determining cost estimates, management uses historical and forecasted cost information which is based on estimated volumes, external and internal costs and other factors necessary in estimating the total costs over the term of the contract. Changes in estimates are accounted for using a cumulative catch-up adjustment which could impact the amount and timing of revenue for any period. Unit-price services – These arrangements typically require us to perform certain services on a periodic basis as requested by the customer for a per-unit amount which is typically billed in the month following the performance of the service. Revenue under these arrangements is recognized over the time the services are performed at the per-unit amount. Revenue is presented net of any sales tax charged to our clients that we are required to remit to taxing authorities. We recognize contract assets or unbilled receivables related to revenue recognized for services completed but not invoiced to the clients. Unbilled receivables are classified as receivables when we have an unconditional right to contract consideration. A contract liability is recognized as deferred revenue when we invoice clients in advance of performing the related services under the terms of a contract. Deferred revenue is recognized as revenue when we have satisfied the related performance obligation. Deferred Contract Costs Deferred contract costs, net is stated at gross deferred costs less accumulated amortization. We defer commissions and incentives, including payroll taxes, if they are incremental and recoverable costs of obtaining a renewable customer contract. Deferred contract costs are amortized over the estimated term of the contract, including renewals, which generally ranges from three to five years. The contract term was estimated by considering factors such as historical customer attrition rates and product life. The amortization period is adjusted for significant changes in the estimated remaining term of a contract. An impairment of deferred contract costs is recognized when the unamortized balance of deferred contract costs exceeds the remaining amount of consideration we expect to receive net of the expected future costs directly related to providing those services. We have elected the practical expedient to expense contract costs when incurred for any nonrenewable contracts with a term of one year or less. We deferred incremental costs of obtaining a contract of $454,000, $1.9 million and $3.7 million in the years ended December 31, 2022, 2021 and 2020, respectively. Deferred contract costs, net of accumulated amortization was $2.4 million and $3.8 million at December 31, 2022 and 2021, respectively. In 2021 we changed our sales compensation structure, reducing the incremental costs associated with obtaining a contract, decreasing the amount of incremental costs to defer and the balance of deferred contract costs. Total amortization by expense classification for the years ended December 31, 2022, 2021 and 2020 was as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Direct expenses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">146</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">157</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">272</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Selling, general and administrative expenses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,625</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,494</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,970</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total amortization </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,771</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,651</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,242</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> Additional expense included in selling, general and administrative expenses for impairment of costs capitalized due to lost clients was $14,000, $31,000 and $63,000 for the years December 31, 2022, 2021 and 2020, respectively. Trade Accounts Receivable The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable, determined based on our historical write-off experience, current economic conditions and reasonable and supportable forecasts about the future. We review the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The following table provides the activity in the allowance for doubtful accounts for the years ended December 31, 2022, 2021 and 2020 (in thousands): <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Balance at Beginning of Year </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Bad Debt Expense </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Write-offs, net of Recoveries </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Balance at End of Year </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 48%;"> Year Ended December 31, 2020 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">144</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">46</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">70</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">120</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Year Ended December 31, 2021 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">120</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">38</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">64</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">94</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Year Ended December 31, 2022 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">94</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">19</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">48</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">65</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> Property and Equipment Property and equipment is stated at cost. Major expenditures to purchase property or to substantially increase useful lives of property are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income. We capitalize certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software projects and external direct costs of materials and services. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs are expensed as incurred. We capitalized approximately $3.6 million, $2.8 million and $2.7 million of costs incurred for the development of internal-use software for the years ended December 31, 2022, 2021 and 2020, respectively. When a software license is included in a cloud computing arrangement and we have the legal right, ability and feasibility to download the software, it is accounted for as software, included in property and equipment, and amortized. If a software license is not included or we do not have the ability or feasibility to download software included in a cloud computing arrangement, it is accounted for as a service contract, which is expensed to direct expenses or selling, general and administrative expenses during the service period. We provide for depreciation and amortization of property and equipment using annual rates which are sufficient to amortize the cost of depreciable assets over their estimated useful lives. We use the straight-line method of depreciation and amortization over estimated useful lives of two to ten years for furniture and equipment, three to five years for computer equipment, one to five years for capitalized software, and seven to forty years for our office building and related improvements. Software licenses are amortized over the term of the license. Impairment of Long-Lived Assets and Amortizing Intangible Assets Long-lived assets, such as property and equipment and purchased intangible assets subject to depreciation or amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, we first compare undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. No significant impairments were recorded during the years ended December 31, 2022, 2021, or 2020. Among others, management believes the following circumstances are important indicators of potential impairment of such assets and as a result may trigger an impairment review: <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Significant underperformance in comparison to historical or projected operating results; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Significant changes in the manner or use of acquired assets or our overall strategy; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Significant negative trends in our industry or the overall economy; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> A significant decline in the market price for our common stock for a sustained period; and </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Our market capitalization falling below the book value of our net assets. </td></tr> </tbody></table> Goodwill and Intangible Assets Intangible assets include customer relationships, trade names, technology, and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. We review intangible assets with indefinite lives for impairment annually as of October 1 and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. When performing the impairment assessment, we will first assess qualitative factors to determine whether it is necessary to determine the fair value of the intangible assets with indefinite lives. If we believe, as a result of the qualitative assessment, that it is more likely than not that the fair value of an indefinite-lived intangible is less than its carrying amount, we calculate the fair value using a market or income approach. If the carrying value of the indefinite-lived intangible asset exceeds its fair value, then the intangible asset is written-down to its fair value. We did not recognize any impairments related to indefinite-lived intangibles during 2022, 2021 or 2020. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. All of our goodwill is allocated to our reporting unit, which is the same as our operating segment. Goodwill is reviewed for impairment at least annually, as of October 1, and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable. We review goodwill for impairment by first assessing qualitative factors to determine whether any impairment may exist. If we believe, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the carrying value of the reporting unit exceeds the fair value, then goodwill is written down by this difference. We performed a qualitative analysis as of October 1, 2022 and determined the fair value of our reporting unit likely exceeded the carrying value. No impairments were recorded during the years ended December 31, 2022 or 2021. A substantial portion of the revenue earned by our Canadian subsidiary was concentrated with one customer. While the customer exercised its option to extend its existing contract to September 2022, during December 2020 we chose not to enter into a new contract with this customer or otherwise extend the term of the contract beyond September 2022. We closed the Canada office at the end of the contract in September 2022. As a result, we tested for impairment of the then Canada reporting unit’s goodwill at December 31, 2020. We recognized an impairment of $714,000 for the excess of the then Canada reporting unit’s carrying value over the fair value, using discounted cash flows. In March 2021, we changed our operating segments from six to one to reflect a change in the way we operated and managed our business, including changes to our corporate reporting structure to the Company’s Chief Executive Officer and chief operating decision maker. In connection with this change, our previous reporting units were combined into one reporting unit. We performed an interim qualitative analysis immediately before and after the reorganization and concluded that the fair value of our reporting units likely exceeded the carrying values and no impairments were recorded. Following the reorganization, we considered the current and expected future economic and market conditions, including the impact of the COVID-19 pandemic, on our reporting unit. We also assessed our current market capitalization compared to book value, forecasts and margins in our last quantitative impairment testing. We concluded that a triggering event has not occurred which would require an additional interim impairment test to be performed as it is not more likely than not that an impairment loss had been incurred at December 31, 2022. Insurance Recoveries We record insurance recoveries when the realization of the claim is probable. In 2020 we received $3.3 million in insurance recoveries, and $447,000 was paid directly to certain vendors from the insurer related to a cyber-attack in February 2020 (the “February incident”). We recorded $533,000, representing reimbursement for lost revenues, as insurance recoveries, and the remainder as a reduction to operating expenses. Due to insurance recoveries, the February incident did not have a significant impact on our consolidated financial statements. In 2020, we also recorded a gain in other income of $260,000 from insurance recoveries for property damage due to a flooding. Income Taxes We use the asset and liability method of accounting for income taxes. Under that method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances, if any, are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. We use the deferral method of accounting for our investment tax credits related to state tax incentives. During the years ended December 31, 2022, 2021, and 2020, we recorded income tax benefits relating to these tax credits of $36,000, $10,000, and $45,000, respectively. Interest and penalties related to income taxes are included in income taxes in the Consolidated Statements of Income. We recognize the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. In 2021, we adopted ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). Among other clarifications and simplifications related to income tax accounting, this ASU simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, hybrid taxes and the recognition of deferred tax liabilities for outside basis differences. The adoption of this standard had no material impact to our consolidated financial statements. Share-Based Compensation All of our existing stock option awards and non-vested stock awards have been determined to be equity-classified awards. The compensation expense on share-based payments is recognized based on the grant-date fair value of those awards. We recognize the excess tax benefits and tax deficiencies in the income statement when options are exercised. Amounts recognized in the financial statements with respect to these plans are as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Amounts charged against income, before income tax benefit </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,200</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">623</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">680</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Amount of related income tax benefit </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(436</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(919</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(6,764</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net (benefit) expense to net income </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">764</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(296</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(6,084</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td></tr> </tbody></table> We refer to our restricted stock awards as “non-vested” stock in these consolidated financial statements. Cash and Cash Equivalents We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash equivalents were $24.9 million and $6.3 million as of December 31, 2022, and 2021, respectively, consisting primarily of money market accounts. At certain times, cash equivalent balances may exceed federally insured limits. Leases We determine whether a lease is included in an agreement at inception. We recognize a lease liability and a right-of-use (“ROU”) asset on the balance sheet for our operating leases under which we are lessee. Operating lease ROU assets are included in operating lease right-of-use assets in our consolidated balance sheet. Finance lease assets are included in property and equipment. Operating and finance lease liabilities are included in other current liabilities and other long-term liabilities. Certain lease arrangements may include options to extend or terminate the lease. We include these provisions in the ROU asset and lease liabilities only when it is reasonably certain that we will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term and is included in direct expenses and selling, general and administrative expenses. Our lease agreements do not contain any residual value guarantees. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments during the lease term. ROU assets and lease liabilities are recorded at lease commencement based on the estimated present value of lease payments. Because the rate of interest implicit in each lease is not readily determinable, we use our estimated incremental collateralized borrowing rate at lease commencement, to calculate the present value of lease payments. When determining the appropriate incremental borrowing rate, we consider our available credit facilities, recently issued debt and public interest rate information. Due to remote working arrangements, we reassessed our office needs and subleased our Seattle location under an agreement considered to be an operating lease beginning in May 2021. We have not been legally released from our primary obligations under the original lease and therefore we continue to account for the original lease separately. We recorded an ROU asset impairment charge in 2021 of $324,000, which was the amount by which the carrying value of the Seattle office lease ROU asset exceeded the fair value. We estimated the fair value based on the discounted cash flows of estimated net rental income for the office space subleased. The ROU asset impairment charge is included in depreciation, amortization and impairment expenses. There were no ROU asset impairment charges in 2022 or 2020. Rent income from the sublessee are included in the statement of operations on a straight-line basis as an offset to rent expense associated with the original operating lease included in other expenses. Fair Value Measurements Our valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. The inputs are then classified into the following hierarchy: (1) Level 1 Inputs—quoted prices in active markets for identical assets and liabilities; (2) Level 2 Inputs—observable market-based inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar or identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; (3) Level 3 Inputs—unobservable inputs. The following details our financial assets within the fair value hierarchy at December 31, 2022 and 2021: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Level 1 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Level 2 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Level 3 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Total </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="14" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 48%;"> As of December 31, 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Money Market Funds </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">24,927</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">24,927</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total Cash Equivalents </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">24,927</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">24,927</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> As of December 31, 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Money Market Funds </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,306</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,306</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total Cash Equivalents </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,306</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,306</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> There were no transfers between levels during the years ended December 31, 2022 and 2021. Our long-term debt described in Note 8 is recorded at historical cost. The fair value of long-term debt is classified in Level 2 of the fair value hierarchy and was estimated based primarily on estimated current rates available for debt of the same remaining duration and adjusted for nonperformance and credit. The following are the carrying amount and estimated fair values of long-term debt: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 68%;"> Total carrying amount of long-term debt </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">22,315</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">26,620</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Estimated fair value of long-term debt </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">21,668</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">27,708</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> The carrying amounts of accounts receivable, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are not recognized or disclosed at fair value in the financial statements on a recurring basis, which includes ROU assets, property and equipment, goodwill, intangibles and cost method investments, are measured at fair value in certain circumstances (for example, when there is evidence of impairment). We estimated the fair value of the Seattle office ROU asset using discounted cash flows of the sublease based on management’s most recent projections, which are considered level 3 inputs in the fair value hierarchy and recorded an ROU asset impairment charge of $324,000 during 2021. As of December 31, 2022 and 2021, there was no indication of impairment related to these assets. As discussed above, we recognized an impairment of $714,000 for the then Canada reporting unit’s goodwill at December 31, 2020. We estimated the fair value of the Canada reporting unit using discounted cash flows based on management’s most recent projections which are considered level 3 inputs in the fair value hierarchy. Commitments and Contingencies From time to time, we are involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable. Legal fees, net of estimated insurance recoveries, are expensed as incurred. We do not believe the final disposition of claims at December 31, 2022 will have a material adverse effect on our consolidated financial position, results of operations or liquidity. We are self-insured for group medical and dental insurance. We carry excess loss coverage in the amount of $150,000 per covered person per year for group medical insurance. We do not self-insure for any other types of losses, and therefore do not carry any additional excess loss insurance. In addition, we had aggregate claims loss coverage with a minimum aggregate deductible of $4.7 million, $3.2 million and $2.8 million, in 2022, 2021 and 2020, respectively. We record a reserve for our group medical and dental insurance for all unresolved claims and for an estimate of incurred but not reported (“IBNR”) claims. On a quarterly basis, we adjust our accrual based on a review of our claims experience and a third-party actuarial IBNR analysis. As of December 31, 2022 and 2021, our accrual related to self-insurance was $424,000 and $406,000, respectively. Earnings Per Share Basic net income per share was computed using the weighted-average number of common shares outstanding during the period. Diluted net income per share was computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method. We had 83,070, 127,185 and 65,127 options of Common Stock for the years ended December 31, 2022, 2021 and 2020, respectively which have been excluded from the diluted net income per share computation because their inclusion would be anti-dilutive. <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" rowspan="1" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands, except per share data) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Numerator for net income per share - basic: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">31,800</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">37,466</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">37,260</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Allocation of distributed and undistributed income to unvested restricted stock shareholders </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(16</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(18</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(57</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income attributable to common shareholders </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">31,784</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,448</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,203</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Denominator for net income per share - basic: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Weighted average common shares outstanding – basic </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">24,922</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,422</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,170</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income per share – basic </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.28</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.47</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.48</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Numerator for net income per share - diluted: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income attributable to common shareholders for basic computation </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">31,784</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,448</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,203</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Denominator for net income per share - diluted: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Weighted average common shares outstanding – basic </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">24,922</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">25,422</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">25,170</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Weighted average effect of dilutive securities – stock options </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">130</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">218</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">526</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Denominator for diluted earnings per share – adjusted weighted average shares </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,052</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,640</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,696</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income per share – diluted </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.27</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.46</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.45</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table>

Principles of Consolidation The consolidated financial statements include the accounts of the Company and our wholly-owned subsidiary, National Research Corporation Canada. All significant intercompany transactions and balances have been eliminated.

Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Translation of Foreign Currencies Gains and losses related to transactions denominated in a currency other than the functional currency of the country in which we operate and short-term intercompany accounts are included in other income (expense) in the consolidated statements of income. Our Canadian subsidiary uses Canadian dollars as its functional currency. We translate its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. We translate its revenue and expenses at the average exchange rate during the period. We included foreign currency translation gains and losses in accumulated other comprehensive income (loss), a component of shareholders’ equity. During December 2022, we substantially liquidated our investment in Canada. As a result, we reclassified the cumulative foreign currency translation adjustment balance into earnings and recognized a net cumulative foreign currency translation loss of $2.6 million, which is included in Other income (expense), net in our Consolidated Statements of Income. Any future currency changes, will be recognized in Other income (expense), net in our Consolidated Statements of Income.

-2600000

Revenue Recognition We derive a majority of our revenues from our annually renewable subscription-based service agreements with our customers, which include performance measurement and improvement services, healthcare analytics and governance education services. Such agreements are generally cancelable on short or no notice without penalty. See Note 3 for further information about our contracts with customers. We account for revenue using the following steps: <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Identify the contract, or contracts, with a customer; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Identify the performance obligations in the contract; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Determine the transaction price; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Allocate the transaction price to the identified performance obligations; and </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Recognize revenue when, or as, we satisfy the performance obligations. </td></tr> </tbody></table> Our revenue arrangements with a client may include combinations of more than one service offering which may be executed at the same time, or within close proximity of one another. We combine contracts with the same customer into a single contract for accounting purposes when the contract is entered into at or near the same time and the contracts are negotiated together. For contracts that contain more than one separately identifiable performance obligation, the total transaction price is allocated to the identified performance obligations based upon the relative stand-alone selling prices of the performance obligations. The stand-alone selling prices are based on an observable price for services sold to other comparable customers, when available, or an estimated selling price using a cost-plus margin or residual approach. We estimate the amount of total contract consideration we expect to receive for variable arrangements based on the most likely amount we expect to earn from the arrangement based on the expected quantities of services we expect to provide and the contractual pricing based on those quantities. We only include some or a portion of variable consideration in the transaction price when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. We consider the sensitivity of the estimate, our relationship and experience with the client and variable services being performed, the range of possible revenue amounts and the magnitude of the variable consideration to the overall arrangement. Our revenue arrangements do not contain any significant financing element due to the contract terms and the timing between when consideration is received and when the service is provided. Our arrangements with customers consist principally of four different types of arrangements: 1) subscription-based service agreements; 2) one-time specified services performed at a single point in time; 3) fixed, non-subscription service agreements; and 4) unit-priced service agreements. Subscription-based services - Services that are provided under subscription-based service agreements are usually for a twelve- month period and represent a single promise to stand ready to provide reporting, tools and services throughout the subscription period as requested by the customer. These agreements are renewable at the option of the customer at the completion of the initial contract term for an agreed upon price increase each year. These agreements represent a series of distinct monthly services that are substantially the same, with the same pattern of transfer to the customer as the customer receives and consumes the benefits throughout the contract period. Accordingly, subscription services are recognized ratably over the subscription period. Subscription services are typically billed either annually or quarterly in advance but may also be billed on a monthly basis. One-time services – These agreements typically require us to perform a specific one-time service in a particular month. We are entitled to a fixed payment upon completion of the service. Under these arrangements, we recognize revenue at the point in time we complete the service and it is accepted by the customer. Fixed, non-subscription services – These arrangements typically require us to perform an unspecified amount of services for a fixed price during a fixed period of time. Revenues are recognized over time based upon the costs incurred to date in relation to the total estimated contract costs. In determining cost estimates, management uses historical and forecasted cost information which is based on estimated volumes, external and internal costs and other factors necessary in estimating the total costs over the term of the contract. Changes in estimates are accounted for using a cumulative catch-up adjustment which could impact the amount and timing of revenue for any period. Unit-price services – These arrangements typically require us to perform certain services on a periodic basis as requested by the customer for a per-unit amount which is typically billed in the month following the performance of the service. Revenue under these arrangements is recognized over the time the services are performed at the per-unit amount. Revenue is presented net of any sales tax charged to our clients that we are required to remit to taxing authorities. We recognize contract assets or unbilled receivables related to revenue recognized for services completed but not invoiced to the clients. Unbilled receivables are classified as receivables when we have an unconditional right to contract consideration. A contract liability is recognized as deferred revenue when we invoice clients in advance of performing the related services under the terms of a contract. Deferred revenue is recognized as revenue when we have satisfied the related performance obligation.

Deferred Contract Costs Deferred contract costs, net is stated at gross deferred costs less accumulated amortization. We defer commissions and incentives, including payroll taxes, if they are incremental and recoverable costs of obtaining a renewable customer contract. Deferred contract costs are amortized over the estimated term of the contract, including renewals, which generally ranges from three to five years. The contract term was estimated by considering factors such as historical customer attrition rates and product life. The amortization period is adjusted for significant changes in the estimated remaining term of a contract. An impairment of deferred contract costs is recognized when the unamortized balance of deferred contract costs exceeds the remaining amount of consideration we expect to receive net of the expected future costs directly related to providing those services. We have elected the practical expedient to expense contract costs when incurred for any nonrenewable contracts with a term of one year or less. We deferred incremental costs of obtaining a contract of $454,000, $1.9 million and $3.7 million in the years ended December 31, 2022, 2021 and 2020, respectively. Deferred contract costs, net of accumulated amortization was $2.4 million and $3.8 million at December 31, 2022 and 2021, respectively. In 2021 we changed our sales compensation structure, reducing the incremental costs associated with obtaining a contract, decreasing the amount of incremental costs to defer and the balance of deferred contract costs. Total amortization by expense classification for the years ended December 31, 2022, 2021 and 2020 was as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Direct expenses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">146</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">157</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">272</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Selling, general and administrative expenses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,625</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,494</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,970</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total amortization </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,771</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,651</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,242</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> Additional expense included in selling, general and administrative expenses for impairment of costs capitalized due to lost clients was $14,000, $31,000 and $63,000 for the years December 31, 2022, 2021 and 2020, respectively.

454000 1900000 3700000

2400000

3800000

146000

157000

272000

1625000

2494000

2970000

1771000

2651000

3242000

14000

31000

63000

Trade Accounts Receivable The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable, determined based on our historical write-off experience, current economic conditions and reasonable and supportable forecasts about the future. We review the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The following table provides the activity in the allowance for doubtful accounts for the years ended December 31, 2022, 2021 and 2020 (in thousands): <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Balance at Beginning of Year </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Bad Debt Expense </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Write-offs, net of Recoveries </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Balance at End of Year </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 48%;"> Year Ended December 31, 2020 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">144</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">46</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">70</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">120</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Year Ended December 31, 2021 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">120</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">38</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">64</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">94</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Year Ended December 31, 2022 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">94</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">19</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">48</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">65</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table>

144000

46000

70000

120000

38000

64000

94000

19000

48000

65000

Property and Equipment Property and equipment is stated at cost. Major expenditures to purchase property or to substantially increase useful lives of property are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. When assets are retired or otherwise disposed of, their costs and related accumulated depreciation are removed from the accounts and resulting gains or losses are included in income. We capitalize certain costs incurred in connection with obtaining or developing internal-use software, including payroll and payroll-related costs for employees who are directly associated with the internal-use software projects and external direct costs of materials and services. Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose. Costs incurred during the preliminary project and post-implementation stages, as well as software maintenance and training costs are expensed as incurred. We capitalized approximately $3.6 million, $2.8 million and $2.7 million of costs incurred for the development of internal-use software for the years ended December 31, 2022, 2021 and 2020, respectively. When a software license is included in a cloud computing arrangement and we have the legal right, ability and feasibility to download the software, it is accounted for as software, included in property and equipment, and amortized. If a software license is not included or we do not have the ability or feasibility to download software included in a cloud computing arrangement, it is accounted for as a service contract, which is expensed to direct expenses or selling, general and administrative expenses during the service period. We provide for depreciation and amortization of property and equipment using annual rates which are sufficient to amortize the cost of depreciable assets over their estimated useful lives. We use the straight-line method of depreciation and amortization over estimated useful lives of two to ten years for furniture and equipment, three to five years for computer equipment, one to five years for capitalized software, and seven to forty years for our office building and related improvements. Software licenses are amortized over the term of the license.

3600000

2800000

2700000

Impairment of Long-Lived Assets and Amortizing Intangible Assets Long-lived assets, such as property and equipment and purchased intangible assets subject to depreciation or amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, we first compare undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. No significant impairments were recorded during the years ended December 31, 2022, 2021, or 2020. Among others, management believes the following circumstances are important indicators of potential impairment of such assets and as a result may trigger an impairment review: <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Significant underperformance in comparison to historical or projected operating results; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Significant changes in the manner or use of acquired assets or our overall strategy; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Significant negative trends in our industry or the overall economy; </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> A significant decline in the market price for our common stock for a sustained period; and </td></tr> <tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> ● </td><td style="width: auto;"> Our market capitalization falling below the book value of our net assets. </td></tr> </tbody></table>

Goodwill and Intangible Assets Intangible assets include customer relationships, trade names, technology, and goodwill. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. We review intangible assets with indefinite lives for impairment annually as of October 1 and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. When performing the impairment assessment, we will first assess qualitative factors to determine whether it is necessary to determine the fair value of the intangible assets with indefinite lives. If we believe, as a result of the qualitative assessment, that it is more likely than not that the fair value of an indefinite-lived intangible is less than its carrying amount, we calculate the fair value using a market or income approach. If the carrying value of the indefinite-lived intangible asset exceeds its fair value, then the intangible asset is written-down to its fair value. We did not recognize any impairments related to indefinite-lived intangibles during 2022, 2021 or 2020. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. All of our goodwill is allocated to our reporting unit, which is the same as our operating segment. Goodwill is reviewed for impairment at least annually, as of October 1, and whenever events or changes in circumstances indicate that the carrying value of goodwill may not be recoverable. We review goodwill for impairment by first assessing qualitative factors to determine whether any impairment may exist. If we believe, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative analysis will be performed, and the fair value of the reporting unit is compared with its carrying value (including goodwill). If the carrying value of the reporting unit exceeds the fair value, then goodwill is written down by this difference. We performed a qualitative analysis as of October 1, 2022 and determined the fair value of our reporting unit likely exceeded the carrying value. No impairments were recorded during the years ended December 31, 2022 or 2021. A substantial portion of the revenue earned by our Canadian subsidiary was concentrated with one customer. While the customer exercised its option to extend its existing contract to September 2022, during December 2020 we chose not to enter into a new contract with this customer or otherwise extend the term of the contract beyond September 2022. We closed the Canada office at the end of the contract in September 2022. As a result, we tested for impairment of the then Canada reporting unit’s goodwill at December 31, 2020. We recognized an impairment of $714,000 for the excess of the then Canada reporting unit’s carrying value over the fair value, using discounted cash flows. In March 2021, we changed our operating segments from six to one to reflect a change in the way we operated and managed our business, including changes to our corporate reporting structure to the Company’s Chief Executive Officer and chief operating decision maker. In connection with this change, our previous reporting units were combined into one reporting unit. We performed an interim qualitative analysis immediately before and after the reorganization and concluded that the fair value of our reporting units likely exceeded the carrying values and no impairments were recorded. Following the reorganization, we considered the current and expected future economic and market conditions, including the impact of the COVID-19 pandemic, on our reporting unit. We also assessed our current market capitalization compared to book value, forecasts and margins in our last quantitative impairment testing. We concluded that a triggering event has not occurred which would require an additional interim impairment test to be performed as it is not more likely than not that an impairment loss had been incurred at December 31, 2022.

714000

Insurance Recoveries We record insurance recoveries when the realization of the claim is probable. In 2020 we received $3.3 million in insurance recoveries, and $447,000 was paid directly to certain vendors from the insurer related to a cyber-attack in February 2020 (the “February incident”). We recorded $533,000, representing reimbursement for lost revenues, as insurance recoveries, and the remainder as a reduction to operating expenses. Due to insurance recoveries, the February incident did not have a significant impact on our consolidated financial statements. In 2020, we also recorded a gain in other income of $260,000 from insurance recoveries for property damage due to a flooding.

3300000

447000

533000

260000

Income Taxes We use the asset and liability method of accounting for income taxes. Under that method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances, if any, are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized. We use the deferral method of accounting for our investment tax credits related to state tax incentives. During the years ended December 31, 2022, 2021, and 2020, we recorded income tax benefits relating to these tax credits of $36,000, $10,000, and $45,000, respectively. Interest and penalties related to income taxes are included in income taxes in the Consolidated Statements of Income. We recognize the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. In 2021, we adopted ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). Among other clarifications and simplifications related to income tax accounting, this ASU simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, hybrid taxes and the recognition of deferred tax liabilities for outside basis differences. The adoption of this standard had no material impact to our consolidated financial statements.

36000

10000

45000

Share-Based Compensation All of our existing stock option awards and non-vested stock awards have been determined to be equity-classified awards. The compensation expense on share-based payments is recognized based on the grant-date fair value of those awards. We recognize the excess tax benefits and tax deficiencies in the income statement when options are exercised. Amounts recognized in the financial statements with respect to these plans are as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Amounts charged against income, before income tax benefit </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,200</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">623</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">680</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Amount of related income tax benefit </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(436</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(919</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(6,764</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net (benefit) expense to net income </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">764</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(296</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(6,084</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td></tr> </tbody></table> We refer to our restricted stock awards as “non-vested” stock in these consolidated financial statements.

1200000

623000

680000

436000

919000

6764000

764000

-296000

-6084000

Cash and Cash Equivalents We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash equivalents were $24.9 million and $6.3 million as of December 31, 2022, and 2021, respectively, consisting primarily of money market accounts. At certain times, cash equivalent balances may exceed federally insured limits.

24900000

6300000

Leases We determine whether a lease is included in an agreement at inception. We recognize a lease liability and a right-of-use (“ROU”) asset on the balance sheet for our operating leases under which we are lessee. Operating lease ROU assets are included in operating lease right-of-use assets in our consolidated balance sheet. Finance lease assets are included in property and equipment. Operating and finance lease liabilities are included in other current liabilities and other long-term liabilities. Certain lease arrangements may include options to extend or terminate the lease. We include these provisions in the ROU asset and lease liabilities only when it is reasonably certain that we will exercise that option. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term and is included in direct expenses and selling, general and administrative expenses. Our lease agreements do not contain any residual value guarantees. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments during the lease term. ROU assets and lease liabilities are recorded at lease commencement based on the estimated present value of lease payments. Because the rate of interest implicit in each lease is not readily determinable, we use our estimated incremental collateralized borrowing rate at lease commencement, to calculate the present value of lease payments. When determining the appropriate incremental borrowing rate, we consider our available credit facilities, recently issued debt and public interest rate information. Due to remote working arrangements, we reassessed our office needs and subleased our Seattle location under an agreement considered to be an operating lease beginning in May 2021. We have not been legally released from our primary obligations under the original lease and therefore we continue to account for the original lease separately. We recorded an ROU asset impairment charge in 2021 of $324,000, which was the amount by which the carrying value of the Seattle office lease ROU asset exceeded the fair value. We estimated the fair value based on the discounted cash flows of estimated net rental income for the office space subleased. The ROU asset impairment charge is included in depreciation, amortization and impairment expenses. There were no ROU asset impairment charges in 2022 or 2020. Rent income from the sublessee are included in the statement of operations on a straight-line basis as an offset to rent expense associated with the original operating lease included in other expenses.

324000

Fair Value Measurements Our valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. The inputs are then classified into the following hierarchy: (1) Level 1 Inputs—quoted prices in active markets for identical assets and liabilities; (2) Level 2 Inputs—observable market-based inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar or identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; (3) Level 3 Inputs—unobservable inputs. The following details our financial assets within the fair value hierarchy at December 31, 2022 and 2021: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Level 1 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Level 2 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Level 3 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Total </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="14" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 48%;"> As of December 31, 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Money Market Funds </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">24,927</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">24,927</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total Cash Equivalents </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">24,927</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">24,927</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> As of December 31, 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Money Market Funds </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,306</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">6,306</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total Cash Equivalents </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,306</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">6,306</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> There were no transfers between levels during the years ended December 31, 2022 and 2021. Our long-term debt described in Note 8 is recorded at historical cost. The fair value of long-term debt is classified in Level 2 of the fair value hierarchy and was estimated based primarily on estimated current rates available for debt of the same remaining duration and adjusted for nonperformance and credit. The following are the carrying amount and estimated fair values of long-term debt: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 68%;"> Total carrying amount of long-term debt </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">22,315</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">26,620</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Estimated fair value of long-term debt </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">21,668</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">27,708</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> The carrying amounts of accounts receivable, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are not recognized or disclosed at fair value in the financial statements on a recurring basis, which includes ROU assets, property and equipment, goodwill, intangibles and cost method investments, are measured at fair value in certain circumstances (for example, when there is evidence of impairment). We estimated the fair value of the Seattle office ROU asset using discounted cash flows of the sublease based on management’s most recent projections, which are considered level 3 inputs in the fair value hierarchy and recorded an ROU asset impairment charge of $324,000 during 2021. As of December 31, 2022 and 2021, there was no indication of impairment related to these assets. As discussed above, we recognized an impairment of $714,000 for the then Canada reporting unit’s goodwill at December 31, 2020. We estimated the fair value of the Canada reporting unit using discounted cash flows based on management’s most recent projections which are considered level 3 inputs in the fair value hierarchy.

24927000

6306000

22315000

26620000

21668000

27708000

324000

714000

Commitments and Contingencies From time to time, we are involved in certain claims and litigation arising in the normal course of business. Management assesses the probability of loss for such contingencies and recognizes a liability when a loss is probable and estimable. Legal fees, net of estimated insurance recoveries, are expensed as incurred. We do not believe the final disposition of claims at December 31, 2022 will have a material adverse effect on our consolidated financial position, results of operations or liquidity. We are self-insured for group medical and dental insurance. We carry excess loss coverage in the amount of $150,000 per covered person per year for group medical insurance. We do not self-insure for any other types of losses, and therefore do not carry any additional excess loss insurance. In addition, we had aggregate claims loss coverage with a minimum aggregate deductible of $4.7 million, $3.2 million and $2.8 million, in 2022, 2021 and 2020, respectively. We record a reserve for our group medical and dental insurance for all unresolved claims and for an estimate of incurred but not reported (“IBNR”) claims. On a quarterly basis, we adjust our accrual based on a review of our claims experience and a third-party actuarial IBNR analysis. As of December 31, 2022 and 2021, our accrual related to self-insurance was $424,000 and $406,000, respectively.

150000 4700000 3200000 2800000

424000

406000

Earnings Per Share Basic net income per share was computed using the weighted-average number of common shares outstanding during the period. Diluted net income per share was computed using the weighted-average number of common shares and, if dilutive, the potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and vesting of restricted stock. The dilutive effect of outstanding stock options is reflected in diluted earnings per share by application of the treasury stock method. We had 83,070, 127,185 and 65,127 options of Common Stock for the years ended December 31, 2022, 2021 and 2020, respectively which have been excluded from the diluted net income per share computation because their inclusion would be anti-dilutive. <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" rowspan="1" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands, except per share data) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Numerator for net income per share - basic: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">31,800</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">37,466</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">37,260</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Allocation of distributed and undistributed income to unvested restricted stock shareholders </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(16</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(18</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(57</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income attributable to common shareholders </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">31,784</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,448</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,203</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Denominator for net income per share - basic: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Weighted average common shares outstanding – basic </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">24,922</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,422</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,170</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income per share – basic </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.28</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.47</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.48</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Numerator for net income per share - diluted: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income attributable to common shareholders for basic computation </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">31,784</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,448</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,203</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Denominator for net income per share - diluted: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Weighted average common shares outstanding – basic </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">24,922</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">25,422</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">25,170</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Weighted average effect of dilutive securities – stock options </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">130</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">218</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">526</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Denominator for diluted earnings per share – adjusted weighted average shares </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,052</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,640</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25,696</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net income per share – diluted </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.27</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.46</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.45</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table>

83070 127185 65127

31800000

37466000

37260000

16000

18000

57000

31784000

37448000

37203000

24922000

25422000

25170000

1.28

1.47

1.48

31784000

37448000

37203000

24922000

25422000

25170000

130000

218000

526000

25052000

25640000

25696000

1.27

1.46

1.45

3000000.0

5000000.0

2000000.0

184000

10000

100000

600000

4340000

5234000

284000

4950000

P5Y

119000

141981000

137008000

122499000

4231000

3216000

2932000

3134000

3065000

2907000

2222000

4665000

4939000

151568000

147954000

133277000

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> Accounts receivables </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">14,461</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">13,728</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Contract assets included in other current assets </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">102</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">99</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred revenue </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">15,198</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">17,213</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Contract Asset </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Deferred Revenue </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Contract Asset </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Deferred Revenue </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="14" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Increase (Decrease) </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 48%;"> Revenue recognized that was included in deferred revenue at beginning of year due to completion of services </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(17,170</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(15,631</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Increases due to invoicing of client, net of amounts recognized as revenue </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">15,081</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">16,694</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Decreases due to completion of services (or portion of services) and transferred to accounts receivable </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(99</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(311</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Change due to cumulative catch-up adjustments arising from changes in expected contract consideration </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">74</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">326</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Increases due to revenue recognized in the period with additional performance obligations before invoicing </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">102</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">99</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 10%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">-</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table>

14461000

13728000

102000

99000

15198000

17213000

17170000 15631000 15081000 16694000

99000

311000

74000

326000

102000 99000

1600000

972000

621000

15000

1300000

0.138

4753000

4901000

2639000

2672000

29876000

27828000

12561000

9271000

502000

425000

50756000

45599000

33508000

33208000

17248000

12391000

5100000

5700000

6500000

216000

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 27pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Gross </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Accumulated Impairment </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Net </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Goodwill </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">62,328</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(714</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">61,614</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 27pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 9%;"> Useful Life </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> Gross </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> Accumulated Amortization </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> Net </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 9%;"> (In years) </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 1%;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Non-amortizing intangible assets: </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Indefinite trade name </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,191</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,191</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Amortizing intangible assets: </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Customer related </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 6%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">5</td><td style="width: 2%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; text-align: center;">-</td><td style="width: 6%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">15</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">9,192</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">9,132</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">60</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Technology </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 6%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3</td><td style="width: 2%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; text-align: center;">-</td><td style="width: 6%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">7</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,959</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,599</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">360</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Trade names </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="width: 2%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; text-align: center;">10</td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,572</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,572</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Total amortizing intangible assets </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">12,723</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">12,303</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">420</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Total intangible assets other than goodwill </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">13,914</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,303</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,611</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 27pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Gross </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Accumulated Impairment </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Net </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Goodwill </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">62,328</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(714</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">61,614</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 27pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 9%;"> Useful Life </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> Gross </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> Accumulated Amortization </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> Net </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 9%;"> (In years) </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; width: 1%;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Non-amortizing intangible assets: </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Indefinite trade name </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,191</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,191</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Amortizing intangible assets: </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 12%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Customer related </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 6%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">5</td><td style="width: 2%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; text-align: center;">-</td><td style="width: 6%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">15</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">9,445</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">9,325</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">120</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Technology </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 6%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3</td><td style="width: 2%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; text-align: center;">-</td><td style="width: 6%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">7</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,959</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,480</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">479</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Trade names </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 6%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 2%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; text-align: center;">10</td><td style="width: 6%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,572</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,572</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Total amortizing intangible assets </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">12,976</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">12,377</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">599</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 38%;"> Total intangible assets other than goodwill </td><td style="font-family: "Times New Roman"; font-size: 10pt; width: 1%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 2%;"> </td><td style="text-align: right; font-family: "Times New Roman"; font-size: 10pt; width: 6%;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; width: 1%;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">14,167</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">12,377</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,790</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table>

62328000

714000

61614000

1191000

P5Y

P15Y

9192000

9132000

60000

P3Y

P7Y

1959000

1599000

360000

P10Y

1572000

12723000

12303000

420000

13914000

12303000

1611000

62328000

714000

61614000

1191000

P5Y

P15Y

9445000

9325000

120000

P3Y

P7Y

1959000

1480000

479000

P10Y

1572000

12976000

12377000

599000

14167000

12377000

1790000

57255000

4340000

19000

61614000

714000

180000

320000

318000

140000

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 27pt;"> (7) </td><td style="width: auto;"> Income Taxes </td></tr> </tbody></table> For the years ended December 31, 2022, 2021, and 2020, income before income taxes consists of the following: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 54pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> U.S. Operations </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">43,156</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">48,145</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">41,357</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Foreign Operations </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(341</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">476</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">110</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Income before income taxes </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">42,815</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">48,621</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">41,467</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> Income tax expense consisted of the following components: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 54pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> Federal: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Current </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">9,988</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">9,092</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3,546</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,427</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(224</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(308</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">8,561</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">8,868</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,238</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Foreign: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Current </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(90</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">143</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">225</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(17</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(6</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(90</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">126</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">219</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> State: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Current </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,846</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,197</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">578</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(302</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(36</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">172</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,544</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,161</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">750</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,015</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,155</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,207</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> As a result of the Tax Cuts and Jobs Act (the “Tax Act”), we determined that we would no longer indefinitely reinvest the earnings of our Canadian subsidiary. Our Canadian subsidiary declared a deemed dividend to the Company for $1.4 million and $9.6 million in 2022 and 2020, respectively. Additionally, a withholding tax of 5% was paid for the dividend distribution. Due to the closure of the Canadian office, we also processed a return of capital from the Canadian subsidiary to the Company of $1.2 million. We qualify for tax incentives through the Nebraska Advantage LB312 Act (“NAA”). The NAA provides direct refunds of sales tax on qualified property, as well as investment credits and employment credits that can be claimed through credits of Nebraska income tax, employment tax, and sales tax on non-qualified property. For the year ended December 31, 2022, 2021 and 2020, adjustments for credits reduced operating expenses by approximately $510,000, $473,000 and $435,000, respectively. In addition, income tax credits of $36,000, $10,000 and $45,000 were recorded as a reduction to income tax expense for the years ended December 31, 2022, 2021 and 2020, respectively. The differences between income taxes expected at the U.S. federal statutory income tax rate of 21 percent and the reported income tax (benefit) expense are summarized as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 54pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> Expected federal income taxes </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">8,991</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">10,210</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">8,708</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Foreign tax rate differential </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(24</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">26</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">6</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> State income taxes, net of federal benefit and state tax credits </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,100</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,531</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">607</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Share-based compensation </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(120</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(660</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(5,713</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Compensation limit for covered employees </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">463</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Federal tax credits </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(408</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(272</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(261</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Uncertain tax positions </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">22</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">254</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">157</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Reclassification of cumulative translation adjustment into earnings </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">539</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Goodwill Impairment </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">184</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Withholding tax on repatriation of foreign earnings </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(100</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">8</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">18</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> GILTI </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">10</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Other </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">15</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">58</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">28</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,015</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,155</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,207</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> Deferred tax assets and liabilities at December 31, 2022 and 2021, were comprised of the following: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 54pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> Deferred tax assets: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Allowance for doubtful accounts </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">16</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">24</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Accrued expenses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">691</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">687</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Share-based compensation </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,072</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">740</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Accrued bonuses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">96</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">267</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Employer payroll tax deferral </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">200</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Uncertain tax positions </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">256</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">161</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Research & experimental expenditures </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">856</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Other </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">78</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">66</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Gross deferred tax assets </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3,065</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,145</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Less valuation allowance </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred tax assets </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,065</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,145</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred tax liabilities: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Prepaid expenses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">135</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">89</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred contract costs </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">601</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">945</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Property and equipment </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,066</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,579</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Intangible assets </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">6,523</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">6,338</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Repatriation withholding </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">182</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred tax liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">8,325</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">9,133</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net deferred tax liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(5,260</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(6,988</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td></tr> </tbody></table> In March 27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The CARES Act is an emergency economic stimulus package in response to the coronavirus outbreak which, among other things, contains numerous income tax provisions. As a result of the CARES Act, we had deferred $1.3 million of employer social security tax payments as of December 31, 2020. In accordance with the CARES Act, we paid half of this liability in December 2021, and paid the remaining $656,000 in December 2022. We have had no other impacts to our consolidated financial statements or related disclosures from the CARES Act. On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into U.S. law. The IRA includes implementation of a new alternative minimum tax, an excise tax on stock buybacks, and significant tax incentives for energy and climate initiatives, among other provisions. After evaluating the provisions included under the IRA, the Company does not expect the provisions to have a material impact to the Company’s consolidated financial statements. In assessing the realizability of deferred tax assets, we consider whether it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. We consider projected future taxable income, carry-back opportunities, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods which the deferred tax assets are deductible, we believe it is more likely than not that we will realize the benefits of these deductible differences excluding the foreign tax credit carryforward. In 2020, we wrote off the deferred tax asset for prior year foreign tax credit carryforwards of $535,000 and the related valuation allowance. We made the assessment that due to our Canadian subsidiary’s decreased projected future income and the lower US tax rate compared to the Canadian tax rate, it was unlikely we would realize this asset. The Tax Act amended Section 174 rules for the federal tax treatment of research or experimental (“R&E”) expenditures paid or incurred during the taxable year. The new Section 174 rules require taxpayers to capitalize and amortize specified R&E expenditures over a period of five years (attributable to domestic research) or 15 years (attributable to foreign research), beginning with the midpoint of the taxable year in which the expenses are paid or incurred. Software development costs are expressly included in the definition of specified R&E expenditures after 2021. Due to this change in legislation the Company has deferred costs of $3.5 million for tax purposes, resulting in a deferred tax asset of $856,000 at December 31, 2022. The Company also recorded a deferred tax asset of $52,000 related to software development costs included in the overall fixed asset deferred tax liability. We had an unrecognized tax benefit at December 31, 2022 and 2021, of $1.6 million and $1.1 million, respectively, excluding interest of $25,000 and $19,000 at December 31, 2022 and 2021, respectively. Of these amounts, $1.3 million and $918,000 at December 31, 2022 and 2021, respectively, represents the net unrecognized tax benefits that, if recognized, would favorably impact the effective income tax rate. The change in the unrecognized tax benefits for 2022 and 2021 was as follows: <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 84%;"> Balance of unrecognized tax benefits at December 31, 2020 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">768</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Reductions due to lapse of applicable statute of limitations </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(38</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Reductions due to tax positions of prior years </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Reductions due to settlement with taxing authorities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Additions based on tax positions related to the current year </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">345</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Balance of unrecognized tax benefits at December 31, 2021 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,075</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Reductions due to lapse of applicable statute of limitations </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(76</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Additions due to tax positions of prior years </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Reductions due to settlement with taxing authorities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Additions based on tax positions related to the current year </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">558</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Balance of unrecognized tax benefits at December 31, 2022 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,557</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> We file income tax returns in the U.S. federal jurisdiction, various state jurisdictions, and Canada federal and provincial jurisdictions. Tax years 2019 and forward remain subject to U.S. federal examination. Tax years 2016 and forward remain subject to state examination. Tax years 2018 and forward remain subject to Canadian federal and provincial examination.

43156000

48145000

41357000

-341000

476000

110000

42815000

48621000

41467000

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 54pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> Federal: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Current </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">9,988</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">9,092</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3,546</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,427</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(224</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(308</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">8,561</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">8,868</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,238</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Foreign: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Current </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(90</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">143</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">225</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(17</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(6</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(90</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">126</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">219</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> State: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Current </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,846</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,197</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">578</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(302</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(36</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">172</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,544</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,161</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">750</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,015</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,155</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,207</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table>

9988000

9092000

3546000

-1427000

-224000

-308000

8561000

8868000

3238000

-90000

143000

225000

-17000

-6000

-90000

126000

219000

2846000

2197000

578000

-302000

-36000

172000

2544000

2161000

750000

11015000

11155000

4207000

1400000 9600000 0.05 1200000 510000 473000 435000

36000

10000

45000

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 54pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="10" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 49%;"> Expected federal income taxes </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">8,991</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">10,210</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">8,708</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Foreign tax rate differential </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(24</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">26</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">6</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> State income taxes, net of federal benefit and state tax credits </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,100</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,531</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">607</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Share-based compensation </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(120</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(660</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(5,713</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Compensation limit for covered employees </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">463</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Federal tax credits </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(408</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(272</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(261</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Uncertain tax positions </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">22</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">254</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">157</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Reclassification of cumulative translation adjustment into earnings </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">539</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Goodwill Impairment </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">184</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr class="GFJY4-DIN-com-rdg-thunderdome-client-resources-CssResource-html-element-highlighted" style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Withholding tax on repatriation of foreign earnings </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">(100</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">8</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">18</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> GILTI </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">10</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Other </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">15</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">58</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">28</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,015</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,155</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,207</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table>

8991000

10210000

8708000

-24000

26000

6000

2100000

1531000

607000

-120000

-660000

-5713000

0 0 463000

408000

272000

261000

22000 254000 157000 539000 0 0

184000

-100000 8000 18000 0 0 10000

15000

58000

28000

11015000

11155000

4207000

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 54pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> (In thousands) </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 66%;"> Deferred tax assets: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Allowance for doubtful accounts </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">16</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">24</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Accrued expenses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">691</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">687</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Share-based compensation </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,072</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">740</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Accrued bonuses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">96</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">267</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Employer payroll tax deferral </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">200</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Uncertain tax positions </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">256</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">161</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Research & experimental expenditures </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">856</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Other </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">78</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">66</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Gross deferred tax assets </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3,065</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2,145</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Less valuation allowance </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred tax assets </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,065</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,145</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred tax liabilities: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Prepaid expenses </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">135</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">89</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred contract costs </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">601</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">945</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Property and equipment </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,066</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,579</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Intangible assets </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">6,523</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">6,338</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Repatriation withholding </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">182</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Deferred tax liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">8,325</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">9,133</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Net deferred tax liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(5,260</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(6,988</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> ) </td></tr> </tbody></table>

16000

24000

691000

687000

1072000

740000

96000

267000

0 200000 256000 161000 856000 0

78000

66000

3065000

2145000

3065000

2145000

135000

89000

601000 945000

1066000

1579000

6523000

6338000

0 182000

8325000

9133000

5260000

6988000

1300000 656000 535000 P15Y 3500000 856000 52000

1600000

1100000

25000

19000

1300000

918000

768000

38000

345000

1075000

76000

558000

1557000

22315000

26620000

4491000

4278000

134000

73000

17690000

22269000

30000000

23412383

75000000

462988

0.05

0.0235

0.0610

0.0020

5500000

4529000

4762000

5011000

5271000

2742000

3000000

100000

707862

2292138

1800000

751778

1048222

127227

101091

70471

<table cellpadding="0" cellspacing="0" class="finTable" style="margin-right: auto; width: 90%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 36pt;"><tbody><tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 46%;"> Expected dividend yield at date of grant </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">3.39</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">2.15</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">1.84</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Expected stock price volatility </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">35.52</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">34.85</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">33.62</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Risk-free interest rate </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">2.33</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">0.91</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">1.35</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> % </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"><td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> Expected life of options (in years) </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">6.3</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">7.01</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">7.39</td><td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table>

0.0339

0.0215

0.0184

0.3552

0.3485

0.3362

0.0233

0.0091

0.0135

P6Y3M18D

P7Y3D

P7Y4M20D

477640

30.88

127227

36.67

23581

13.17

581286

32.86

P5Y5M8D

4739000

323140

26.97

P3Y6M18D

4369000

9.43

12.55

18.67

648000

3535000

25912000

4369000 4805000 1965000

1200000

P2Y7M17D

446000

1700000

1100000

607000

680000

160000

862000

6300000

12698

109000

17000

23000

235000

12698

42.92

-0

12698

42.92

327000

P3Y

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 27pt;"> (10) </td> <td style="width: auto;"> Leases </td> </tr> </tbody> </table> We lease printing, computer, other equipment and office space in the United States and Canada. The leases remaining terms as of December 31, 2022 range from less than one year to 3.93 years. Certain equipment and office lease agreements include provisions for periodic adjustments to rates and charges. The rates and charges are adjusted based on actual usage or actual costs for internet, common area maintenance, taxes or insurance, as determined by the lessor and are considered variable lease costs. The components of lease expense for the years ended December 31, 2022, 2021 and 2020 included (in thousands): <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Operating leases </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">527</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">669</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">600</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Finance leases: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Asset amortization </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">462</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">489</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">355</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Interest on lease liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">19</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">34</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">37</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Variable lease cost </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">95</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">99</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">62</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Short-term lease cost </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">87</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">59</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">42</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Sublease income </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(123</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(81</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> ) </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total net lease cost </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,067</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,269</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,096</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> In 2020, we adjusted the useful life of the operating right of use assets associated with our Atlanta, Georgia and Markham, Ontario office leases based on the expectation that we will vacate the office space before the end of the lease term. Supplemental balance sheet information related to leases (in thousands): <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 36pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 68%;"> Operating leases: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Operating ROU assets </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">556</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">975</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Current operating lease liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">522</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">493</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Noncurrent operating lease liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">333</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">820</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total operating lease liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">855</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,313</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 36pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> December 31, 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 68%;"> Finance leases: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Furniture and equipment </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,042</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,042</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Computer Equipment </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">659</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">659</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Computer Software </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">207</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">207</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Property and equipment under finance lease, gross </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,908</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1,908</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Less accumulated amortization </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,537</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,074</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Property and equipment under finance lease, net </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">371</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">834</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Current obligations of finance leases </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">311</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">470</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Noncurrent obligations of finance leases </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">39</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">348</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total finance lease liabilities </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">350</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">818</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Weighted average remaining lease term (in years): </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Operating leases </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1.95</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">2.80</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Finance leases </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1.15</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">1.93</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Weighted average discount rate: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Operating leases </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3.97</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> % </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3.85</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> % </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Finance leases </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3.54</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> % </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">3.42</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> % </td></tr> </tbody></table> Supplemental cash flow and other information related to leases were as follows (in thousands): <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 36pt;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 52%;"> Cash paid for amounts included in the measurement of lease liabilities: </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Operating cash flows from operating leases </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">563</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">680</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">596</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Operating cash flows from finance leases </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">18</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">34</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">36</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Financing cash flows from finance leases </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">469</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">493</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">332</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> ROU assets obtained in exchange for operating lease liabilities </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">83</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">560</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">276</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> ROU assets obtained in exchange for finance lease liabilities </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">40</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">817</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> Undiscounted payments under non-cancelable finance and operating leases at December 31, 2022 were as follows (in thousands): <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 36pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Finance Leases </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Operating Leases </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 68%;"> 2023 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">315</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">547</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> 2024 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">23</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">227</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> 2025 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">11</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">118</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> 2026 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">10</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> 2027 </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Thereafter </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total minimum lease payments </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">359</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">892</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr class="GFJY4-DFU-com-rdg-thunderdome-client-resources-CssResource-html-lineItem-v2v-addition" style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Less: Amount representing interest </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">9</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">37</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Present value of minimum lease payments </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">350</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">855</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Less: Current portion </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">311</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">522</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Lease obligations, net of current portion </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">39</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 13%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">333</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> Undiscounted cash receipts due under the sublease agreement at December 31, 2022 are as follows (in thousands): <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 36pt;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> Operating Lease </td> <td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt; width: 83%;"> 2023 </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">122</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> 2024 </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">127</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> 2025 </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">65</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman"; font-size: 10pt;"> Total minimum lease receipts </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">314</td> <td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody> </table>

P3Y11M4D

527000

669000

600000

462000

489000

355000

19000

34000

37000

95000

99000

62000

87000

59000

42000

123000

81000

-0

1067000

1269000

1096000

556000

975000

522000

493000

333000

820000

855000

1313000

1042000

659000

207000

1908000

1537000

1074000

371000

834000

311000

470000

39000

348000

350000

818000

P1Y11M12D

P2Y9M18D

P1Y1M24D

P1Y11M4D

0.0397

0.0385

0.0354

0.0342

563000

680000

596000

18000

34000

36000

469000

493000

332000

83000

560000

276000

40000

817000

315000

547000

23000

227000

11000

118000

10000

359000

892000

9000

37000

350000

855000

311000

522000

39000

333000

122000

127000

65000

314000

196000

1700000

278000

248000

1100000

35000

294000

0.250

0.060

0.20

588000

531000

521000

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 15%; width: 85%; font-size: 10pt; font-family: "Times New Roman"; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2022 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2021 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> 2020 </td><td style="font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt; width: 46%;"> Revenue: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> United States </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">150,775</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">144,987</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">130,305</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Canada </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">793</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,967</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,972</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">151,568</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">147,954</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">133,277</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Long-lived assets: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> United States </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">86,718</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">83,722</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">77,448</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Canada </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">27</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">111</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,863</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">86,745</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">83,833</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">79,311</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total assets: </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="font-family: "Times New Roman"; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> United States </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">130,151</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">153,879</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;">128,319</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Canada </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">310</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,661</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">5,104</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: "Times New Roman"; font-size: 10pt;"> Total </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">130,461</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">157,540</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt;"> </td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 15%; text-align: right; font-family: "Times New Roman"; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">133,423</td><td style="width: 1%; font-family: "Times New Roman"; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table>

150775000

144987000

130305000

793000

2967000

2972000

151568000

147954000

133277000

86718000

83722000

77448000

27000

111000

1863000

86745000

83833000

79311000

130151000

153879000

128319000

310000

3661000

5104000

130461000

157540000

133423000

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�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

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2022	Feb. 23, 2023	Jun. 30, 2022
Document Information [Line Items]
Entity Central Index Key	0000070487
Entity Registrant Name	National Research Corporation
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	001-35929
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-0634000
Entity Address, Address Line One	1245 Q Street
Entity Address, City or Town	Lincoln
Entity Address, State or Province	NE
Entity Address, Postal Zip Code	68508
City Area Code	402
Local Phone Number	475-2525
Title of 12(b) Security	Common Stock, $.001 par value
Trading Symbol	NRC
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 444,018,792
Entity Common Stock, Shares Outstanding		24,594,390
Auditor Name	KPMG LLP
Auditor Firm ID	1997
Auditor Location	Lincoln, Nebraska